**Current stage:** Gate H–K COMPLETE / PASS / CLOSED; Program A COMPLETE / PASS / CLOSED; Program B COMPLETE / PASS / CLOSED; Program C master plan FROZEN; C0 is the only authorized next checkpoint; branch remains UNMERGED / NOT PRODUCTION OPERATIONAL; Program D and productionization NOT AUTHORIZED.



---

## K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `industrialsK4bScoringMethodology.ts`;
- `industrialsK4bScoringMethodology.test.ts`;
- `industrialsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_2_INDUSTRIALS_CAPITAL_GOODS_CHECKPOINT_B.md`;
- canonical router extended for PROJECT_EPC / CAPITAL_EQUIPMENT_ELECTRICAL / DEFENCE_AEROSPACE;
- registry maps all three profiles to INDUSTRIALS_CAPITAL_GOODS in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct growth and cash-flow contracts for EPC, capital equipment and defence;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 2 · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 2 failed tests and 49 passed.

Both failures were stale expectations created by legitimate prior state transitions:

1. `industrialsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED` after Checkpoint A had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.
2. `scoringProfileResolution.test.ts` still expected completed `IT_TECH` to fail closed to GENERAL. IT_TECH is now an implemented engine identity, so profile resolution correctly returns `IT_TECH` with `SECTOR_RULE`; its legacy ruleProfile remains GENERAL because specialised IT scoring is separately owned by the read-only K4B authority rather than the old GENERAL-derived database scaffold.

Only the tests were corrected. No runtime methodology, classification, score, recommendation, persistence, provider, scheduler, deployment or production behavior was changed.

Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = PROJECT_EPC / CAPITAL_EQUIPMENT_ELECTRICAL / DEFENCE_AEROSPACE;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- working-capital/cash-conversion evidence remains mandatory;
- PHARMA_V1 / BANK_NBFC / IT_TECH isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS = COMPLETE / PASS / CLOSED.**

K4 Package 3 — AUTO_COMPONENTS Checkpoint A is now IN PROGRESS.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A implementation — 22 September 2026

INDUSTRIALS_CAPITAL_GOODS is closed COMPLETE / PASS.

Added:
- `autoComponentsK4aMethodologyContract.ts`;
- `autoComponentsK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_3_AUTO_COMPONENTS_CHECKPOINT_A.md`.

Proposed subprofiles:
1. AUTO_OEM — M&M and TVSMOTOR references;
2. AUTO_COMPONENTS — MOTHERSON and SONACOMS references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- OEM and component economics remain separate;
- EV transition is exposure/risk/durability metadata, not an automatic third score;
- minimum 3 annual years / 8 quarters / 252 trading days;
- cash conversion and ROCE/ROIC are mandatory;
- capex-cycle context is mandatory;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 2 failed tests and 24 passed.

Both failures were stale registry expectations after the legitimate closure of earlier K4 packages:

1. the registry test still expected 9 packages in `K4_FROZEN_PENDING`; after IT_TECH and INDUSTRIALS_CAPITAL_GOODS are implemented, the correct count is 8;
2. the registry test still expected `PROJECT_EPC` to belong to a pending Industrials engine; INDUSTRIALS_CAPITAL_GOODS is now implemented, so the correct lifecycle is `IMPLEMENTED`.

Only regression expectations were updated. No AUTO methodology, routing, scoring, recommendation, production, persistence, provider, scheduler or deployment behavior changed.

AUTO_COMPONENTS Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A FINAL — 22 September 2026

Owner-local contract tests and TypeScript passed completely and the owner approved proceeding.

`AUTO_COMPONENTS_K4A_METHODOLOGY_V1` is now frozen with two subprofiles:
- AUTO_OEM;
- AUTO_COMPONENTS.

EV transition remains exposure/risk/durability metadata rather than a separate score.

Runtime activation remains OFF until Checkpoint B portability/isolation validation passes.

**AUTO_COMPONENTS Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `autoComponentsK4bScoringMethodology.ts`;
- `autoComponentsK4bScoringMethodology.test.ts`;
- `autoComponentsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_3_AUTO_COMPONENTS_CHECKPOINT_B.md`;
- canonical router extended for AUTO_OEM / AUTO_COMPONENTS coverage including tractors/farm equipment and tyres/rubber products;
- registry maps both profiles to AUTO_COMPONENTS in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct OEM vs component growth contracts;
- EV transition remains durability/risk metadata and never creates a second score;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- completed INDUSTRIALS_CAPITAL_GOODS preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 50 passed.

The single failure was a stale Checkpoint A expectation:
- `autoComponentsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED`;
- the contract had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.

Only the regression expectation was updated. No AUTO routing, scoring methodology, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

AUTO_COMPONENTS Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 3 · AUTO_COMPONENTS FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = AUTO_OEM / AUTO_COMPONENTS;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- EV transition = durability/risk/exposure metadata only;
- PHARMA_V1 / BANK_NBFC / IT_TECH / INDUSTRIALS_CAPITAL_GOODS isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 3 · AUTO_COMPONENTS = COMPLETE / PASS / CLOSED.**

K4 Package 4 — CHEMICALS_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A implementation — 22 September 2026

AUTO_COMPONENTS is closed COMPLETE / PASS.

Added:
- `chemicalsK4aMethodologyContract.ts`;
- `chemicalsK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_4_CHEMICALS_CHECKPOINT_A.md`.

Proposed subprofiles:
1. SPECIALTY_CHEMICALS — PIIND / SRF references; VINATIORGA control;
2. AGRO_FERTILISER — PIIND / DEEPAKFERT references;
3. COMMODITY_PROCESS_CHEMICALS — SRF / DEEPAKFERT references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- minimum 3 annual years / 8 quarters / 252 trading days;
- cycle-normalised growth, margin and ROCE interpretation;
- capacity/utilisation must be reconciled with return on capital;
- feedstock/global pricing context mandatory where material;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 2 failed tests and 24 passed.

Both failures were stale registry lifecycle expectations after AUTO_COMPONENTS was legitimately promoted to IMPLEMENTED:
1. pending K4 package count was still hard-coded as 8, but the correct current count is 7;
2. AUTO_OEM was still expected to belong to a pending AUTO_COMPONENTS engine, while AUTO_COMPONENTS is now IMPLEMENTED.

To prevent the same avoidable failure after every subsequent K4 package, the registry lifecycle test was improved rather than merely changing 8 → 7:
- total registry entries must remain 12;
- excluding inherited PHARMA_V1 and BANK_NBFC, exactly 10 K4 packages must exist;
- each K4 package must be either IMPLEMENTED or K4_FROZEN_PENDING.

AUTO_OEM lifecycle expectation was updated to IMPLEMENTED.

No Chemicals methodology, routing, scoring, recommendation, persistence, provider, production, scheduler or deployment behavior changed.

CHEMICALS_V1 Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local contract tests and TypeScript passed completely and the owner approved proceeding.

`CHEMICALS_V1_K4A_METHODOLOGY_V1` is now frozen with three subprofiles:
- SPECIALTY_CHEMICALS;
- AGRO_FERTILISER;
- COMMODITY_PROCESS_CHEMICALS.

Runtime activation remains OFF until Checkpoint B portability/isolation validation passes.

**CHEMICALS_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `chemicalsK4bScoringMethodology.ts`;
- `chemicalsK4bScoringMethodology.test.ts`;
- `chemicalsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_4_CHEMICALS_CHECKPOINT_B.md`;
- canonical router extended for SPECIALTY_CHEMICALS / AGRO_FERTILISER / COMMODITY_PROCESS_CHEMICALS;
- registry maps all three profiles to CHEMICALS_V1 in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct growth contracts for specialty, agro/fertiliser and commodity/process chemicals;
- cycle normalization required;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- completed INDUSTRIALS_CAPITAL_GOODS preserved;
- completed AUTO_COMPONENTS preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 51 passed.

The single failure was a stale Checkpoint A expectation:
- `chemicalsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED`;
- the contract had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.

Only the regression expectation was updated. No Chemicals routing, scoring methodology, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

CHEMICALS_V1 Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 4 · CHEMICALS_V1 FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = SPECIALTY_CHEMICALS / AGRO_FERTILISER / COMMODITY_PROCESS_CHEMICALS;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- cycle normalization = mandatory;
- PHARMA_V1 / BANK_NBFC / prior K4 engine isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 4 · CHEMICALS_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 5 — HEALTHCARE_SERVICES_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A implementation — 22 September 2026

CHEMICALS_V1 is closed COMPLETE / PASS.

Added:
- `healthcareServicesK4aMethodologyContract.ts`;
- `healthcareServicesK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_5_HEALTHCARE_SERVICES_CHECKPOINT_A.md`.

Initial scope intentionally contains one subprofile:
- HOSPITAL_OPERATORS — MAXHEALTH / NH / MEDANTA / YATHARTH references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- diagnostics are explicitly excluded from hospital scoring and must fail review pending separate methodology authority;
- minimum 3 annual years / 8 quarterly observations / 252 trading days;
- hospital operating evidence includes occupancy, ARPOB/equivalent and bed-ramp context where disclosed;
- bed additions must reconcile with ramp and ROCE;
- cash conversion must reconcile with capex/receivables;
- unknown/non-hospital Healthcare identity → METHOD_NOT_AVAILABLE / review;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 1 failed test and 26 passed.

The single failure was a stale registry lifecycle expectation:
- `SPECIALTY_CHEMICALS` was still expected to belong to CHEMICALS_V1 with lifecycle `K4_FROZEN_PENDING`;
- CHEMICALS_V1 had already been closed and promoted to `IMPLEMENTED`.

Only the regression expectation was updated. No Healthcare Services methodology, routing, scoring, recommendation, persistence, provider, production, scheduler or deployment behavior changed.

HEALTHCARE_SERVICES_V1 Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed. The hospital-only initial methodology is frozen.

From this checkpoint onward, K4 regression tests must avoid stale lifecycle assumptions:
- completed engines are asserted as IMPLEMENTED;
- only the active package may be K4_FROZEN_PENDING;
- package-count invariants remain dynamic;
- no test may retain a pre-approval or pre-closure expected state after the state transition is committed.

**HEALTHCARE_SERVICES_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `healthcareServicesK4bScoringMethodology.ts`;
- `healthcareServicesK4bScoringMethodology.test.ts`;
- `healthcareServicesK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_5_HEALTHCARE_SERVICES_CHECKPOINT_B.md`;
- registry maps `HOSPITAL` to HEALTHCARE_SERVICES_V1 in validation-pending state;
- diagnostics remain deliberately unmapped from the hospital engine.

Deterministic scoring:
- ten dimensions totaling 100;
- hospital-specific operating durability evidence;
- no missing-input renormalization;
- diagnostics → REVIEW_REQUIRED / separate methodology required;
- symbol-independent methodology;
- score/recommendation persistence remain OFF.

Regression policy improvement:
- the current package test is lifecycle-stable and valid both before and after promotion;
- no stale pre-approval/pre-closure expectation is intentionally carried into this B suite;
- completed packages are asserted only in their durable IMPLEMENTED state.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- IT_TECH / INDUSTRIALS_CAPITAL_GOODS / AUTO_COMPONENTS / CHEMICALS_V1 preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint B precision correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 52 passed.

The failure was not a stale lifecycle expectation and not a methodology error. JavaScript floating-point arithmetic produced `73.99999999999999` for a weighted score that is mathematically 74.

Correction:
- deterministic K4B scorers now apply a stable output rounding step with `Number(value.toFixed(6))` to the final weighted overall score;
- the same stable precision rule was applied proactively to IT_TECH, INDUSTRIALS_CAPITAL_GOODS, AUTO_COMPONENTS and CHEMICALS_V1 scorers to prevent the same numerical artifact from recurring.

No weights, dimensions, methodology, evidence rules, routing, recommendation logic, persistence, provider behavior, production behavior, scheduler or deployment behavior changed.

HEALTHCARE_SERVICES_V1 Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported authority = HOSPITAL;
- diagnostics remain deliberately outside hospital scoring;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- PHARMA_V1 / BANK_NBFC / prior K4 engine isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- stable weighted-score precision = 6 decimals;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 5 · HEALTHCARE_SERVICES_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 6 — FIN_SERVICES_NON_LENDER Checkpoint A is now IN PROGRESS.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint A implementation — 22 September 2026

HEALTHCARE_SERVICES_V1 is closed COMPLETE / PASS.

Added:
- `finServicesNonLenderK4aMethodologyContract.ts`;
- `finServicesNonLenderK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_6_FIN_SERVICES_NON_LENDER_CHECKPOINT_A.md`.

Proposed mandatory subprofiles:
1. CAPITAL_MARKETS_AMC — NAM-INDIA / HDFCAMC / ANGELONE / CAMS;
2. INSURANCE — STARHEALTH;
3. FINTECH_PLATFORM — PAYTM / POLICYBZR.

Key methodology locks proposed:
- non-lender Financial Services must not inherit BANK_NBFC lender metrics or thresholds;
- no NPA / CET1 / deposit-growth methodology leakage;
- Nifty Bank is not a benchmark authority for this package;
- subprofile-specific evidence and valuation are mandatory;
- insurance claims/reserving evidence cannot be replaced by generic margins;
- fintech growth cannot override cash burn/unit economics;
- cross-subprofile peer percentiles prohibited;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active for this package and subsequent K4 packages.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed. The three-subprofile non-lender Financial Services methodology is frozen.

Frozen subprofiles:
- CAPITAL_MARKETS_AMC;
- INSURANCE;
- FINTECH_PLATFORM.

Hard separation from BANK_NBFC remains mandatory.

**FIN_SERVICES_NON_LENDER Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `finServicesNonLenderK4bScoringMethodology.ts`;
- `finServicesNonLenderK4bScoringMethodology.test.ts`;
- `finServicesNonLenderK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_6_FIN_SERVICES_NON_LENDER_CHECKPOINT_B.md`;
- canonical router now uses CAPITAL_MARKETS_AMC / INSURANCE / FINTECH_PLATFORM;
- NBFC_LENDING remains separate under BANK_NBFC;
- registry maps all three non-lender profiles to FIN_SERVICES_NON_LENDER in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- subprofile-specific evidence contracts;
- no missing-input renormalization;
- no lender-metric inheritance;
- symbol-independent methodology;
- unknown/lender Industry → METHOD_NOT_AVAILABLE for this engine.

Regression policy:
- Checkpoint A test was proactively aligned before B validation;
- current-package isolation is lifecycle-stable before/after promotion;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 and BANK_NBFC isolated;
- K4 Packages 1–5 preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint B routing regression correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 53 passed.

The failure was a legacy profile-code expectation in `researchProfileRouting.test.ts`:
- old expected `CAPITAL_MARKET_FINANCIAL` while the frozen Package 6 profile is `CAPITAL_MARKETS_AMC`;
- old expected `DIGITAL_PLATFORM` while the frozen Package 6 profile is `FINTECH_PLATFORM`.

Only the regression expectations were updated to the frozen K4 profile identities. No routing logic, scoring methodology, lender separation, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

FIN_SERVICES_NON_LENDER Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = CAPITAL_MARKETS_AMC / INSURANCE / FINTECH_PLATFORM;
- lender methodology inheritance = prohibited;
- NBFC_LENDING remains under BANK_NBFC;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- six-decimal stable weighted score precision retained;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 6 · FIN_SERVICES_NON_LENDER = COMPLETE / PASS / CLOSED.**

K4 Package 7 — METALS_COMMODITIES Checkpoint A is now IN PROGRESS.


---

## K4 Package 7 · METALS_COMMODITIES · Checkpoint A implementation — 22 September 2026

FIN_SERVICES_NON_LENDER is closed COMPLETE / PASS.

Added:
- `metalsCommoditiesK4aMethodologyContract.ts`;
- `metalsCommoditiesK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_7_METALS_COMMODITIES_CHECKPOINT_A.md`.

K1 open question resolved:
- METALS_COMMODITIES requires two methodology curves:
  1. STEEL_FERROUS — JINDALSTEL reference;
  2. NON_FERROUS_DIVERSIFIED_METALS — HINDALCO / HINDZINC references.

Key locks proposed:
- commodity exposure metadata mandatory;
- minimum 5 annual years / 12 quarters / 252 trading days;
- through-cycle normalization mandatory;
- cost curve/input integration context mandatory;
- leverage assessed at mid-cycle;
- spot P/E cannot be the sole valuation anchor;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 7 · METALS_COMMODITIES · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`METALS_COMMODITIES_K4A_METHODOLOGY_V1` is frozen with:
- STEEL_FERROUS;
- NON_FERROUS_DIVERSIFIED_METALS.

**METALS_COMMODITIES Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 7 · METALS_COMMODITIES · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `metalsCommoditiesK4bScoringMethodology.ts`;
- `metalsCommoditiesK4bScoringMethodology.test.ts`;
- `metalsCommoditiesK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_7_METALS_COMMODITIES_CHECKPOINT_B.md`;
- canonical router extended for STEEL_FERROUS / NON_FERROUS_DIVERSIFIED_METALS;
- registry maps both profiles to METALS_COMMODITIES in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory commodity exposure metadata readiness gate;
- through-cycle normalization;
- mid-cycle leverage assessment;
- distinct steel vs non-ferrous growth contracts;
- spot P/E cannot be sole valuation anchor;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–6 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 7 · METALS_COMMODITIES FINAL CLOSURE — 22 September 2026

Owner-local Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = STEEL_FERROUS / NON_FERROUS_DIVERSIFIED_METALS;
- commodity-exposure metadata = mandatory readiness gate;
- through-cycle normalization = mandatory;
- spot P/E as sole valuation anchor = prohibited;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 7 · METALS_COMMODITIES = COMPLETE / PASS / CLOSED.**

K4 Package 8 — CONSUMER_FMCG Checkpoint A is now IN PROGRESS.


---

## K4 Package 8 · CONSUMER_FMCG · Checkpoint A implementation — 22 September 2026

METALS_COMMODITIES is closed COMPLETE / PASS.

Added:
- `consumerFmcgK4aMethodologyContract.ts`;
- `consumerFmcgK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_8_CONSUMER_FMCG_CHECKPOINT_A.md`.

Initial profile:
- BRANDED_CONSUMER_FMCG.

Reference anchors:
- HINDUNILVR;
- VBL;
- LTFOODS;
- RADICO as alcohol-specific risk control.

Key methodology locks proposed:
- one initial branded/staples curve per K1;
- Industry selects methodology; Sector alone cannot;
- product/category metadata mandatory;
- alcohol excise/regulatory exposure is explicit risk metadata, not a separate universal score curve;
- minimum 3 annual years / 8 quarters / 252 trading days;
- volume/price/mix context where disclosed;
- raw-material inflation read with margin history;
- working capital and cash conversion are core evidence;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain profile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 8 · CONSUMER_FMCG · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`CONSUMER_FMCG_K4A_METHODOLOGY_V1` is frozen with one initial profile:
- BRANDED_CONSUMER_FMCG.

Product/category metadata remains mandatory. Alcohol remains an excise/regulatory risk variant rather than a separate universal score curve.

**CONSUMER_FMCG Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 8 · CONSUMER_FMCG · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `consumerFmcgK4bScoringMethodology.ts`;
- `consumerFmcgK4bScoringMethodology.test.ts`;
- `consumerFmcgK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_8_CONSUMER_FMCG_CHECKPOINT_B.md`;
- canonical router extended for BRANDED_CONSUMER_FMCG;
- registry maps the profile to CONSUMER_FMCG in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory PRODUCT_CATEGORY_METADATA readiness gate;
- one branded/staples scoring curve per K1;
- alcohol remains explicit excise/regulatory risk metadata, not a separate universal curve;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–7 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 8 · CONSUMER_FMCG FINAL CLOSURE — 22 September 2026

Owner-local Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported profile = BRANDED_CONSUMER_FMCG;
- product/category metadata = mandatory readiness gate;
- alcohol = explicit excise/regulatory risk metadata, not a separate score curve;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 8 · CONSUMER_FMCG = COMPLETE / PASS / CLOSED.**

K4 Package 9 — OIL_GAS_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 9 · OIL_GAS_V1 · Checkpoint A implementation — 22 September 2026

CONSUMER_FMCG is closed COMPLETE / PASS.

Added:
- `oilGasK4aMethodologyContract.ts`;
- `oilGasK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_9_OIL_GAS_CHECKPOINT_A.md`.

Mandatory K1 subprofiles preserved:
1. UPSTREAM_E_AND_P — ONGC;
2. MIDSTREAM_CITY_GAS — GAIL / MGL / IGL;
3. INTEGRATED_REFINING_PETCHEM — RELIANCE as mixed-business control, not sole authority.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- minimum 5 annual years / 12 quarterly cycle observations / 252 trading days;
- commodity and refining-cycle normalization mandatory;
- reserve/volume/throughput context required by subprofile;
- administered pricing/tax context required where material;
- energy-transition risk explicit;
- mixed-business controls cannot override pure-play economics;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 9 · OIL_GAS_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`OIL_GAS_V1_K4A_METHODOLOGY_V1` is frozen with:
- UPSTREAM_E_AND_P;
- MIDSTREAM_CITY_GAS;
- INTEGRATED_REFINING_PETCHEM.

**OIL_GAS_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 9 · OIL_GAS_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `oilGasK4bScoringMethodology.ts`;
- `oilGasK4bScoringMethodology.test.ts`;
- `oilGasK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_9_OIL_GAS_CHECKPOINT_B.md`;
- canonical router extended for UPSTREAM_E_AND_P / MIDSTREAM_CITY_GAS / INTEGRATED_REFINING_PETCHEM;
- registry maps all three profiles to OIL_GAS_V1 in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory SUBPROFILE_OPERATING_CONTEXT readiness gate;
- through-cycle commodity/refining normalization;
- distinct subprofile growth contracts;
- RELIANCE remains a mixed-business control, not sole methodology authority;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- completed engines are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–8 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 9 · OIL_GAS_V1 FINAL CLOSURE — 22 September 2026

Owner-local Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = UPSTREAM_E_AND_P / MIDSTREAM_CITY_GAS / INTEGRATED_REFINING_PETCHEM;
- mandatory operating-context readiness gate retained;
- commodity/refining-cycle normalization mandatory;
- RELIANCE remains mixed-business control rather than sole authority;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 9 · OIL_GAS_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 10 — POWER_RENEWABLES_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 10 · POWER_RENEWABLES_V1 · Checkpoint A implementation — 22 September 2026

OIL_GAS_V1 is closed COMPLETE / PASS.

Added:
- `powerRenewablesK4aMethodologyContract.ts`;
- `powerRenewablesK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_10_POWER_RENEWABLES_CHECKPOINT_A.md`.

Mandatory K1 subprofiles preserved:
1. REGULATED_NETWORK — POWERGRID;
2. GENERATION_INTEGRATED_UTILITY — TATAPOWER / NHPC;
3. RENEWABLE_IPP — ACMESOLAR / KPIGREEN subject to identity review.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- minimum 5 annual years / 12 operating quarters / 252 trading days;
- tariff/regulatory context required where material;
- fuel/resource variability normalized for generation;
- PPA/offtaker/DISCOM quality required for contracted assets;
- leverage and refinancing sensitivity are core evidence;
- capacity growth cannot override cash-flow/execution weakness;
- transmission/grid-evacuation constraints are explicit risks;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 10 · POWER_RENEWABLES_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed completely.

`POWER_RENEWABLES_V1_K4A_METHODOLOGY_V1` is frozen with:
- REGULATED_NETWORK;
- GENERATION_INTEGRATED_UTILITY;
- RENEWABLE_IPP.

**POWER_RENEWABLES_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 10 · POWER_RENEWABLES_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `powerRenewablesK4bScoringMethodology.ts`;
- `powerRenewablesK4bScoringMethodology.test.ts`;
- `powerRenewablesK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_10_POWER_RENEWABLES_CHECKPOINT_B.md`;
- canonical router extended for REGULATED_NETWORK / GENERATION_INTEGRATED_UTILITY / RENEWABLE_IPP;
- registry maps all three profiles to POWER_RENEWABLES_V1 in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- six-decimal stable weighted output;
- mandatory TARIFF_PPA_OFFTAKER_GRID_CONTEXT readiness gate;
- distinct regulated-network / generation-utility / renewable-IPP growth contracts;
- leverage/refinancing is core evidence;
- project/grid/offtaker risk cannot be bypassed by capacity growth;
- symbol-independent methodology;
- missing mandatory evidence fails closed.

Regression policy:
- Checkpoint A test aligned before B validation;
- current-package isolation is lifecycle-stable;
- Packages 1–9 are asserted only as IMPLEMENTED;
- no hard-coded shrinking pending-package count.

Incremental controls:
- PHARMA_V1 / BANK_NBFC and K4 Packages 1–9 isolated/preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion and formal K4 closure occur only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 10 · POWER_RENEWABLES_V1 FINAL CLOSURE — 22 September 2026

Owner-local final Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = REGULATED_NETWORK / GENERATION_INTEGRATED_UTILITY / RENEWABLE_IPP;
- tariff/PPA/offtaker/grid context = mandatory readiness gate;
- leverage/refinancing = core evidence;
- capacity growth cannot bypass cash-flow, execution, counterparty or grid-risk evidence;
- symbol-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 10 · POWER_RENEWABLES_V1 = COMPLETE / PASS / CLOSED.**

---

## Gate K4 FINAL CLOSURE — 22 September 2026

All ten K4 packages are now COMPLETE / PASS / CLOSED:

1. IT_TECH
2. INDUSTRIALS_CAPITAL_GOODS
3. AUTO_COMPONENTS
4. CHEMICALS_V1
5. HEALTHCARE_SERVICES_V1
6. FIN_SERVICES_NON_LENDER
7. METALS_COMMODITIES
8. CONSUMER_FMCG
9. OIL_GAS_V1
10. POWER_RENEWABLES_V1

K4 global invariants preserved:
- Industry is the minimum micro-methodology selector;
- Sector is macro context only;
- no ticker-specific runtime methodology;
- no missing-input renormalization;
- no cross-subprofile leakage;
- deterministic read-only scoring;
- golden Pharma controls preserved;
- universal Research shell preserved;
- no score persistence;
- no recommendation persistence;
- no provider calls during K4 builds;
- no production mutation/migration;
- no scheduler change;
- no deployment;
- PR #101 remains OPEN / DRAFT / UNMERGED;
- no automatic trading.

**Gate K4 = COMPLETE / PASS / CLOSED.**

Next planned stage: **K5 — whole-portfolio coexistence and routing validation**.


---

## Gate K5 · Cross-Sector Isolation & Whole-Portfolio Validation implementation — 22 September 2026

Gate K4 is closed COMPLETE / PASS.

K5 implementation added:
- `k5CrossSectorValidation.ts`;
- `k5CurrentPortfolioRoutingSnapshot.ts` containing the frozen 238-equity K1 routing fixture;
- `k5CrossSectorIsolation.test.ts`;
- `k5WholePortfolioRouting.test.ts`;
- `k5RecommendationPortability.test.ts`;
- `docs/PortfolioAI_GATE_K_K5_CROSS_SECTOR_WHOLE_PORTFOLIO_VALIDATION.md`.

K5 validation design:
- registry-driven complete ordered pairwise engine isolation matrix;
- unique profile ownership;
- foreign methodology/benchmark/valuation/recommendation authority retrieval prohibited;
- all ten K4 engines required to remain IMPLEMENTED;
- every frozen current-portfolio row required to end in an explicit research architecture state;
- synthetic future-stock portability fixture for every currently SUPPORTED profile;
- unsupported sectors → METHODOLOGY_NOT_AVAILABLE;
- missing/conflicting classification → REVIEW_REQUIRED;
- no nearest-looking sector fallback;
- pending NBFC_LENDING and DIAGNOSTICS remain fail-closed;
- universal Research shell preserved;
- TORNTPHARM/AUROPHARMA golden controls preserved.

Recommendation portability study:
- universal semantics remain portable;
- numeric threshold portability = NOT_ESTABLISHED;
- pre-declared falsification tests encoded before any future portability claim;
- K5 introduces NO universal numeric recommendation thresholds;
- sector/profile-specific numeric policy still requires evidence and owner approval.

Safety unchanged:
- provider calls = 0;
- production mutation/migration = NO;
- score/recommendation persistence = OFF;
- position sizing = OFF;
- scheduler changes = NO;
- deployment = NO;
- PR merge = NO;
- automatic trading = NO.

**K5 status = IMPLEMENTED / LOCAL VALIDATION PENDING.**


---

## Gate K5 · Consolidated validation checkpoint — 22 September 2026

Current K5 candidate implementation was audited against the canonical Gate K plan before any additional methodology work.

Audit result:
- K5 is correctly implemented as a confirmation gate, not a methodology-building gate;
- 12 registered engine families imply 132 ordered pairwise isolation checks;
- methodology / benchmark / valuation / recommendation authority lookups are registry-owned and cross-engine lookup fails closed;
- every frozen K1 portfolio row is required to resolve to SUPPORTED_ENGINE / METHODOLOGY_NOT_AVAILABLE / REVIEW_REQUIRED / NOT_APPLICABLE;
- supported future-stock routing is classification-driven rather than ticker-driven;
- NBFC_LENDING and DIAGNOSTICS remain intentionally fail-closed pending dedicated authority;
- universal Research shell continuity is explicitly asserted;
- recommendation universal semantics are retained while numeric-threshold portability remains NOT_ESTABLISHED;
- pre-declared portability falsification tests are encoded before any future universal-threshold claim;
- no universal numeric recommendation threshold was introduced.

Consolidation improvement:
- added `scripts/k5-validate-cross-sector.sh`;
- this is now the single owner-local K5 closure command;
- it runs the full K5 isolation, routing, recommendation-portability, registry, profile-routing, scoring-resolution, K2 recommendation-safety, Research-workspace regression set, then TypeScript;
- no stale pre-approval / pre-promotion lifecycle assertion was added.

CI observation:
- initial K5 GitHub Architecture Guard run ended before any job step was created/executed, so it does not demonstrate a K5 test failure;
- separate Vercel status failed on a build-rate-limit condition;
- no runtime methodology or safety change was made in response.

Safety remains unchanged:
- provider calls = 0;
- production mutation/migration = NO;
- score persistence = OFF;
- recommendation persistence = OFF;
- position sizing = OFF;
- scheduler changes = NO;
- deployment = NO;
- PR merge = NO;
- automatic trading = NO.

**K5 status remains IMPLEMENTED / LOCAL VALIDATION PENDING.**

Required owner-local closure command:

```bash
git pull
bash scripts/k5-validate-cross-sector.sh
```


---

## Gate K5 · Chat rollover checkpoint — 22 September 2026

The owner explicitly instructed that K5 is now to be executed and supplied the canonical Gate K plan for continuity.

Canonical K5 scope reaffirmed:
- K5 is a confirmation gate, not a new methodology-building stage;
- complete registry-driven cross-sector isolation must be validated;
- every registered engine pair must remain isolated for methodology, benchmark, valuation, durability/recommendation authority and fallback behavior;
- future supported stocks must route by canonical classification without ticker-specific logic;
- unsupported sectors must fail safely to METHODOLOGY_NOT_AVAILABLE;
- conflicting or missing canonical classification must fail to REVIEW_REQUIRED rather than use a nearest-looking fallback;
- the universal Research workspace must remain shared across all engines;
- recommendation-policy portability must be evaluated using pre-declared falsification tests rather than assumed.

Current K5 repository state at chat rollover:
- K5 implementation is already present;
- consolidated K5 validation script exists at `scripts/k5-validate-cross-sector.sh`;
- frozen 238-equity K1 routing snapshot is part of K5 validation;
- complete cross-sector isolation/routing/recommendation-portability tests are present;
- universal numeric recommendation-threshold portability remains NOT_ESTABLISHED;
- no new methodology or threshold policy was introduced during the latest inspection;
- no provider refresh was authorized or performed.

Current owner-local closure command remains:

```bash
git pull
bash scripts/k5-validate-cross-sector.sh
```

K5 must not be marked COMPLETE / PASS / CLOSED until that consolidated owner-local validation passes and the result is recorded.

Permanent safety boundaries remain:
- no production mutation/migration;
- no score persistence;
- no recommendation persistence;
- no provider refresh unless explicitly approved;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

PR #101 remains OPEN / DRAFT / UNMERGED.

**Current checkpoint: K5 IMPLEMENTED / LOCAL VALIDATION PENDING.**


---

## Gate K5 · First consolidated validation correction — 22 September 2026

Owner-local consolidated K5 validation result:
- 8 test files executed;
- 7 passed / 1 failed;
- 56 tests passed / 1 failed;
- the only failure was the synthetic future-stock portability case for `AUTO_OEM`.

Root cause:
- the K5 synthetic future-stock fixture used sector text `Automobile & Auto Components`;
- the frozen canonical routing identity is `Automobile and Auto Components`;
- the router correctly remained fail-closed because the synthetic fixture did not match the canonical classification key;
- the frozen 238-equity whole-portfolio routing test passed;
- the dedicated AUTO routing regression already passed;
- therefore this was a stale/non-canonical synthetic fixture, not a runtime methodology or routing defect.

Correction:
- updated only the two synthetic AUTO future-stock fixtures in `k5CrossSectorValidation.ts`;
- `AUTO_OEM` fixture now uses canonical sector `Automobile and Auto Components`;
- `AUTO_COMPONENTS` fixture now uses the same canonical sector identity;
- no router broadening was introduced;
- no methodology, benchmark, valuation, recommendation authority, lifecycle, persistence, provider, scheduler, deployment or production behavior changed.

K5 remains **IMPLEMENTED / LOCAL VALIDATION PENDING** until the consolidated suite is rerun.

Required rerun:

```bash
git pull
bash scripts/k5-validate-cross-sector.sh
```


---

## Gate K5 · FINAL CLOSURE — 22 September 2026

Owner-local consolidated K5 validation rerun passed completely after the non-canonical AUTO synthetic future-stock fixture was corrected.

Final K5 validation outcome:
- consolidated runner `scripts/k5-validate-cross-sector.sh` = PASS;
- cross-sector isolation = PASS;
- whole-portfolio routing = PASS;
- future-stock portability = PASS;
- recommendation portability study = PASS;
- registry regression = PASS;
- research profile routing = PASS;
- scoring profile resolution = PASS;
- K2 recommendation safety = PASS;
- universal Research workspace contract = PASS;
- TypeScript = PASS.

K5 exit conditions are satisfied:
- all 12 registered engine families coexist without methodology / benchmark / valuation / recommendation authority leakage;
- complete registry-driven ordered pairwise isolation passes;
- all ten K4 engines remain in durable IMPLEMENTED state;
- the frozen 238-equity K1 portfolio routing snapshot resolves only to explicit supported / unavailable / review / not-applicable architecture states;
- supported future stocks route by canonical classification without ticker-specific methodology;
- unsupported sectors fail safely to `METHODOLOGY_NOT_AVAILABLE`;
- missing/conflicting classification fails safely to `REVIEW_REQUIRED`;
- no nearest-looking fallback exists;
- the universal Research workspace contract remains intact;
- TORNTPHARM/AUROPHARMA golden controls remain stable;
- universal recommendation semantics are portable;
- universal numeric recommendation thresholds are NOT established as portable and must not be assumed;
- any future sector/profile-specific numeric recommendation authority still requires evidence and owner approval.

Permanent safety boundaries remain unchanged:
- no production mutation/migration;
- no score persistence;
- no recommendation persistence;
- no provider refresh unless explicitly approved;
- no position sizing activation;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

PR #101 remains OPEN / DRAFT / UNMERGED.

**Gate K5 = COMPLETE / PASS / CLOSED.**

Next and final hard-capped Gate K stage: **K-FINAL — Portfolio Sector-Coverage Closure**.


---

## Gate K-FINAL · Portfolio Sector-Coverage Closure implementation — 22 September 2026

K5 is closed COMPLETE / PASS.

K-FINAL has been implemented as the final Gate K confirmation/closure package only. No new methodology or threshold policy was introduced.

Added:
- `src/features/research/kFinalPortfolioCoverage.ts`;
- `src/features/research/kFinalPortfolioCoverage.test.ts`;
- `scripts/k-final-validate-portfolio-coverage.sh`;
- `docs/PortfolioAI_GATE_K_FINAL_PORTFOLIO_SECTOR_COVERAGE_CLOSURE.md`.

Portfolio-wide closure matrix:
- generated from the frozen 238-equity K1/K5 routing snapshot;
- every holding resolves to exactly one architecture state:
  - ARCHITECTURE_READY;
  - METHODOLOGY_NOT_AVAILABLE;
  - REVIEW_REQUIRED;
  - NOT_APPLICABLE;
- supported holdings are deliberately marked score/recommendation EVIDENCE_DEPENDENT rather than falsely claiming evidence completeness;
- unsupported methodology fails closed to SCORE_NOT_COMPUTABLE / RECOMMENDATION_NOT_COMPUTABLE;
- unresolved/conflicting classification remains REVIEW_REQUIRED.

K-FINAL acceptance coverage includes:
- explicit architecture state for every frozen current holding;
- no cross-sector methodology leakage;
- future-stock portability;
- universal Research workspace continuity;
- fail-closed missing evidence;
- N/A distinct from missing;
- recommendation safety;
- complete registry-driven isolation;
- stable Pharma golden controls;
- unsupported-sector fail-safe behavior;
- score persistence OFF;
- recommendation persistence OFF;
- position sizing OFF;
- Gate K AI interpretation activation OFF;
- production mutation/migration OFF;
- deployment OFF;
- PR merge OFF;
- automatic trading OFF.

Consolidated owner-local validation command:

```bash
git pull
bash scripts/k-final-validate-portfolio-coverage.sh
```

The K-FINAL suite is lifecycle-stable and does not reintroduce stale pre-approval/pre-promotion expectations.

Permanent safety boundaries remain unchanged:
- no production mutation/migration;
- no score persistence;
- no recommendation persistence;
- no provider refresh unless explicitly approved;
- no position sizing activation;
- no AI interpretation activation under Gate K;
- no portfolio mutation;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

**K-FINAL status = IMPLEMENTED / LOCAL VALIDATION PENDING.**

Gate K must not be marked COMPLETE / PASS until the consolidated K-FINAL command passes and the result is recorded.


---

## Gate K-FINAL · FINAL CLOSURE — 22 September 2026

Owner-local consolidated K-FINAL validation passed completely.

Final validation outcome:
- `scripts/k-final-validate-portfolio-coverage.sh` = PASS;
- K-FINAL portfolio coverage closure test = PASS;
- K5 cross-sector isolation = PASS;
- K5 whole-portfolio routing = PASS;
- K5 future-stock portability = PASS;
- K5 recommendation portability = PASS;
- K3 BANK_NBFC N/A semantics = PASS;
- K2 recommendation safety = PASS;
- Pharma read-only downstream safety = PASS;
- universal Research workspace regression = PASS;
- TypeScript = PASS.

Gate K final acceptance:
1. every frozen current holding has an explicit research-engine architecture state — PASS;
2. no stock silently inherits unrelated methodology — PASS;
3. supported sectors remain portable to future stocks — PASS;
4. all engines share the universal Research workspace — PASS;
5. missing mandatory evidence fails closed — PASS;
6. N/A remains distinct from missing — PASS;
7. recommendation safety semantics remain preserved — PASS;
8. cross-sector methodology isolation passes — PASS;
9. golden control outputs remain stable — PASS;
10. unsupported sectors safely report METHODOLOGY_NOT_AVAILABLE — PASS;
11. score persistence remains OFF — PASS;
12. recommendation persistence remains OFF — PASS;
13. position sizing remains OFF — PASS;
14. AI interpretation activation remains OFF under Gate K — PASS;
15. production mutation/migration remains OFF — PASS;
16. deployment remains OFF — PASS;
17. PR merge remains OFF — PASS;
18. automatic trading remains OFF — PASS.

Closure interpretation:
- portfolio classification + methodology architecture coverage is now complete/fail-closed;
- this does not claim all 238 holdings already have full evidence, computable scores or eligible recommendations;
- supported holdings may remain evidence-dependent;
- unsupported or unresolved holdings remain explicitly unavailable/review-required.

Permanent safety boundaries remain unchanged:
- no production mutation/migration;
- no provider refresh unless separately approved;
- no score persistence;
- no recommendation persistence;
- no position sizing activation;
- no AI interpretation activation under Gate K;
- no portfolio mutation;
- no scheduler changes;
- no deployment;
- no PR merge;
- no automatic trading.

**Gate K-FINAL = COMPLETE / PASS / CLOSED.**

**Gate K = COMPLETE / PASS.**

**Sector-specific research layer = PORTFOLIO COVERAGE COMPLETE.**

PR #101 remains OPEN / DRAFT / UNMERGED pending a separate explicit owner decision.


---

## Post-Gate-K architecture / roadmap audit — 23 September 2026

A detailed post-K reconciliation was completed against:
- PortfolioAI Master Blueprint;
- Research & Intelligence Architecture;
- Integration & Execution Plan;
- Requirements Register;
- living Development Status;
- R3/R4 routing plan;
- actual H→K implementation and closure records.

Audit document:
- `docs/PortfolioAI_POST_GATE_K_ARCHITECTURE_AND_ROADMAP_AUDIT.md`.

Primary conclusion:
- **no Gate L or Gate M is currently required or canonically defined**;
- creating L/M now would duplicate the existing R-roadmap and confuse methodology completion with evidence/execution breadth;
- Gate K has effectively superseded/completed the old **R4 generic sector/profile Research contract** objective.

What Gate K completed:
- portfolio-coverage/fail-closed research methodology architecture for the frozen Gate-K scope;
- 12 registered engine families;
- one universal Research workspace;
- industry/business-model methodology selection;
- future-stock portability;
- cross-sector isolation;
- unsupported/review-required fail-safe behavior;
- deterministic sector scoring methodology authorities;
- universal recommendation semantics, without assuming portable numeric thresholds.

What remains materially incomplete:
- R3 portfolio-wide fundamental/research evidence breadth;
- R5 portfolio-wide historical market evidence;
- R6 actual company-specific deterministic scoring execution;
- sector/profile numeric recommendation policy calibration where still pending;
- R7 recommendation + position-sizing rollout;
- R8 Core Health / Portfolio Fit / Risk / Exit engines;
- R9 Movement / meaningful-change detection;
- R10 Combined Action Center;
- R11 general scheduled maintenance;
- R12 optional AI Investment Committee.

Recommended consolidation:
- Program A = R3 + R5 Evidence Coverage;
- Program B = R6 + recommendation calibration + R7 Deterministic Portfolio Intelligence;
- Program C = R8 + R9 + R10 Portfolio Decision Engines;
- Program D = R11 + R12 Operations & Optional AI.

Immediate governance recommendation:
- do not add another large development chain to PR #101;
- PR #101 remains OPEN / DRAFT / UNMERGED and currently carries a very large accumulated scope;
- freeze the Gate-K handoff and decide PR #101 disposition before beginning Program A on a clean branch;
- production/provider execution remains separately approval-gated.

Living Development Status was reconciled to reflect:
- Gate K COMPLETE / PASS;
- old R4 objective superseded/completed by H→K;
- next substantive work = R3 + R5 breadth, not Gate L/M.

**Post-K roadmap status: AUDITED / RECONCILED / OWNER REVIEW PENDING.**


---

## Post-Gate-K canonical forthcoming action plan — 23 September 2026

Canonical plan created:
- `docs/PortfolioAI_POST_GATE_K_FORTHCOMING_ACTION_PLAN.md`.

This file is now the required roadmap reference before any new post-K Program begins.

Mandatory review rule:
- before Program A, B, C or D, review the forthcoming action plan;
- review this cumulative handoff;
- inspect the current branch/PR/runtime state;
- confirm prerequisites and stale assumptions;
- create a bounded Program-specific plan;
- obtain separate owner approval for any provider, production, persistence, scheduler, deployment or merge action.

Frozen post-K Program sequence:
- **Program A — Evidence Coverage = R3 + R5**;
- **Program B — Deterministic Portfolio Intelligence = R6 + recommendation calibration + R7**;
- **Program C — Portfolio Decision Engines = R8 + R9 + R10**;
- **Program D — Operations & Optional AI = R11 + R12**.

Gate L / Gate M:
- not currently required;
- not canonically defined;
- must not be created merely to rename the remaining R-roadmap;
- a new letter Gate is justified only by a genuinely new architecture problem.

Immediate prerequisite before Program A implementation:
- freeze Gate-K state;
- explicitly decide PR #101 disposition / branch strategy;
- start substantive Program A work on a clean post-K branch after that strategy is frozen.

Current statuses:
- Gate K = COMPLETE / PASS;
- Program A = NOT STARTED;
- Program B = NOT STARTED;
- Program C = NOT STARTED;
- Program D = NOT STARTED;
- PR #101 = OPEN / DRAFT / UNMERGED.

Permanent safety boundaries remain unchanged:
- no production mutation/migration without explicit approval;
- no provider execution without explicit approval;
- no broad Trendlyne cohort without explicit approval;
- no Angel One history backfill without explicit approval;
- no score/recommendation/sizing persistence without explicit approval;
- no scheduler activation;
- no portfolio mutation;
- no deployment;
- no PR merge;
- no automatic trading.

**Post-K forthcoming action plan = CREATED / CANONICAL / REQUIRED BEFORE EACH PROGRAM.**


---

## Post-K Reconciliation Checkpoint PKR-1 / PKR-1B — 23 September 2026

Purpose:
- reconcile the live Research scoring path and regression suite with the already-closed Gate-K fail-closed architecture before Program A begins;
- this checkpoint did not start Program A and did not change any financial scoring methodology.

Implementation commits:
- PKR-1: `412e3e36a6f435675d4293c4678c54d0b4acea8e`
- PKR-1B: `f22b4efc8607102c51abadd46c62f362fd837084`

### PKR-1 corrections

- TypeScript-safe optional access added to BANK/NBFC profile-authority regression tests;
- stale pre-closure K4 lifecycle tests updated to durable `IMPLEMENTED` expectations;
- unsupported/pending methodology no longer falls through to a scoreable `GENERAL` profile;
- missing/conflicting classification remains `REVIEW_REQUIRED`;
- unsupported/pending methodology becomes `METHODOLOGY_NOT_AVAILABLE`;
- fail-closed states short-circuit before scoring-model/evidence queries;
- Research UI shows explicit blocked state instead of a generic score preview;
- cached score snapshots cannot override a newer fail-closed state;
- `BANK_NBFC` family lifecycle remains intentionally `RECONCILIATION_REQUIRED` because BANK is supported while NBFC_LENDING remains `PENDING_METHODOLOGY`;
- no BANK benchmark/valuation/recommendation leakage into NBFC.

### PKR-1B final live-scoring reconciliation

A second issue was identified during ChatGPT diff audit: completed K4 engines still retained `ruleProfile = GENERAL`, which could have allowed legacy GENERAL numeric previews even though their Gate-K methodologies are sector-specific.

PKR-1B introduced an explicit separation:

```text
Methodology state
AVAILABLE
METHODOLOGY_NOT_AVAILABLE
REVIEW_REQUIRED

Score-execution state
AVAILABLE
PENDING_ADAPTER
BLOCKED
```

Final behavior:
- PHARMA_V1 and supported BANK scoring: methodology AVAILABLE + score execution AVAILABLE;
- completed K4 engines: methodology AVAILABLE + score execution PENDING_ADAPTER;
- completed K4 engines retain their sector engine identity but select no GENERAL rule profile;
- routed and reviewed K4 assignments cannot bypass the guard;
- unsupported methodology: METHODOLOGY_NOT_AVAILABLE + BLOCKED;
- missing/conflicting classification: REVIEW_REQUIRED + BLOCKED;
- NBFC_LENDING remains fail-closed;
- an explicit canonical GENERAL assignment may remain available where genuinely reviewed/authorized;
- Program B / R6 remains the owner of actual K4 live scorer-adapter activation.

This means Program A may expand evidence without causing a legacy GENERAL numeric score to appear increasingly authoritative for a K4 company.

### Validation

Owner/Codex local validation reported:
- PKR-1 focused K3/K4/scoring/UI suite: 201 tests PASS;
- PKR-1 K-FINAL consolidated suite: 39 tests PASS;
- PKR-1B focused scoring/UI/K3/K4 suite: 95 tests PASS;
- PKR-1B K-FINAL including K5 isolation: 39 tests PASS;
- TypeScript = PASS;
- architecture guard = PASS;
- production build = PASS;
- TORNTPHARM golden control = PASS;
- AUROPHARMA fail-closed control = PASS;
- cross-sector isolation = PASS;
- universal Research workspace = PASS.

Known non-blocking repository debt:
- full-repository lint still contains 77 pre-existing errors outside PKR-1/PKR-1B;
- existing Vite chunk-size warning remains.

Safety unchanged:
- no provider calls;
- no production mutation/migration;
- no score/recommendation/sizing persistence activation;
- no scheduler activation;
- no AI activation;
- no portfolio mutation;
- no deployment;
- no PR merge;
- no automatic trading.

**PKR-1 / PKR-1B = COMPLETE / PASS / CLOSED.**

Program A remains NOT STARTED.

Next governance step:
- freeze PR #101 at this post-K reconciled state;
- choose a clean post-K Program A working branch from commit `f22b4efc8607102c51abadd46c62f362fd837084`;
- do not merge PR #101 without a separate explicit owner decision;
- Program A A1 must be planned/frozen before Codex implementation.


---

## Program A launch · A1 plan freeze — 23 September 2026

Clean Program A branch created:
- `program-a-evidence-coverage`;
- branched from reconciled post-K tip `239c209005b549ce4c6eff260d284091afe972fc`;
- PR #101 remains untouched / OPEN / DRAFT / UNMERGED.

Canonical A1 plan:
- `docs/PortfolioAI_PROGRAM_A_A1_EVIDENCE_BASELINE_AND_EXECUTION_PLAN.md`.

A1 title:
- **Read-only Evidence Baseline & Execution Contract Freeze**.

A1 purpose:
- establish current portfolio eligibility;
- produce cache-only R3 evidence coverage baseline;
- produce cache-only R5 market-history baseline;
- define pure incremental history-window planning;
- inventory benchmark dependencies;
- quantify projected provider work without executing it;
- propose bounded R3/R5 pilot cohorts for the next checkpoint.

Mandatory Codex behavior before build:
- read the canonical post-K plan, cumulative handoff, architecture audit, A1 plan, Integration & Execution Plan, Research & Intelligence Architecture and relevant current implementation;
- perform a bounded planning verification only;
- identify only hard contradictions, reuse points and minimal file-change set;
- STOP only for a genuine safety/architecture blocker;
- otherwise proceed directly into A1 implementation in the same Codex task;
- no open-ended re-audit cycle.

A1 explicitly prohibits:
- Trendlyne execution;
- Angel One execution;
- NSE/provider execution;
- production mutation/migration;
- score/recommendation/sizing persistence;
- scheduler activation;
- AI activation;
- portfolio mutation;
- deployment;
- PR merge;
- automatic trading.

Post-PKR scoring safety must remain:
- unsupported methodology → METHODOLOGY_NOT_AVAILABLE + BLOCKED;
- missing/conflicting classification → REVIEW_REQUIRED + BLOCKED;
- completed K4 methodology → AVAILABLE + scoring execution PENDING_ADAPTER;
- no legacy GENERAL numeric scoring for K4;
- PHARMA_V1 and supported BANK scoring preserved;
- NBFC_LENDING fail-closed.

**Program A = IN PROGRESS (planning started).**
**A1 plan = FROZEN / IMPLEMENTATION NOT STARTED.**
**Provider execution = NOT AUTHORIZED.**


---

## Program A · A1 implementation status — 23 September 2026

### A1.1 — Planner / contract implementation

Commit:
- `a8ed4867801abee34d3d9ab84c9cbdadbf5ad287`

Status:
- COMPLETE / PASS.

Implemented:
- Program A eligibility resolver;
- deterministic R3 evidence-coverage planner;
- deterministic R5 market-history planner;
- pure incremental-history window planning;
- benchmark dependency inventory;
- projected provider-cost planner;
- bounded pilot-cohort proposal;
- explicit zero-provider / zero-budget safety state.

Important architectural result:
- completed K4 methodologies remain `AVAILABLE + PENDING_ADAPTER`;
- no K4 engine falls through to legacy GENERAL numeric scoring;
- unsupported/review-required methodology stays fail-closed.

### A1.2 — Real cache-only baseline materializer

Commit:
- `3534c2b69ccb14d3c73d6437b9685882ba1a03e6`

Status:
- IMPLEMENTATION COMPLETE / PASS.

Implemented:
- cache-only snapshot SQL using `BEGIN TRANSACTION READ ONLY`;
- local-only execution guard restricted to localhost / 127.0.0.1 port 54322;
- materialization of current Portfolio Coverage Registry rows into `ProgramAHoldingInput[]`;
- canonical R3 materialization for fundamentals, ownership, ratings applicability/evidence, documents, valuation and honest durability-missing state;
- R5 materialization from Angel One mapping state, stored candle bounds and existing market metrics;
- runtime benchmark evidence only for implemented NIFTY_BANK / NIFTY_PHARMA support;
- deterministic JSON + CLI-safe Markdown report;
- local command `bash scripts/program-a-a1-materialize-local.sh <local-portfolio-uuid> [YYYY-MM-DD]`.

Validation reported:
- 47 focused tests PASS;
- K-FINAL consolidated 39 tests PASS;
- TypeScript PASS;
- architecture guard PASS;
- changed-file lint PASS;
- build PASS;
- existing chunk-size warning only.

Real local execution:
- successfully materialized the six-holding `LOCAL UI Research Review` portfolio;
- eligible = 1;
- review required = 5;
- projected Trendlyne calls = 2;
- projected Angel One security requests = 1;
- actual provider calls = 0;
- budget consumed = 0;
- writes = 0.

Observed data gaps from the local run:
- classification coverage incomplete for five of six holdings;
- canonical business-durability materialization unavailable;
- authoritative portfolio weight remains owned by the client read model and is not persisted in the local database snapshot.

Safety:
- no Trendlyne call;
- no Angel One call;
- no NSE/provider call;
- no production access;
- no migration;
- no score/recommendation/sizing persistence;
- no scheduler/AI activation;
- no deployment;
- no merge;
- no trading.

A1 engineering implementation is complete. Formal full-portfolio closure requires either:
1. running the same cache-only materializer against the owner's full current local portfolio dataset, if present locally; or
2. explicitly accepting the six-holding local portfolio as the A1 runtime validation cohort and carrying full-portfolio data coverage into the next Program A execution checkpoint.

No additional architecture work is required for A1.


---

## Program A · A1 formal closure — 23 September 2026

Local portfolio inventory check confirmed that the current local Supabase instance contains only the small UI/test portfolios:
- `10000000-0000-4000-8000-000000000001` — `LOCAL UI Research Review`;
- `a1000000-0000-4000-8000-000000000001` — `Local UI Review`.

No full owner portfolio dataset is presently available in local Supabase.

Therefore the already-successful six-holding `LOCAL UI Research Review` execution is accepted as the A1 runtime validation cohort.

Accepted runtime result:
- eligible = 1;
- review required = 5;
- projected Trendlyne calls = 2;
- projected Angel One security requests = 1;
- actual provider calls = 0;
- actual budget consumed = 0;
- writes = 0.

A1 acceptance interpretation:
- A1's purpose was to prove the real cache-only materialization path and quantify current coverage gaps without provider execution;
- that objective is satisfied;
- absence of the full current portfolio in local Supabase is an environment/data-availability issue, not an A1 architecture or implementation blocker;
- full-portfolio breadth will be handled by subsequent Program A execution checkpoints when the appropriate local/current portfolio scope is available.

Final status:
- A1.1 = COMPLETE / PASS;
- A1.2 = COMPLETE / PASS;
- **Program A · A1 = COMPLETE / PASS / CLOSED**;
- Program A = IN PROGRESS;
- provider execution = STILL NOT AUTHORIZED.

Next step:
- plan/freeze the first bounded provider-backed Program A execution checkpoint;
- no provider execution until that next checkpoint is explicitly approved.


---

## Program A · A2 plan freeze — 23 September 2026

Canonical plan:
- `docs/PortfolioAI_PROGRAM_A_A2_BOUNDED_PROVIDER_PILOT_PLAN.md`.

A2 title:
- **Prerequisite-First Bounded Provider Pilot**.

A2 is the first provider-backed Program A checkpoint, but provider execution remains gated behind an exact generated PLAN and explicit owner approval.

A1 local runtime evidence showed:
- six-holding validation cohort;
- eligible = 1;
- review required = 5;
- main immediate blocker = incomplete canonical classification.

Therefore A2 sequence is frozen as:
1. A2A classification prerequisite pilot for at most five review-blocked securities;
2. re-materialize the A1 baseline;
3. A2B bounded R3 evidence pilot for at most three eligible securities;
4. A2C bounded R5 Angel One history pilot for at most three eligible securities;
5. re-materialize and validate;
6. stop.

Hard ceilings:
- A2A Trendlyne classification calls <= 5;
- A2B Trendlyne physical calls <= 6;
- A2A + A2B Trendlyne physical calls <= 10;
- A2C Angel One security requests <= 3;
- A2C benchmark requests <= 2;
- total Angel One historical requests <= 5;
- retries count toward ceilings.

Mandatory execution contract:
- PLAN = zero provider calls;
- Codex may implement and run PLAN only;
- EXECUTE requires exact owner-approved confirmation after ChatGPT audits the generated plan;
- local Supabase only;
- production execution prohibited.

A2 implementation must reuse existing provider control plane, leases, freshness, retry/accounting and idempotent persistence rather than direct ad-hoc provider calls.

Safety unchanged:
- no score/recommendation/sizing activation;
- no scheduler change;
- no AI activation;
- no deployment;
- no PR merge;
- no automatic trading.

**Program A · A1 = COMPLETE / PASS / CLOSED.**
**Program A · A2 plan = FROZEN / IMPLEMENTATION NOT STARTED.**
**Provider execution = NOT AUTHORIZED.**


---

## Program A · A2 implementation checkpoint — 23 September 2026

Implementation commit:
- `94335ffcd561df3f292129156c3913322f5465e1`

Status:
- implementation = COMPLETE / PASS;
- provider execution = NOT YET RUN;
- A2 formal closure = PENDING owner-approved staged execution + validation.

Implemented:
- deterministic A2 PLAN builder with SHA-256 plan ID and exact confirmation token;
- exact bounded A2A classification cohort;
- bounded A2B Complete Research cohort;
- bounded A2C incremental Angel One history cohort;
- local-only guards in controller and A2-specific Edge Function paths;
- existing provider budgets, leases, accounting, lineage and idempotent persistence reused;
- stale-plan/cache-drift guard;
- runtime call ceilings;
- classification conflict / ambiguous identity hard stops;
- A1 incremental history window passed into existing Angel One history adapter;
- CLI with explicit PLAN / EXECUTE modes.

Audited current local PLAN:
- plan ID `cc238e54b2d904c4298b9cdb29f4d02f13067dc2787d289a859e4e5471d995a3`;
- A2A classification cohort: ALIVUS, AUROPHARMA, BIOCON, HDFCBANK, SYNGENE;
- A2B provisional cohort: TORNTPHARM via reviewed four-call Complete Research capability;
- A2C provisional cohort: TORNTPHARM incremental history, 2026-09-12 through 2026-09-23;
- projected Trendlyne total = 9;
- projected Angel One total in the generated local plan = 1;
- actual calls/budget = 0;
- confirmation token `APPROVE_PROGRAM_A_A2_CC238E54B2D904C4`.

Critical staged-execution behavior:
- after A2A classification writes, A2 re-materializes the cache and rebuilds the plan;
- any classification change alters the plan fingerprint;
- execution therefore stops before A2B with `STALE_PLAN_REPLAN_REQUIRED`;
- a new PLAN and a new explicit owner approval are required before A2B/A2C;
- this prevents one approval from silently expanding into deeper evidence/history execution after classification state changes.

Validation reported:
- 52 focused application tests PASS;
- 143 Edge/provider-control tests PASS;
- K-FINAL regressions PASS;
- TypeScript PASS;
- architecture guard PASS;
- changed-file lint PASS;
- build PASS;
- no provider contacted during implementation.

Safety unchanged:
- local Supabase only;
- no production mutation;
- no score/recommendation/sizing activation;
- no scheduler/AI activation;
- no deployment;
- no merge;
- no trading.

**A2 implementation = PASS / READY FOR OWNER REVIEW OF A2A EXECUTION.**


---

## Program A · A2A first-run rejection diagnosis and contract correction — 23 September 2026

The owner-approved V2 A2A run stopped on its first action, ALIVUS, after one
successful Trendlyne `search_entities` provider attempt. No classification source
record, observation or decision was written, and A2B/A2C did not run.

Correlated local append-only audit evidence:
- ingestion run `c9c24be1-09b3-4ced-a398-7172a7ff756b`;
- ALIVUS run item `975c2264-6c30-4ca1-9128-52f6c2697c10`;
- item status `REJECTED`;
- exact safe reason `NO_EXACT_PROVIDER_IDENTITY`;
- attempted calls = 1, accepted records = 0;
- provider usage event outcome = `SUCCEEDED`, proving the transport/tool call completed;
- no `data_source_records` row exists for the run and the item metadata is empty.

Therefore the incident was not proven ambiguous. The provider response produced
zero candidates satisfying both the exact canonical ALIVUS ISIN and exact symbol
contract. The earlier implementation did not retain safe candidate-count
diagnostics, so the historical evidence cannot distinguish no parsed candidates,
symbol-only matches, ISIN-only matches or other non-exact candidates. No repeat
provider call was made merely to diagnose that missing historical detail.

Focused correction:
- exact canonical-ISIN plus exact-symbol matching remains mandatory and fail-closed;
- no symbol/name similarity fallback was introduced;
- `NO_EXACT_PROVIDER_IDENTITY`, `AMBIGUOUS_PROVIDER_IDENTITY` and
  `CLASSIFICATION_MISSING` now remain distinct from Edge audit through the A2 runner;
- rejected items retain only non-secret aggregate match counts, never raw provider payloads;
- rejected-only ingestion runs finish `FAILED`, rather than misleadingly `SUCCEEDED`;
- arbitrary provider text is collapsed to a safe generic code;
- the A2 plan contract advances to V3, invalidating the previous V2 plan approval.

Validation:
- pure classification matcher/rejection-path tests = PASS;
- runner safe-code propagation and zero-write rejection tests = PASS;
- A2 controller fingerprint, local-target, budget and stage-boundary regressions = PASS;
- focused application regressions = 39 PASS;
- Edge/provider-control suite = 147 PASS;
- TypeScript, architecture guard, changed-file lint and production build = PASS;
- no live provider call was made by this correction.

Fresh zero-provider-call plan:
- version `PROGRAM_A_A2_BOUNDED_PILOT_V3`;
- plan ID `d0e5319836c579567f94cce1ad25c0485de77b0f9cc46a29d36d53f0545836de`;
- confirmation token `APPROVE_PROGRAM_A_A2_D0E5319836C57956`;
- exact A2A cohort remains ALIVUS, AUROPHARMA, BIOCON, HDFCBANK, SYNGENE;
- all five canonical ISIN prerequisites are `READY`;
- A2A Trendlyne ceiling = 5, actual PLAN calls/budget/writes = 0.

Remaining sequence:
1. generate and review a fresh zero-provider-call V3 PLAN;
2. obtain explicit owner approval for its exact plan ID/token;
3. run classification-only A2A;
4. verify local canonical writes and rematerialized A1 baseline;
5. require `STALE_PLAN_REPLAN_REQUIRED` before any A2B/A2C execution.

**Program A · A2 remains IN PROGRESS.**
**The prior V2 plan approval must not be reused.**

---

## Program A · A2A V3 safe-shape diagnosis and V4 replan — 23 September 2026

The owner-executed V3 A2A attempt again stopped on ALIVUS after one successful
Trendlyne tool attempt and before any local classification write. A2B and A2C did
not run.

Correlated local audit evidence:
- ingestion run `8adbb1bb-213e-431b-b310-7b91928934e4`;
- ALIVUS run item `ae073f41-3492-4228-b1b5-82374114e19b`;
- run status `FAILED`, attempted = 1, accepted = 0, rejected = 1, failed = 0;
- item status `REJECTED`, safe reason `NO_EXACT_PROVIDER_IDENTITY`, attempted calls = 1, accepted records = 0;
- safe item counts: candidates = 0, symbol matches = 0, ISIN matches = 0,
  exact matches = 0, classified exact matches = 0.

This audit inspection made zero provider calls and no writes. The V3 metadata
proved that the parser produced no candidates, but it could not distinguish a
valid empty provider table from an unrecognized response envelope or table shape.
Raw provider content was not retained, so the historical V3 response cannot be
reconstructed and no unsupported claim about Trendlyne identity data is made.

Focused V4 correction:
- recognizes the reviewed marked table, plain Markdown pipe tables, compact pipe
  delimiters, and JSON string envelopes under `markdown_data`, `result`, or `data`;
- locates required fields by normalized header name instead of fixed column offset;
- preserves exact canonical symbol plus exact canonical ISIN matching;
- records only safe parse-shape metadata: parse state, envelope class, marker
  presence, nonempty-line count, pipe-line count and parsed-row count;
- distinguishes valid empty results from nonempty unrecognized response shapes;
- rejects an unrecognized shape as `PROVIDER_SCHEMA_MISMATCH`, with zero writes;
- retains `NO_EXACT_PROVIDER_IDENTITY` for a successfully parsed table with no
  exact candidate and retains all other distinct rejection reasons;
- advances the plan contract to V4, invalidating the V3 plan approval.

Validation:
- Edge/provider-control suite = 150 PASS;
- focused A1/A2 application regressions = 20 PASS;
- runner safe-code propagation suite = 6 PASS;
- TypeScript and architecture guard = PASS;
- PLAN generation made zero provider calls and consumed zero provider budget.

Fresh zero-provider-call V4 plan:
- version `PROGRAM_A_A2_BOUNDED_PILOT_V4`;
- plan ID `c35d2b1c8d39c6ea7c065fc3dfa63f4f56e2c4a95cb581e5e024a7342197c29e`;
- confirmation token `APPROVE_PROGRAM_A_A2_C35D2B1C8D39C6EA`;
- exact A2A cohort remains ALIVUS, AUROPHARMA, BIOCON, HDFCBANK, SYNGENE;
- all five canonical identity prerequisites are `READY`;
- HDFCBANK uses canonical local ISIN `INE040A01034`;
- A2A Trendlyne ceiling = 5; total planned Trendlyne = 9; Angel One = 1;
- actual PLAN provider calls, budget consumed and writes = 0.

Remaining sequence:
1. review and explicitly approve the exact V4 plan ID/token;
2. run classification-only A2A;
3. inspect the first item safe counts and new parse-shape metadata;
4. verify any accepted local canonical writes and rematerialized A1 baseline;
5. require `STALE_PLAN_REPLAN_REQUIRED` before any A2B/A2C execution.

**Program A · A2 remains IN PROGRESS.**
**No V2 or V3 approval may be reused.**

---

## Program A · A2A V4 execution result — 23 September 2026

The owner explicitly approved V4 plan
`c35d2b1c8d39c6ea7c065fc3dfa63f4f56e2c4a95cb581e5e024a7342197c29e`
and its exact confirmation token. The first invocation stopped before dispatch
because the runner process lacked its three required local environment variables;
that invocation made zero provider calls. The same approved plan was then invoked
with credentials resolved only from the running local Supabase instance and local
Vault, without printing or persisting them.

Bounded execution result:
- status `PARTIAL_STOPPED`;
- stop reason `PROVIDER_SCHEMA_MISMATCH`;
- Trendlyne calls = 1; Angel One calls = 0; retries = 0;
- successful local classification writes = 0;
- score, recommendation and sizing writes = 0;
- A2B and A2C did not execute.

Correlated local audit evidence:
- ingestion run `f38aa9e7-5cdc-4062-b71f-05810cf6609e`;
- ALIVUS item `f2eba073-3b49-4b1e-a542-d464596d22e5`;
- run status `FAILED`, attempted = 1, accepted = 0, rejected = 1, failed = 0;
- item status `REJECTED`, safe reason `PROVIDER_SCHEMA_MISMATCH`;
- provider usage outcome `SUCCEEDED`, retry attempt = 0, internal units = 1;
- source records written for this run = 0;
- safe parse shape: `UNRECOGNIZED_RESPONSE`, envelope `PLAIN_TEXT`, data marker
  present, end marker absent, nonempty lines = 1, pipe-delimited lines = 0,
  parsed candidate rows = 0.

Conclusion:
- this is not evidence of an ambiguous identity or of no exact ALIVUS identity;
- Trendlyne returned a successful nonempty one-line response whose shape is not
  recognized by the approved parser;
- raw provider content was deliberately not retained, so its schema cannot be
  reconstructed from this audit and must not be guessed;
- existing local K1 evidence shows Trendlyne has previously returned nested
  `markdown_data` and non-header pipe data for a different capture, but that does
  not prove the V4 ALIVUS response used the same schema.

The V4 approval is consumed and must not be reused. Before another provider call,
the response contract must be established through provider capability/schema
evidence or a newly reviewed safe diagnostic plan. A fresh fingerprinted plan and
explicit owner approval are required.

**Program A · A2 remains IN PROGRESS at A2A.**
**A2B and A2C remain blocked by the classification stage boundary.**

---

## Program A · A2A Trendlyne contract recovery and closure — 23 September 2026

Owner authorization allowed bounded Trendlyne calls needed to diagnose and clear
the A2A classification blockade. Provider capability discovery established the
current `search_entities` contract: exact identity/classification records are
returned under `data`, using either a `status/data` text table or the documented
JSON `data[]` envelope. The prior adapter expected an obsolete pipe-table shape.

Verified provider behavior:
- symbol-only `ALIVUS` returned a valid empty result;
- canonical ISIN search was semantic and returned a non-exact candidate, which
  confirms that ISIN may never be accepted without exact result reconciliation;
- canonical company-name search returned ALIVUS with exact symbol
  `ALIVUS` and exact ISIN `INE03Q201024`;
- HDFCBANK returned the documented identity fields and exact ISIN
  `INE040A01034`.

Implemented contract correction:
- A2 classification actions bind canonical company name, symbol, ISIN and
  prerequisite readiness into the plan fingerprint;
- the runner sends the fingerprinted canonical name to the local Edge adapter;
- the Edge adapter verifies that the requested name still equals local canonical
  identity before provider dispatch;
- the parser supports current `status/data`, documented JSON `data[]`, reviewed
  Markdown wrappers and valid empty results;
- candidate acceptance still requires one exact symbol plus exact canonical ISIN
  and non-null sector/industry;
- raw source values remain immutable and auditable;
- safe execution accounting now retains accepted evidence-write counts even when
  a new mapping pair stops the run for review.

Canonical normalization correction:
- migration `20260923111000_add_program_a_canonical_taxonomy_prerequisites.sql`
  materializes the stable Banking/Pharma sector and industry identities required
  by the reviewed mappings, and normalizes pre-existing local fixture codes
  without replacing those identities;
- migration `20260923110816_use_normalized_current_security_classification.sql`
  makes the security-invoker canonical view prefer reviewed `normalized_value`
  while retaining raw `text_value` in immutable observations;
- the adapter resolves reviewed mapping IDs to canonical sector/industry names;
- a mapping-authority change creates a new hashed source-record version rather
  than updating prior evidence;
- exact reviewed mappings were added through migrations for:
  - `Pharmaceuticals & Biotechnology / Pharmaceuticals` →
    `Pharma / Pharmaceuticals`;
  - `Pharmaceuticals & Biotechnology / Biotechnology` →
    `Pharma / Pharmaceuticals`, supported by the existing BIOCON Gate J G10.3
    classification lock;
  - `Banking and Finance / Banks` → `Banking / Private Sector Bank`, supported by
    the existing HDFCBANK canonical classification;
- routing now recognizes the canonical `Private Sector Bank` industry as BANK,
  alongside the legacy generic `Banks` token. No BANK_NBFC scoring formula changed.

Bounded A2A results:
- V5 proved exact ALIVUS resolution and stopped on its new mapping pair;
- V7 normalized ALIVUS and AUROPHARMA, then stopped on BIOCON's reviewed pair;
- V8 normalized BIOCON, then stopped on HDFCBANK's reviewed pair;
- V9 normalized HDFCBANK and SYNGENE and stopped at
  `STALE_PLAN_REPLAN_REQUIRED` before A2B;
- every provider call had zero retries;
- no Angel One call, score write, recommendation write or sizing write occurred.

Final A2A canonical **sector/industry normalization** cohort:
- ALIVUS → `Pharma / Pharmaceuticals`;
- AUROPHARMA → `Pharma / Pharmaceuticals`;
- BIOCON → `Pharma / Pharmaceuticals`;
- HDFCBANK → `Banking / Private Sector Bank`;
- SYNGENE → `Pharma / Pharmaceuticals`;
- TORNTPHARM remains `PHARMA / PHARMACEUTICALS` from its prior authority.

IMPORTANT: these A2A values are only the canonical sector/industry layer. They are **not** the final Pharma research subprofile or scoring-methodology classification.

Post-A2A V10 zero-call plan:
- plan ID `162f683dbcd3701bb1f9b0289bf70de9c24ef184f0805d91da47249129842626`;
- confirmation token `APPROVE_PROGRAM_A_A2_162F683DBCD3701B`;
- A2A action count = 0;
- A2B proposes one four-call ALIVUS Complete Research action;
- A2C proposes three security-history calls and one NIFTY Bank benchmark call;
- actual PLAN calls, budget and writes = 0.

Validation:
- the five A2 migrations applied to local Supabase only;
- the complete migration history replayed successfully in a shadow database and
  `supabase db diff --local` reported `No schema changes found`;
- focused provider-contract, parser, controller, cache-materializer and BANK/NBFC
  portability tests passed;
- Edge test suite, typecheck, architecture guard, changed Edge lint and production
  build passed.
- no production migration, deployment or merge occurred.

**Program A · A2A = COMPLETE / PASS / CLOSED.**
**Program A · A2 remains IN PROGRESS; A2B and A2C require their separately reviewed V10 execution boundary.**


---

## ChatGPT audit confirmation — Program A · A2A closure — 23 September 2026

Remote audit range:
- base: `b30db340c8204e98afe15f0eda220cf699d70fe5`
- closure tip: `5367f3ea53561938ea4a11dcbc1ac0c279372b04`
- three commits reviewed on `program-a-evidence-coverage`.

Audit conclusion:
- A2A implementation and local execution are consistent with the frozen prerequisite-first Program A plan;
- the Trendlyne classification adapter now parses the current provider response contract rather than the obsolete table-only shape;
- provider identity reconciliation remains exact symbol + canonical ISIN and now also fingerprints canonical company name;
- provider source values remain immutable while reviewed canonical normalization is stored separately;
- reviewed mapping-pair additions are explicit and fail-closed rather than ticker inference;
- current canonical view prefers reviewed `normalized_value` while retaining original `text_value`;
- canonical `Private Sector Bank` routes to BANK_NBFC/BANK without enabling NBFC_LENDING;
- no BANK/NBFC scoring formula changed;
- accepted local evidence writes are now accounted even when a new mapping pair causes a review stop;
- A2 stage isolation held: after the A2A classification changes, execution stopped before A2B/A2C and a fresh plan was required.

Reviewed local-only migrations:
- `20260923110816_use_normalized_current_security_classification.sql`;
- `20260923111000_add_program_a_canonical_taxonomy_prerequisites.sql`;
- `20260923111115_add_reviewed_trendlyne_pharma_mapping.sql`;
- `20260923111330_add_reviewed_trendlyne_biotechnology_mapping.sql`;
- `20260923111553_add_reviewed_trendlyne_bank_mapping.sql`.

These migrations were applied to local Supabase only. Codex reported full migration shadow replay PASS and `supabase db diff --local` = `No schema changes found`. No production migration was applied.

Final A2A cohort state:
- ALIVUS → Pharma / Pharmaceuticals;
- AUROPHARMA → Pharma / Pharmaceuticals;
- BIOCON → Pharma / Pharmaceuticals;
- HDFCBANK → Banking / Private Sector Bank;
- SYNGENE → Pharma / Pharmaceuticals.

Fresh V10 zero-call plan after A2A:
- plan ID `162f683dbcd3701bb1f9b0289bf70de9c24ef184f0805d91da47249129842626`;
- confirmation token `APPROVE_PROGRAM_A_A2_162F683DBCD3701B`;
- A2A actions = 0;
- A2B proposal = one ALIVUS Complete Research action / 4 Trendlyne calls;
- A2C proposal = 4 Angel One calls;
- plan-generation provider calls = 0;
- plan-generation budget consumed = 0.

Safety audit:
- no production mutation;
- no production migration;
- no deployment;
- no PR merge;
- no score/recommendation/sizing activation;
- no scheduler/AI activation;
- no trading;
- A2B and A2C remain separately approval-gated.

**ChatGPT audit verdict: Program A · A2A = COMPLETE / PASS / CLOSED.**
**Program A · A2 = IN PROGRESS.**
**Current next boundary = separate review of V10 A2B and A2C; neither is authorized yet.**


---

## Critical Pharma classification hierarchy clarification — 23 September 2026

This clarification is canonical and must be preserved in all future Program A/B work.

### A2A classification is NOT the Pharma scoring subprofile

Program A · A2A resolved the broad canonical provider taxonomy needed for routing prerequisites:

```text
Provider classification
        ↓
Canonical Sector / Industry
```

For Pharma holdings this currently produces a broad canonical identity such as:

```text
Sector:   Pharma
Industry: Pharmaceuticals
```

That result is **necessary but not sufficient** for Pharma methodology execution.

The Pharma architecture built through Gates G/H/I/J must retain the deeper business-model classification layer:

```text
Sector
  ↓
Industry
  ↓
Pharma subprofile / business-model classification
  ↓
PHARMA_V1 methodology contract
  ↓
Subprofile-specific evidence requirements
  ↓
Deterministic scoring
  ↓
Recommendation policy
```

Canonical Pharma subprofiles remain distinct:

- `API_BULK_DRUGS`
- `DOMESTIC_FORMULATIONS`
- `GLOBAL_GENERICS`
- `BIOPHARMA_BIOSIMILARS`
- `CDMO_CRAMS`

These subprofiles are **not interchangeable** and must not be collapsed into generic `Pharma / Pharmaceuticals`.

### ALIVUS example

Current A2A result:

```text
ALIVUS
→ Sector/Industry normalization:
  Pharma / Pharmaceuticals
```

This does **not** establish ALIVUS's Pharma scoring subprofile.

For downstream Pharma research/scoring, the separate Pharma subprofile authority must resolve the company to its approved business-model classification. The intended current classification discussed by the owner is:

```text
ALIVUS
→ Health Care sector context
→ Pharma industry
→ API_BULK_DRUGS Pharma subprofile
→ PHARMA_V1 / API_BULK_DRUGS methodology
```

A2A must never overwrite, infer, or replace that subprofile authority merely because the provider returns a broad `Pharmaceuticals` industry.

### Architectural rule

The hierarchy is permanently:

```text
Sector          = macro context
Industry        = minimum methodology-routing context
Basic Industry / business model = refinement
Pharma subprofile = Pharma-specific metric/applicability/valuation authority
Company evidence = scoring evidence
Score           = deterministic assessment
Recommendation  = downstream action logic
```

Therefore:

- A2A owns provider-to-canonical sector/industry normalization only;
- Pharma subprofile authority remains separate;
- `Pharma / Pharmaceuticals` must never be treated as sufficient authority for choosing the Pharma scoring formula;
- a Pharma security without a resolved approved subprofile must fail closed before subprofile-specific scoring;
- Program A evidence acquisition must respect the resolved Pharma subprofile's required domains;
- Program B / R6 must execute the scorer associated with the approved Pharma subprofile, not a generic Pharmaceuticals scorer;
- no ticker-specific runtime workaround may replace the canonical subprofile contract.

### Current A2A closure interpretation

A2A remains COMPLETE / PASS / CLOSED because its scope was broad classification prerequisite normalization.

Its closure means:

```text
Provider classification path        = proven
Canonical sector/industry mapping    = proven
Exact identity reconciliation        = proven
```

It does **not** mean:

```text
Pharma subprofile classification     = newly proven by A2A
Pharma subprofile methodology        = replaced by broad industry
Pharma scoring readiness             = automatically established
```

The previously built Pharma subprofile architecture remains authoritative and must be consulted before A2B evidence selection and, especially, before Program B / R6 scoring.

**This distinction must not be removed or simplified in future handoffs, plans, scoring adapters, or UI contracts.**

---

## Program A · A2B Pharma subprofile prerequisite wiring — 23 September 2026

A focused A2B contract correction now binds Pharma Complete Research actions to
the canonical active reviewed subprofile assignment before provider dispatch.

Implemented:
- the cache-only snapshot reads persisted `research_subprofile_assignments` for
  held securities; the provisional candidate registry is not an input;
- the existing fail-closed Pharma assignment resolver determines whether the
  assignment is active and reviewed;
- the resolved assignment version must match the existing effective subprofile
  contract authority;
- the A2B action binds the resolved subprofile, `REVIEWED` assignment state,
  effective contract version and registered Gate-J methodology version into the
  plan fingerprint;
- missing, provisional, disputed, conflicting, inactive or contract-mismatched
  Pharma authority produces no A2B provider action;
- execution independently refuses a malformed Pharma A2B action with
  `PHARMA_SUBPROFILE_PREREQUISITE_MISSING` before dispatch;
- non-Pharma A2B behavior and the indivisible four-call Complete Research
  capability are unchanged.

Fresh local cache-only V11 plan:
- plan ID `281076d2367ee4e8b6c799a56454f4d0da2da1522973ed453e5bf4524cf78b5e`;
- confirmation token `APPROVE_PROGRAM_A_A2_281076D2367EE4E8`;
- A2A action count = 0;
- A2B = ALIVUS / `API_BULK_DRUGS` / `API_BULK_DRUGS_V1` /
  `PHARMA_API_G10_1_NUMERIC_METHODOLOGY_V1_CANDIDATE` / four calls;
- PLAN provider calls, budget and writes = 0;
- A2B and A2C were not executed.

Validation:
- focused A1/A2, assignment, contract and Gate-J portability suite: 38 tests PASS;
- TypeScript: PASS;
- architecture guard: PASS;
- changed-file lint: PASS;
- production build: PASS with the inherited chunk-size warning.

**Program A · A2B remains PLANNED / NOT EXECUTED pending review of the new V11 plan.**

### A2 stage-specific execution authority

The local A2 execution boundary now requires an explicit approved stage:

```text
EXECUTE_STAGE <portfolio-id> <date> <A2A|A2B|A2C> <plan-id> <confirmation-token>
```

Execution filters the fingerprinted plan to that stage and refuses before any
provider dispatch when stage authority is missing, invalid, or has no planned
actions. Full-plan stale-plan and provider-ceiling checks remain in force, as do
the A2A identity and A2B reviewed-Pharma-subprofile prerequisites. A successful
stage run rematerializes the cache-only A1 summary and stops; it does not advance
to another stage.

The fresh zero-provider V11 plan remains unchanged:
- plan ID `281076d2367ee4e8b6c799a56454f4d0da2da1522973ed453e5bf4524cf78b5e`;
- A2A action count = 0;
- the sole A2B action is ALIVUS, reviewed `API_BULK_DRUGS`, contract
  `API_BULK_DRUGS_V1`, methodology
  `PHARMA_API_G10_1_NUMERIC_METHODOLOGY_V1_CANDIDATE`, four Trendlyne calls;
- A2C remains separately planned and is not authorized by A2B execution;
- PLAN provider calls, budget and writes = 0.

Stage-boundary validation:
- focused A1/A2, Pharma assignment, contract and Gate-J portability suite:
  39 tests PASS;
- TypeScript: PASS;
- architecture guard: PASS;
- changed-file lint and shell syntax: PASS;
- production build: PASS with the inherited chunk-size warning.

**The stage-boundary implementation is ready for the conditionally approved
local A2B-only execution. A2C remains NOT EXECUTED and requires a separate fresh
plan and approval.**

### A2B Trendlyne provider-identity prerequisite

The first stage-scoped A2B attempt correctly stopped before dispatch because
ALIVUS had no canonical `TRENDLYNE_MCP` provider identity observation. It used
zero provider calls and made zero writes.

The V12 contract now binds provider-identity readiness and the provider
instrument ID, when available, into each A2B action and plan fingerprint. States
are explicit: `VERIFIED_EXISTING_IDENTITY`, `IDENTITY_DISCOVERY_REQUIRED`, and
`BLOCKED_IDENTITY_CONFLICT`; successful discovery returns
`VERIFIED_DURING_PREREQUISITE_DISCOVERY`.

For a missing identity, the bounded local prerequisite performs two calls:
exact `search_entities` reconciliation against canonical name, NSE symbol and
ISIN, followed by an overview call that supplies and revalidates the stable
Trendlyne stock ID. It persists immutable raw provenance and an idempotent
`MATCHED` `security_identity_observations` row. Ambiguity, symbol/ISIN/name/BSE
conflict, or an existing conflicting matched identity fails closed. The normal
four-call Complete Research operation then runs separately against that verified
ID, for a truthful six-call A2B maximum.

Fresh zero-provider V12 plan:
- plan ID `5cd6565e901131bb1a58e5003cba7b5ef7834f258f46087b5c0bde1e27914b25`;
- confirmation token `APPROVE_PROGRAM_A_A2_5CD6565E901131BB`;
- A2A action count = 0;
- sole A2B action = ALIVUS / reviewed `API_BULK_DRUGS` /
  `API_BULK_DRUGS_V1` /
  `PHARMA_API_G10_1_NUMERIC_METHODOLOGY_V1_CANDIDATE`;
- provider identity state = `IDENTITY_DISCOVERY_REQUIRED`;
- bounded A2B Trendlyne calls = 6; PLAN calls and writes = 0;
- A2C remains separately planned and outside A2B execution authority.


---

## Pharma runtime activation guard — canonical reminder — 23 September 2026

A dedicated canonical guard has been added:

- `docs/PortfolioAI_PHARMA_SUBPROFILE_RUNTIME_ACTIVATION_GUARD.md`

Reason:
- all five Pharma methodology authorities exist;
- broad A2A `Pharma / Pharmaceuticals` normalization is not sufficient for Pharma scoring;
- current live Pharma scoring still routes broadly through the parent `PHARMA_V1` path and does not yet safely resolve the reviewed Pharma subprofile before selecting methodology.

Hard rule:
- no reviewed Pharma subprofile → no numeric score;
- provisional/disputed/conflicting Pharma subprofile → no numeric score;
- no cross-subprofile band borrowing;
- no generic Pharma fallback scorer;
- Program B / R6 must implement a focused Pharma runtime adapter before general Pharma scoring activation.

Current reviewed/unresolved examples:
- ALIVUS → API_BULK_DRUGS;
- AUROPHARMA → GLOBAL_GENERICS;
- TORNTPHARM → DOMESTIC_FORMULATIONS;
- BIOCON → provisional BIOPHARMA_BIOSIMILARS only; blocked until reviewed/persisted;
- SYNGENE → provisional CDMO_CRAMS only; blocked until reviewed/persisted.

This guard must be checked explicitly before A2B evidence selection where subprofile-specific evidence matters and must be satisfied before Program B / R6 score execution.


---

## Program A · A2B successful bounded execution and closure — 24 September 2026

The conditionally approved local A2B-only execution completed successfully after
the V12 provider-identity prerequisite was implemented.

Implementation / closure commit:
- `2b76b93c557d74cb4a6b00ad9518cd8e17b7cd6b`
- commit intent: bounded Trendlyne identity discovery + provider-identity-aware A2B
  planning/execution for ALIVUS;
- no database migration was created;
- no production mutation, deployment or merge occurred.

Fresh approved V12 plan:
- plan ID
  `5cd6565e901131bb1a58e5003cba7b5ef7834f258f46087b5c0bde1e27914b25`;
- confirmation token
  `APPROVE_PROGRAM_A_A2_5CD6565E901131BB`;
- A2A actions = 0;
- A2B actions = exactly one: ALIVUS;
- ALIVUS authority remained:
  - research profile: `PHARMA_V1`;
  - reviewed subprofile: `API_BULK_DRUGS`;
  - assignment state: `REVIEWED`;
  - contract: `API_BULK_DRUGS_V1`;
  - methodology:
    `PHARMA_API_G10_1_NUMERIC_METHODOLOGY_V1_CANDIDATE`;
- provider identity state before execution:
  `IDENTITY_DISCOVERY_REQUIRED`;
- bounded A2B Trendlyne ceiling = 6 calls;
- PLAN provider calls and writes = 0;
- A2C remained outside the A2B execution authority.

### Provider-identity resolution result

A2B first established ALIVUS's stable Trendlyne identity through a separate,
bounded prerequisite path.

Identity discovery:
1. `SEARCH_ENTITIES` using canonical company name, symbol and ISIN;
2. `GET_OVERVIEW_NEWS_CORP_EVENTS` to obtain and independently revalidate the
   stable provider stock ID.

Exact reconciliation basis:
- canonical security name;
- exact NSE symbol `ALIVUS`;
- exact ISIN `INE03Q201024`;
- Overview identity consistency;
- company-name normalization;
- BSE-code consistency where available;
- no conflicting existing `MATCHED` provider identity.

Verified provider identity:
- state: `VERIFIED_DURING_PREREQUISITE_DISCOVERY`;
- Trendlyne provider instrument ID: `606572`;
- observed company: `Alivus Life Sciences Ltd.`;
- symbol: `ALIVUS`;
- ISIN: `INE03Q201024`;
- exchange / series: `NSE / EQ`;
- evidence status: `MATCHED`;
- confidence: `1.0000`.

The identity path persisted:
- immutable `data_source_records` provenance;
- canonical `security_identity_observations` evidence;
- idempotent reuse of the same identity on later runs;
- fail-closed handling for ambiguity or conflict.

### Actual A2B provider execution

Execution completed with:
- status: `SUCCEEDED`;
- Trendlyne calls = 6;
- Angel One calls = 0;
- retries = 0;
- successful local writes reported by the bounded runner = 6;
- score writes = 0;
- recommendation writes = 0;
- sizing writes = 0;
- A2C execution = 0.

Call sequence:
1. `SEARCH_ENTITIES` — identity discovery — succeeded;
2. `GET_OVERVIEW_NEWS_CORP_EVENTS` — identity verification — succeeded;
3. `GET_OVERVIEW_NEWS_CORP_EVENTS` — Complete Research fundamentals — succeeded;
4. `GET_PARAMETER_VALUES_MULTI_STOCK` — detailed structured metrics — succeeded;
5. `GET_OWNERSHIP_DEALS_INSIDER_SAST` — ownership / pledge — succeeded;
6. `GET_DOCUMENT_SEARCH_RESULTS` — document/evidence discovery — succeeded.

No retry was required.

The successful local-write count represents:
- two identity/provenance writes;
- four accepted Complete Research domains.

### ALIVUS evidence added

Canonical local evidence captured from the A2B refresh includes:
- Revenue TTM;
- Net profit TTM;
- CFO annual;
- ROE annual;
- ROCE annual;
- PE TTM;
- provider market capitalisation;
- PBV observation retained as `CONFLICTING`;
- promoter ownership;
- FII/FPI ownership;
- DII ownership;
- mutual-fund ownership;
- public ownership;
- promoter pledge;
- one research document with provider source appearance;
- verified Trendlyne provider identity and immutable provenance.

The evidence architecture correctly retains point observations as point
observations. It does not promote them into multi-period Pharma contract evidence
without the required history.

### API_BULK_DRUGS mandatory evidence still missing

After A2B, the effective `API_BULK_DRUGS_V1` contract still reports these
mandatory items as missing:

- `PHARMA_REVENUE_GROWTH_HISTORY`;
- `PHARMA_OPERATING_MARGIN_HISTORY`;
- `PHARMA_ROCE_HISTORY`;
- `PHARMA_PAT_EPS_HISTORY`;
- `PHARMA_CASH_CONVERSION_HISTORY`;
- `PHARMA_BALANCE_SHEET_LEVERAGE`;
- `PHARMA_REGULATORY_SITE_STATUS`;
- `PHARMA_API_CUSTOMER_CONCENTRATION`;
- `PHARMA_API_CAPACITY_UTILIZATION`.

This is expected and correct. A2B proved current evidence acquisition, identity
resolution, provenance, canonical mapping and subprofile-aware planning; it did
not falsely infer multi-period or issuer-disclosed evidence from one current
snapshot.

### Post-A2B A1 baseline

Rematerialized cache-only baseline:
- total holdings = 6;
- eligible = 6;
- review required = 0;
- methodology unavailable = 0.

### Validation and ChatGPT audit

Codex-reported validation:
- focused A1/A2 and Pharma authority tests: PASS;
- TypeScript: PASS;
- architecture guard: PASS;
- changed-file ESLint: PASS;
- shell syntax: PASS;
- production build: PASS with the inherited chunk-size warning;
- `git diff --check`: PASS;
- secret check: PASS.

ChatGPT subsequently audited pushed commit
`2b76b93c557d74cb4a6b00ad9518cd8e17b7cd6b` and confirmed:

- A2B call budgeting is truthful:
  - identity discovery required → 6-call ceiling;
  - verified existing identity → 4-call ceiling;
- provider identity readiness participates in the plan fingerprint;
- conflicting provider identities block A2B;
- exact symbol + ISIN reconciliation remains fail-closed;
- canonical provider identity is persisted through the existing Stage-7 identity
  architecture;
- A2B runner accounts identity calls and research calls together;
- A2B stage authority remains isolated from A2C;
- ALIVUS remains bound to the reviewed `API_BULK_DRUGS` methodology authority;
- no generic Pharma fallback was introduced;
- no score, recommendation or sizing path was activated.

One non-blocking implementation note:
- the new local `resolve-trendlyne-identity` Edge function does not currently
  require a separate `supabase/config.toml` entry for the tested authenticated
  local flow and executed successfully;
- this should only be revisited if a real local-function configuration problem
  appears later.

### Formal status after A2B

```text
Program A
├── A1   COMPLETE / PASS / CLOSED
├── A2A  COMPLETE / PASS / CLOSED
├── A2B  COMPLETE / PASS / CLOSED
└── A2C  NOT EXECUTED
```

**Program A · A2B = COMPLETE / PASS / CLOSED.**

Program A · A2 remains IN PROGRESS only because A2C has not yet executed.

---

## Current next boundary — A2C fresh post-A2B plan required — 24 September 2026

A2C is the separately approval-gated Angel One market-history pilot.

Its purpose is to fill bounded R5 market-history / benchmark gaps required for
later deterministic momentum and risk evidence. It must not perform scoring,
recommendation, sizing or any Program-B runtime activation.

Important rule:
- do not reuse pre-A2B plan
  `5cd6565e901131bb1a58e5003cba7b5ef7834f258f46087b5c0bde1e27914b25`;
- provider identity and research-evidence state changed during A2B, therefore a
  fresh post-A2B PLAN is required before A2C approval.

Next sequence:
1. rematerialize the post-A2B cache-only baseline;
2. generate a fresh V12 A2 plan;
3. inspect only the A2C actions:
   - exact security-history targets;
   - requested date windows;
   - benchmark-history actions;
   - Angel One call count;
4. confirm A2A actions remain zero and no A2B action needs another refresh;
5. approve A2C separately;
6. execute `EXECUTE_STAGE ... A2C ...`;
7. stop after A2C and rematerialize again;
8. then determine whether Program A is fully COMPLETE / PASS / CLOSED.

A2C restrictions remain:
- no Trendlyne execution unless separately required by a newly reviewed plan;
- no scoring;
- no recommendation;
- no position sizing;
- no persistence of scores/recommendations/sizing;
- no scheduler or AI activation;
- no production mutation;
- no deployment;
- no PR merge;
- no trading.

**Current project boundary = fresh post-A2B A2C planning and review.**


---

## Program A · A2C first execution partial stop and canonical BANK guard correction — 24 September 2026

The first A2C execution under V13 stopped safely after two successful Angel One
security-history actions.

Executed V13 plan:
- plan ID `db9e0e5d9e59e8cd1f187174027088203c965d4f32f861140db7b494fbf4a4af`;
- confirmation token `APPROVE_PROGRAM_A_A2_DB9E0E5D9E59E8CD`;
- execution status `PARTIAL_STOPPED`;
- actual Angel One calls = 2;
- Trendlyne calls = 0;
- retries = 0;
- successful local writes = 492;
- score / recommendation / sizing writes = 0.

Successful actions:
- AUROPHARMA market history:
  - 246 candles stored;
  - earliest `2025-09-24`;
  - latest `2026-09-22`;
  - requested one-year window remained incomplete through `2026-09-24`;
- HDFCBANK market history:
  - 246 candles stored;
  - earliest `2025-09-24`;
  - latest `2026-09-22`;
  - requested one-year window remained incomplete through `2026-09-24`.

Safe-stop blocker:
- NIFTY_BANK benchmark dispatch did not occur;
- the legacy guard in `refresh-bank-benchmark` accepted only
  `Banking / Banks`;
- HDFCBANK's reviewed canonical classification is
  `Banking / Private Sector Bank`;
- this is a compatibility defect between the old benchmark guard and the already
  approved canonical BANK routing authority, not a reason to route HDFCBANK to
  NBFC_LENDING;
- TORNTPHARM did not execute because A2C stopped immediately at this blocker.

Post-stop fresh zero-provider plan:
- plan ID `be56e35fc3bd3e4bccd0816258c3d37cf080bcdb365549c12f92b9c9a363f9ee`;
- confirmation token `APPROVE_PROGRAM_A_A2_BE56E35FC3BD3E4B`;
- AUROPHARMA → incremental `2026-09-17 → 2026-09-24`;
- HDFCBANK → incremental `2026-09-17 → 2026-09-24`;
- NIFTY_BANK → full benchmark history `2025-09-24 → 2026-09-24`;
- TORNTPHARM → incremental `2026-09-12 → 2026-09-24`;
- PLAN provider calls = 0.

ChatGPT audited pushed V13 commit
`703e028f2a9b3b9fcfade6320ffe0ae8ae066b59` and confirmed:
- A2C physical Angel One calls are scope-bound with no numeric execution ceiling;
- approved target scope remains bounded;
- a 61-second cooldown is enforced between Angel One A2C dispatches;
- the NIFTY_BANK blocker is the stale exact industry guard in the benchmark Edge
  function.

Focused correction implemented on `program-a-evidence-coverage`:
- new shared helper:
  `supabase/functions/_shared/bank-benchmark-authority.ts`;
- new focused tests:
  `supabase/functions/_shared/bank-benchmark-authority.test.ts`;
- benchmark guard now allows only:
  - `Banking / Banks`;
  - `Banking / Private Sector Bank`;
- NBFC lending, unsupported Banking industries, non-Banking sectors and missing
  classification remain fail-closed;
- `refresh-bank-benchmark` now uses the shared authority helper rather than the
  obsolete exact `Banks` check;
- no BANK/NBFC scoring or methodology logic changed.

Focused-fix commits:
- `6d212e4f4d340fd7c239b52bbc45e9edfc61ef78`;
- `53455c60b3ce9c2497752b4483781d26a07ae0d5`;
- `88422d5bc227ff33c3ddd397129904f9f1e6bdf5`;
- `dbab6db1b5a22829670cfaddee9244e637257152`.

Local execution/validation is still required after pulling these commits.
A2C remains `PARTIAL_STOPPED / IN PROGRESS` until the residual plan is regenerated,
reviewed and executed locally.

Safety state remains:
- A2B did not execute;
- Trendlyne calls = 0;
- no score/recommendation/sizing activation;
- no production mutation or migration;
- no deployment;
- no PR merge;
- no scheduler / AI / trading activation.

**Current boundary: pull the canonical BANK guard fix locally, run focused validation,
regenerate a fresh A2C plan, then resume A2C only.**

---

## Program A · A2C local-auth blocker diagnosis and fail-closed runner correction — 24 September 2026

The post-BANK-guard A2C attempt labelled `AUROPHARMA / CAPABILITY_MISMATCH`
did not reach Angel One and made zero writes. The label was not evidence of an
application capability failure. The runner converted an unrecognised Edge/auth
error to the generic `CAPABILITY_MISMATCH` stop reason.

Verified local evidence:
- the authenticated Chrome session contains `sb-127-auth-token` with a
  775-character, three-segment user JWT;
- the prior browser-to-shell clipboard transfer was empty/truncated, so the
  runner did not have the authenticated browser session token;
- no provider call is necessary to diagnose this boundary;
- local `/auth/v1/user` verification has not yet completed because the browser
  JWT has not been transferred into the shell through an approved secure local
  mechanism.

Focused runner correction:
- trim local credential environment values before use;
- require the classification token only for A2A, and require the user JWT only
  for authenticated A2B/A2C execution;
- validate normal three-segment JWT shape;
- verify the user JWT against local `/auth/v1/user` before any A2B/A2C action or
  provider dispatch;
- fail closed with `AUTH_OR_CONFIG_ERROR` instead of allowing an auth failure to
  be misreported as a provider capability mismatch;
- do not expose the JWT or persist it in repository files.

Validation passed:
- Program A local-auth/provider-result Node tests: 12/12;
- A2 controller tests: 14/14;
- Edge provider-contract, BANK-authority and Angel One tests: 13/13;
- typecheck;
- changed-file ESLint;
- architecture guard;
- production build;
- `git diff --check`.

Execution remains stopped before provider dispatch until local `/auth/v1/user`
returns HTTP 200 with the real browser user JWT. The residual `be56e35...` plan
was not executed, A2A/A2B were not reopened, and Trendlyne was not called.

**Program A · A2C remains IN PROGRESS / NOT CLOSED.**
## Program A · A2C Edge-auth fix and unresolved Angel One Edge-runtime rejection — 24 September 2026

Starting repository state:
- branch `program-a-evidence-coverage`;
- HEAD `212b663ef44a5a9366d522ffade0b862fe18bb53`;
- unrelated untracked local fixture/audit files were preserved untouched.

Edge/JWT root cause and correction:
- local `/auth/v1/user` accepted the fresh 775-character, three-segment ES256
  browser JWT with HTTP 200;
- the installed Supabase CLI/runtime gateway rejected that same JWT with HTTP
  401 `Invalid JWT` before the Edge handler executed;
- `supabase/config.toml` now sets `verify_jwt = false` only for
  `refresh-market-history`, `refresh-bank-benchmark`, and
  `refresh-pharma-benchmark`;
- all three handlers retain mandatory Authorization-header handling, Supabase
  Auth `getUser()` validation, portfolio ownership validation and their existing
  capability/target guards;
- regression coverage binds the scoped configuration to those internal
  fail-closed checks;
- no global bypass or service-role user substitution was introduced.

Live local auth/capability results after restarting the local stack:
- `/auth/v1/user` valid JWT: HTTP 200;
- AUROPHARMA market-history PLAN: HTTP 200, provider calls 0;
- HDFCBANK market-history PLAN: HTTP 200, provider calls 0;
- NIFTY_BANK benchmark PLAN: HTTP 200, provider calls 0;
- TORNTPHARM market-history PLAN: HTTP 200, provider calls 0;
- missing, malformed, random and anonymous credentials: HTTP 401;
- BANK authority regression remained PASS, including rejection of NBFC lending.

Plan reconciliation:
- plan ID remained
  `be56e35fc3bd3e4bccd0816258c3d37cf080bcdb365549c12f92b9c9a363f9ee`;
- confirmation token remained `APPROVE_PROGRAM_A_A2_BE56E35FC3BD3E4B`;
- residual A2C actions/windows remained exactly AUROPHARMA `2026-09-17` to
  `2026-09-24`, HDFCBANK `2026-09-17` to `2026-09-24`, NIFTY_BANK
  `2025-09-24` to `2026-09-24`, and TORNTPHARM `2026-09-12` to `2026-09-24`;
- zero-provider plan generation did not schedule A2A and stage execution remained
  filtered to A2C.

Resumed execution evidence:
- the first post-restart attempt failed before provider dispatch with
  `MARKET_DATA_INTERNAL_ERROR` because the restarted embedded function runtime
  had not loaded the existing untracked `supabase/.env.local` provider secrets;
- after starting the local function server with that env file, two bounded A2C
  attempts reached Angel One session creation but failed with
  `ANGEL_SESSION_EXPIRED_HTTP_403` before historical-data dispatch;
- a safe host-side login diagnostic using the same configured fields and current
  TOTP returned HTTP 200, `status=true`, `message=SUCCESS`;
- explicit User-Agent testing did not change the Edge-runtime rejection and the
  experimental header change was removed;
- an unauthenticated credential-forwarding relay was not started because it did
  not satisfy the approved secure local handling boundary.

Final state for this checkpoint:
- Angel One historical-data calls = 0;
- Trendlyne calls = 0;
- retries that reached historical-data dispatch = 0;
- successful local evidence writes = 0;
- failed writes = 0;
- AUROPHARMA remains 246 rows, `2025-09-24` to `2026-09-22`;
- HDFCBANK remains 246 rows, `2025-09-24` to `2026-09-22`;
- NIFTY_BANK remains missing;
- TORNTPHARM remains 270 rows, `2025-08-17` to `2026-09-17`;
- post-attempt baseline remains 6 eligible, 0 review-required and 0
  methodology-unavailable holdings;
- A2C and the bounded A2 pilot remain **IN PROGRESS / NOT CLOSED** pending a
  secure resolution of the Edge-runtime-specific Angel One HTTP 403.

No production mutation, migration, deployment, merge, A2A/A2B provider work,
score/recommendation/sizing write, scheduler activation or trading action was
performed.

## Program A · A2C bounded execution closure — 24 September 2026

The preceding Edge-runtime blocker was subsequently resolved and the approved
A2C scope was completed locally. The authoritative local provider-secret source
was `supabase/.env.local`: both the successful host diagnostic and the explicitly
started local Edge runtime loaded that file. Safe comparison of every Angel One
variable used by the adapter showed matching presence, trimmed lengths and
non-reversible digests, with no leading/trailing whitespace. The main branch and
this branch use the same direct server/Edge Angel One login contract; neither
uses a browser proxy or credential relay. A temporary Edge diagnostic then
returned HTTP 200 / provider `SUCCESS` with the same configuration. The earlier
403 was therefore an intermittent provider/runtime session rejection, not a
verified request-contract or secret-value mismatch; no speculative provider
adapter change was retained.

Execution reconciliation:
- original approved plan: `be56e35fc3bd3e4bccd0816258c3d37cf080bcdb365549c12f92b9c9a363f9ee`;
- after successful partial writes made that plan stale, the equivalent residual
  plan was regenerated as
  `c4ad4d7daed469ab7e7df216458230e46c6041d6112fbf389438f3de9daee505`;
- the replacement remained A2C-only and contained the same four securities and
  benchmark, with incremental overlap windows advanced only by the newly stored
  evidence;
- final execution status: `SUCCEEDED`;
- final execution Angel One calls: 4, retries: 0, writes reported by the
  controller: 287;
- including the earlier successful partial attempt, controller-accounted A2C
  calls were 6 and writes were 297; net new unique stored candles were 277
  because overlap rows were idempotently upserted;
- Trendlyne calls: 0; score, recommendation and sizing writes: 0.

Final local coverage:
- AUROPHARMA: 247 daily rows, `2025-09-24` through `2026-09-23`;
- HDFCBANK: 247 daily rows, `2025-09-24` through `2026-09-23`;
- NIFTY_BANK: 271 daily rows, `2025-08-20` through `2026-09-23`, source
  `ANGEL_ONE`;
- TORNTPHARM: 274 daily rows, `2025-08-17` through `2026-09-23`.

The 24 September daily candle was not yet final during execution. A fresh
zero-provider-call V13 plan therefore truthfully proposes three one-call overlap
refreshes from `2026-09-18` through `2026-09-24` for AUROPHARMA, HDFCBANK and
TORNTPHARM; it proposes no NIFTY_BANK action. This is an expected intraday
refresh residual, not missing historical coverage, and no synthetic candle was
created. The fresh plan itself made zero provider calls and zero writes.

The one-time browser JWT transfer file was mode 600, was never printed or
committed, and was deleted with absence verified after execution. Program A ·
A2C is **COMPLETE / PASS / CLOSED** for the approved bounded pilot. No production
mutation, migration, deployment, merge, A2A/A2B execution, scheduler activation
or trading action occurred.


---

## Program B master plan frozen; B0 becomes active checkpoint — 24 September 2026

Program A is recorded as closed through the bounded local pilot at commit
`96309657dcd853d83a5c992e0237daa919af709b`.

The owner-approved Program B roadmap is now frozen to exactly six checkpoints:

```text
B0        Program A closure + Program B contract freeze
B1        R6 Contract & Architecture      (Checkpoint A)
B2        R6 Execution & Validation       (Checkpoint B)   → R6 closes here
B3        R7 Contract & Architecture      (Checkpoint A)
B4        R7 Execution & Validation       (Checkpoint B)   → R7 closes here
B-FINAL   Program B closure
```

**Hard cap:** no B5+ checkpoints. Granular requirements remain sections inside the
six checkpoints rather than becoming new gates.

The frozen Program B plan incorporates these corrections and safeguards:

- security-role lineage is mandatory, but `(security_id, role)` is **not** a timeless
  uniqueness key; lineage also carries effective assignment/version, methodology
  version, as-of date and run identity;
- shell-continuity/replay checks compare canonical deterministic business payloads
  after excluding explicitly nondeterministic metadata such as run IDs/timestamps;
- Gate K recommendation-policy portability may be inherited only where repository
  evidence proves K5 explicitly tested that property; Gate K closure alone is not
  sufficient evidence;
- Program B distinguishes **PORTFOLIO-WIDE DISPOSITION COMPLETE** from
  **PORTFOLIO-WIDE NUMERIC COVERAGE COMPLETE**; Program B requires the former and
  must not force numeric outputs where evidence/methodology is incomplete;
- B-FINAL closure language is local/candidate validation only unless a separately
  approved merge/deployment/production reconciliation later establishes production
  operation;
- B1 includes a machine-readable blocker/gap-output contract so Program B can state
  why a security is blocked without fetching evidence itself.

Program B invariants frozen for B0 review:

1. no evidence readiness → no score;
2. no valid score → no recommendation;
3. no valid recommendation → no sizing;
4. R6/R7 computation is cache-only;
5. zero Angel One / Trendlyne / OpenAI decision calls from Program B compute paths;
6. no missing-input renormalization;
7. no nearest-sector / nearest-methodology / generic fallback to authoritative score;
8. AI cannot compute or adjust score/recommendation/sizing;
9. owner target price, stop loss, target weight and role overrides remain untouched;
10. no production mutation, migration application, deployment, merge, scheduler
    activation or trading is authorized by this Program B plan.

The persistent reference copy for the build is:

`PortfolioAI_PROGRAM_B_MASTER_PLAN.md`

A copy is stored in the ChatGPT Library as the Program B master-plan reference.

**Current stop point:** execute **B0 only**. B1 must not begin until B0 verifies
Program A closure and freezes the inherited Gate I / Gate K contracts from actual
repository evidence.

No provider call, score write, recommendation write, sizing write, production
mutation, deployment, merge, scheduler or trading action was authorized or performed
by this documentation update.


---

## Program B · B0 closure verification and contract freeze — 24 September 2026

**Checkpoint:** B0 — Program A Closure Verification + Program B Contract Freeze
**Audit starting HEAD:** `5d4a52c0274f42e2db6078b486713550b854b1a9`
**Branch:** `program-a-evidence-coverage`
**Result:** **COMPLETE / PASS / CLOSED — OWNER APPROVAL REQUIRED BEFORE B1**

### Repository-state verification

B0 was performed from repository evidence only. No provider execution, scoring,
recommendation, sizing, migration, deployment, merge, scheduler change or trading
action was performed.

Program A closure is verified:

- A2A is **COMPLETE / PASS / CLOSED**. Its audited closure tip
  `5367f3ea53561938ea4a11dcbc1ac0c279372b04` is an ancestor of the B0 starting
  HEAD.
- A2B is **COMPLETE / PASS / CLOSED**. Audited commit
  `2b76b93c557d74cb4a6b00ad9518cd8e17b7cd6b` is an ancestor of the B0 starting
  HEAD.
- A2C is **COMPLETE / PASS / CLOSED** for the approved bounded provider pilot at
  commit `96309657dcd853d83a5c992e0237daa919af709b`.
- The B0 starting HEAD is exactly two commits ahead of the A2C closure commit and
  zero commits behind it. The post-closure file changes before B0 are documentation
  only: the cumulative handoff and the Program B master plan.
- Final A2C local coverage remains recorded as:
  - AUROPHARMA: 247 daily rows, `2025-09-24` through `2026-09-23`;
  - HDFCBANK: 247 daily rows, `2025-09-24` through `2026-09-23`;
  - NIFTY_BANK: 271 daily rows, `2025-08-20` through `2026-09-23`;
  - TORNTPHARM: 274 daily rows, `2025-08-17` through `2026-09-23`.
- The 24 September 2026 daily candle was not final during A2C execution. The
  resulting zero-provider-call overlap-refresh proposal is therefore an expected
  intraday freshness residual, not missing historical coverage and not an
  unresolved Program A blocker. No synthetic candle was created.
- Historical A2C authentication/provider-runtime blockers recorded earlier in the
  handoff were superseded by the successful bounded execution and closure commit.
  They are not carried into Program B as unresolved blockers.
- Broader portfolio evidence incompleteness remains an intentional runtime
  readiness condition. It does not reopen Program A and must fail closed inside
  Program B rather than being repaired by hidden fetching or reconstruction.

Therefore:

```text
Program A closure = VERIFIED
Bounded Program A provider pilot = COMPLETE / PASS / CLOSED
Final A2C closure commit in ancestry = VERIFIED
Unresolved Program A blocker carried into Program B = NONE
```

### Inherited Gate I contracts

Program B may inherit the following Gate I facts, within their proved scope:

1. Recommendation authority consumes an already authoritative score; it does not
   reconstruct a missing overall score from partial dimensions.
2. `SCORE_READY` and `SCORE_NOT_COMPUTABLE` remain distinct typed states.
   A non-computable score stays null/fail-closed for recommendation.
3. Missing mandatory recommendation-floor data yields an insufficient/not-ready
   outcome rather than a fabricated negative signal.
4. A failed role floor continues down the approved role ladder; it does not
   silently renormalize or manufacture a different score.
5. Recommendation computation remains deterministic, read-only and non-persisting
   unless a later separately approved contract explicitly changes persistence.
6. User-selected portfolio role remains separate from the PortfolioAI suggested
   research role; recommendation logic must not mutate the owner-selected role.
7. PHARMA_V1 secondary overlays remain contextual and cannot create a second
   independent recommendation or numeric modifier.
8. The owner-approved PHARMA_V1 recommendation policy is valid only for its own
   methodology lineage. Its locked numeric thresholds are:
   - Core candidate: overall score >= 80;
   - Satellite candidate: overall score >= 65;
   - Watch: overall score >= 50;
   with the approved PHARMA_V1 role-floor and caution semantics.
9. Those PHARMA_V1 numeric thresholds are **not** a universal Program B policy and
   must not be imported into another sector/profile without separate authority.

### Inherited Gate K contracts

Program B may inherit the following Gate K facts:

1. Sector is macro context; Industry is the minimum micro-methodology selector;
   Basic Industry is business-model refinement; subprofile/profile selects
   metric/applicability/valuation/risk authority.
2. Registered research engines are isolated. A sector/profile cannot resolve,
   score, benchmark, value or recommend through another sector/profile's authority.
3. Unsupported routing fails closed. No nearest-looking engine,
   `GENERAL_FALLBACK`, nearest-sector or ticker-specific fallback is permitted.
4. Every holding may resolve to an explicit architecture disposition such as
   supported/ready-for-methodology, methodology unavailable, review required or
   not applicable. Architecture coverage does not imply evidence completeness or
   numeric score/recommendation coverage.
5. Supported future-stock routing is based on canonical classification/business
   identity and registry authority, not ticker identity.
6. The universal Research shell remains shared; sector/profile methodology is
   supplied through contracts rather than separate symbol-specific page trees.
7. K5 explicitly confirmed portable recommendation semantics:
   - missing mandatory evidence remains fail-closed;
   - missing recommendation-floor data remains insufficient;
   - MISSING and N/A remain distinct;
   - no score reconstruction from incomplete mandatory inputs;
   - no recommendation computation writes;
   - failed role floors may continue down the approved role ladder.
8. K5 explicitly did **not** establish universal numeric recommendation-threshold
   portability. Its frozen result is:
   `DO_NOT_INTRODUCE_UNIVERSAL_NUMERIC_THRESHOLDS`.
9. Sector/profile-specific numeric recommendation authority therefore remains a
   separate evidence-and-owner-approval question.

### B3 obligations carried forward from the portability audit

These are future contract obligations only; no B3 work is started in B0:

- B3 must not generalize the PHARMA_V1 80 / 65 / 50 thresholds to other
  sectors/profiles merely because Gate I and Gate K are closed.
- B3 must either bind recommendation thresholds/floors/blockers to an explicitly
  approved sector/profile authority or return a non-computable/not-ready state.
- B3 must preserve the portable K5 semantics for missing mandatory inputs,
  MISSING-vs-N/A, fail-closed score authority and zero hidden reconstruction.
- B3/R7 sizing must not borrow another sector's sizing heuristic. Owner target
  price, stop loss, target weight and role overrides remain owner-controlled.

### Program B invariants frozen at B0

The following invariants are now frozen exactly for Program B:

1. **No evidence readiness → no score.**
2. **No valid score → no recommendation.**
3. **No valid recommendation → no sizing.**
4. R6/R7 computation is **cache-only**.
5. **Zero Angel One calls** from scoring/recommendation/sizing computation.
6. **Zero Trendlyne calls** from scoring/recommendation/sizing computation.
7. **Zero OpenAI calls** for numeric scoring, recommendation or sizing decisions.
8. Missing input is never repaired by hidden renormalization.
9. Unsupported methodology is never replaced with `GENERAL_FALLBACK` or
   nearest-sector logic.
10. No sector may borrow another sector's methodology or sizing heuristic.
11. AI may explain a deterministic result later; AI may not create or alter the
    deterministic result.
12. Owner target price, stop loss, target weight and role overrides remain
    owner-controlled.
13. Equity/non-equity applicability remains explicit.
14. No production mutation, deployment, merge, scheduler activation or trading is
    authorized by Program B.
15. Any database migration must be additive, genuinely required, separately
    reviewed and separately approved before application.

### B0 exit

```text
Program A closure = VERIFIED
Program B invariants = FROZEN
Inherited Gate I / Gate K contracts = EXPLICITLY RECORDED
B0 = COMPLETE / PASS / CLOSED
Next stage = B1 only, after explicit owner approval
```

**STOP BOUNDARY:** B1 has not started. No B1 architecture, implementation or
validation work is authorized by this B0 closure.


---

## Program B · B1 R6 contract architecture candidate — 24 September 2026

**Checkpoint:** B1 — R6 Contract & Architecture / Checkpoint A
**Owner authorization:** APPROVED TO BEGIN B1
**Starting commit:** `10c87a5d9a2eb5338db51f3f85e5f5ce1ff9a605`
**Implementation commits:**
- `306a4d9ce8de4fb9e6ccdf478767181471b30072` — B1 contract architecture candidate;
- `b2d37a66380ecf605733dd6f75340002ac97ee80` — strict-TypeScript contract correction.

**Current status:** **IMPLEMENTED CANDIDATE / OWNER-LOCAL VALIDATION PENDING**
**B2 status:** **NOT STARTED / NOT AUTHORIZED**

### B1 artifacts added

- `src/features/research/programBR6Contract.ts`
- `src/features/research/programBR6Contract.test.ts`
- `docs/PortfolioAI_PROGRAM_B_B1_R6_CONTRACT_ARCHITECTURE.md`
- `scripts/b1-validate-r6-contract.sh`

No existing scoring formula, provider adapter, database schema, scheduler, recommendation
engine or sizing engine was modified.

### B1.1 scoring-readiness adapter

The B1 contract now exposes the frozen readiness state set:

```text
READY
INSUFFICIENT_EVIDENCE
STALE_REQUIRED_EVIDENCE
CONFLICTING_EVIDENCE
REVIEW_REQUIRED
METHODOLOGY_NOT_AVAILABLE
NOT_APPLICABLE
BLOCKED_PREREQUISITE
```

Only `READY` returns `canScore = true`.

The adapter evaluates, cache-only:

- security identity;
- equity/non-equity applicability;
- canonical classification state/version;
- methodology resolution/version;
- assignment requirement/state/version/role;
- required evidence applicability/state;
- required market-history state.

Explicit N/A remains distinct from missing evidence.

### B1.2 methodology resolver

B1 deliberately reuses the existing Gate-K authority chain:

```text
canonical classification
        ↓
Gate-K industry-first routing
        ↓
SectorEngineRegistry
        ↓
profile methodology authority
```

No second methodology registry was introduced.

The resolver preserves:
- sector as macro context;
- industry as minimum micro-methodology selector;
- basic industry as business-model refinement context;
- profile/subprofile assignment as downstream role/applicability refinement;
- `NONE_FAIL_CLOSED` fallback.

Pending/unsupported/unresolved methodology remains
`METHODOLOGY_NOT_AVAILABLE` or `REVIEW_REQUIRED`; no nearest-sector,
ticker-specific or `GENERAL_FALLBACK` path exists.

### B1.3 evidence-to-score lineage contract

The future authoritative score contract now requires lineage for:

- security id and as-of date;
- classification version;
- assignment id/version and methodology role;
- methodology id/version;
- evidence snapshot/evidence ids;
- evidence as-of dates/freshness;
- metric values/applicability/component scores/weights;
- category scores and overall score;
- readiness/reason codes;
- calculation version;
- run id and created timestamp.

B1 does not instantiate or calculate an authoritative numeric score.

The lineage-identity helper includes:

```text
security
+ methodology role
+ assignment id/version
+ methodology id/version
+ as-of date
+ run id
```

Therefore `(security_id, role)` is not used as a timeless uniqueness key.

### B1.4 machine-readable blocker/gap contract

Fail-closed readiness may emit structured blockers containing:

- security id;
- readiness state;
- blocking domain/metric;
- required and observed state;
- reason code;
- methodology id/role;
- assignment version;
- as-of date;
- descriptive `recommendedNextEvidenceAction`.

The action is descriptive only. Program B contains no dispatch/fetch path.

### Static/repository audit before local validation

Repository diff from B0 closure commit `10c87a5d...` to B1 candidate
`b2d37a66...` contains exactly four new files and no migration/provider/database
changes.

A strict-TypeScript review before handoff recording corrected:
- Gate-K unresolved-state union mapping into the narrower B1 methodology-state
  contract;
- non-null indexing required by repository `noUncheckedIndexedAccess`.

Remote branch HEAD after correction:
`b2d37a66380ecf605733dd6f75340002ac97ee80`.

No GitHub workflow run was reported for the candidate at audit time. Vercel status
was pending and is not treated as B1 validation evidence.

### Owner-local validation command

After pulling the branch locally:

```bash
git pull
bash scripts/b1-validate-r6-contract.sh
```

The B1 runner executes:
- focused B1 contract tests;
- Gate-K registry/isolation/routing/portability regressions;
- scoring-profile resolution regression;
- TypeScript;
- architecture guard;
- production build;
- `git diff --check`.

B1 must remain open until this consolidated local validation passes and the owner
approves all four B1 components together.

### Safety state

```text
provider calls = 0
Angel One calls = 0
Trendlyne calls = 0
OpenAI decision calls = 0
numeric scoring executed = NO
score persistence = NO
recommendation computation/persistence = NO
position sizing = NO
production mutation = NO
migration = NO
deployment = NO
merge = NO
scheduler mutation = NO
trading = NO
```

**Current stop boundary:** B1 candidate implemented; owner-local validation pending.
Do not begin B2.


### B1 owner-local validation attempt 1 — focused blocker-metric correction

Owner-local command:

```bash
git pull
bash scripts/b1-validate-r6-contract.sh
```

First run result:
- 6 test files executed;
- 5 test files passed;
- 1 test file failed;
- 43 tests passed;
- 1 test failed;
- failure was in
  `programBR6Contract.test.ts > distinguishes missing, stale, conflicting and review-required evidence`.

Observed mismatch:
- expected blocker `blockingMetric = BANK_ASSET_QUALITY`;
- received blocker `blockingMetric = undefined`.

Root cause:
- the B1 input evidence contract names the field `metricCode`;
- the generic blocker contract names the emitted field `blockingMetric`;
- the readiness loop passed the evidence object to the blocker helper without
  explicitly mapping `metricCode -> blockingMetric`;
- readiness classification itself remained correct; the defect affected structured
  blocker lineage only.

Correction:
- commit `bfe3b714a631df631f201e8ad90267702ebce544`;
- explicit field mapping now passes:
  - `blockingDomain = evidence.blockingDomain`;
  - `blockingMetric = evidence.metricCode`;
  - `state = evidence.state`;
  - `recommendedNextEvidenceAction = evidence.recommendedNextEvidenceAction`.

No methodology, readiness-state precedence, scoring logic, provider path, database
schema or safety boundary changed.

**B1 remains OPEN / OWNER-LOCAL VALIDATION REQUIRED.**
B2 remains NOT STARTED / NOT AUTHORIZED.


---

## Program B · B1 owner-local validation closure — 24 September 2026

Owner-local consolidated B1 validation was rerun after the focused
`metricCode -> blockingMetric` lineage correction.

Command:

```bash
git pull
bash scripts/b1-validate-r6-contract.sh
```

Owner-reported final result: **ALL PASS**.

Because the runner is fail-fast and reaches its final PASS marker only after all
steps succeed, this closes the following validation surface:

- B1 R6 contract tests;
- Gate-K registry, isolation, routing and recommendation-portability regressions;
- scoring-profile resolution regression;
- TypeScript;
- architecture guard;
- production build;
- `git diff --check`.

The earlier first-run failure was limited to structured blocker lineage:
`metricCode` was not copied into emitted `blockingMetric`. The correction at
`bfe3b714a631df631f201e8ad90267702ebce544` did not alter readiness-state
precedence, methodology routing, evidence semantics, provider boundaries or any
numeric-scoring logic.

B1 closure:

```text
B1.1 scoring-readiness adapter = COMPLETE / PASS / CLOSED
B1.2 methodology resolver = COMPLETE / PASS / CLOSED
B1.3 evidence-to-score lineage contract = COMPLETE / PASS / CLOSED
B1.4 machine-readable blocker/gap contract = COMPLETE / PASS / CLOSED

Program B · B1 = COMPLETE / PASS / CLOSED
R6 Checkpoint A = CLOSED
Next stage = B2 — R6 Execution & Validation, only after explicit owner approval
```

Safety remained unchanged throughout B1:
- provider calls = 0;
- Angel One calls = 0;
- Trendlyne calls = 0;
- OpenAI decision calls = 0;
- numeric Program B scoring executed = NO;
- score persistence = NO;
- recommendation computation/persistence = NO;
- position sizing = NO;
- production mutation = NO;
- migration = NO;
- deployment = NO;
- merge = NO;
- scheduler change = NO;
- trading = NO.

**STOP BOUNDARY:** B2 has not started and is not authorized by this closure.


---

## Program B · B2 R6 execution/validation candidate — 24 September 2026

**Checkpoint:** B2 — R6 Execution & Validation / Checkpoint B
**Owner authorization:** APPROVED TO BEGIN B2
**Starting commit:** `3a2adc6b8bc04b3645676bf50ce09d3a8ea27720`
**Implementation commits:**
- `1815cb72794e2af8adfe963f6ff18cdf14693427` — R6 deterministic execution/disposition layer;
- `0a8c79602b898ecc4289e99e0d0edd7c08f02e4a` — shared Research UI readiness/methodology integration;
- `2ad45fe78abdd176b8d109bd762024c7f545caa6` — widened B2 regression runner.

**Current status:** **IMPLEMENTED CANDIDATE / OWNER-LOCAL VALIDATION PENDING**
**B3 status:** **NOT STARTED / NOT AUTHORIZED**

### B2 deterministic reference execution

B2 reuses already-closed deterministic artifacts; it does not invent new scoring
curves or fetch evidence.

Reference cohort:
- TORNTPHARM / `DOMESTIC_FORMULATIONS` → existing Gate-H deterministic score;
- ALIVUS / `API_BULK_DRUGS` → existing G10.1 deterministic score;
- AUROPHARMA / `GLOBAL_GENERICS` → preserved fail-closed insufficient-evidence state;
- BIOCON / `BIOPHARMA_BIOSIMILARS` → preserved fail-closed state;
- SYNGENE / `CDMO_CRAMS` → preserved fail-closed state;
- HDFCBANK / `BANK` → included, but B2 does not fabricate a new bank score because
  a cache-pure B2 bank reference score-input snapshot is not materialized in the
  repository artifact layer.

The HDFCBANK outcome is therefore explicitly
`BLOCKED_PREREQUISITE / B2_CACHE_PURE_BANK_REFERENCE_INPUT_SNAPSHOT_NOT_MATERIALIZED`
rather than a reconstructed score.

### Replay and lineage

B2 canonical replay compares deterministic business payload fields only and
excludes nondeterministic run/timestamp/storage metadata.

Role-scoped evidence identity now requires:

```text
security
+ methodology role
+ assignment id/version
+ effective-from date
+ evidence id
```

This prevents same-name subprofile evidence from leaking across companies or
between Primary/Overlay roles.

### Portfolio-wide disposition pass

Repository-wide disposition uses the frozen:

`K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22`

All 238 equity rows receive a canonical outcome from:

```text
SCORED
INSUFFICIENT_EVIDENCE
STALE_REQUIRED_EVIDENCE
CONFLICTING_EVIDENCE
REVIEW_REQUIRED
METHODOLOGY_NOT_AVAILABLE
NOT_APPLICABLE
BLOCKED_PREREQUISITE
```

If routing is supported but a canonical B2 score-input snapshot is not materialized,
the row is explicitly blocked rather than scored.

Important scope note:
- the 238-row K5 snapshot is a frozen 22 September repository validation fixture;
- later Program A pilot evidence/classification is newer for a small reference
  subset;
- therefore the B2 portfolio pass is a **repository-wide frozen-snapshot
  disposition validation**, not a claim of 24 September production/live-state
  reconciliation;
- the controlled reference cohort separately validates the later closed artifacts.

B2 distinguishes:
- `PORTFOLIO-WIDE DISPOSITION COMPLETE`;
- `PORTFOLIO-WIDE NUMERIC COVERAGE COMPLETE`.

The candidate is designed to prove the first without falsely asserting the second.

### Controlled applicability/fail-closed controls

- unsupported-methodology control is selected dynamically from the frozen K5
  portfolio rather than hard-coded by ticker;
- K5's frozen routing fixture contains equities only, therefore the non-equity
  applicability test uses an explicit synthetic ETF contract control;
- this synthetic control is not represented as a real portfolio holding.

### Shared Research UI integration

The universal `ResearchScorecardPanel` now exposes:
- Score readiness;
- Methodology;
- Methodology role;
- Evidence date / snapshot;
- Blocked inputs;
- Fail-closed reason.

`ResearchPage` supplies methodology role through the existing industry-first
router, with reviewed Pharma Primary subprofile taking precedence when available.

The UI retains the distinction:

```text
verified evidence coverage != score readiness
```

No separate Pharma/Bank page tree was introduced.

### Validation runner

Owner-local command:

```bash
git pull
bash scripts/b2-validate-r6-execution.sh
```

The runner:
- validates B2 execution/replay/disposition;
- reruns B1 readiness;
- reruns Gate-H / G10 Pharma controls;
- reruns K5 isolation/routing/portability;
- reruns K3 BANK/NBFC boundaries;
- reruns shared scorecard and Research page tests;
- prints the canonical 238-row disposition summary;
- runs TypeScript;
- runs the architecture guard;
- runs the production build;
- runs `git diff --check`.

### Safety state

```text
provider calls from B2 = 0
Angel One calls = 0
Trendlyne calls = 0
OpenAI decision calls = 0
score persistence = NO
recommendation computation/persistence = NO
position sizing = NO
production mutation = NO
migration = NO
deployment = NO
merge = NO
scheduler mutation = NO
trading = NO
```

**Current stop boundary:** B2 candidate implemented; owner-local validation pending.
Do not begin B3.


### B2 owner-local validation attempt 1 — stale K3 BANK regression correction

Owner-local command:

```bash
git pull
bash scripts/b2-validate-r6-execution.sh
```

First B2 validation run result:
- 14 test files executed;
- 13 test files passed;
- 1 test file failed;
- 88 tests passed;
- 1 test failed;
- failure was in
  `k3BankNbfcClosure.test.ts > makes the NIFTY Bank operational refresh classification-driven rather than HDFCBANK-driven`.

Observed mismatch:
- the legacy K3 test expected inline expressions:
  - `key(classification.data.sector) !== "BANKING"`;
  - `key(classification.data.industry) !== "BANKS"`;
- the current implementation no longer contains that local `key(...)` guard.

Repository audit confirmed this is a stale regression assertion, not a production
BANK-routing regression:

- A2C intentionally replaced the inline K3 guard with the shared canonical helper
  `isBankBenchmarkEligibleClassification`;
- the current benchmark function still reads
  `current_security_enrichment_v1(sector,industry)`;
- it invokes
  `isBankBenchmarkEligibleClassification(classification.data.sector, classification.data.industry)`;
- the shared helper approves only:
  - `Banking / Banks`;
  - `Banking / Private Sector Bank`;
- NBFC lending, unsupported Banking industries, non-Banking sectors and missing
  classification remain fail-closed;
- HDFCBANK is still not used as a runtime symbol selector.

This A2C correction was already recorded under commits including:
- `88422d5bc227ff33c3ddd397129904f9f1e6bdf5` — align NIFTY Bank guard with canonical BANK routing;
- `dbab6db1b5a22829670cfaddee9244e637257152` — remove obsolete local classification key helper.

B2 correction:
- commit `e888d52b26843ee6c6c600f024583dc6d3a35771`;
- updated the stale K3 test to assert:
  - canonical classification lookup;
  - import/use of the shared BANK benchmark authority;
  - absence of an HDFCBANK-specific runtime guard;
- added
  `supabase/functions/_shared/bank-benchmark-authority.test.ts`
  to the B2 consolidated runner.

No production benchmark code, provider behavior, methodology authority, score
logic, database object, migration or safety boundary was changed.

**B2 remains OPEN / OWNER-LOCAL VALIDATION REQUIRED.**
B3 remains NOT STARTED / NOT AUTHORIZED.


---

## Program B · B2 / R6 owner-local validation closure — 24 September 2026

Owner-local consolidated B2 validation was rerun after the stale K3 BANK regression
assertion was aligned with the current shared BANK benchmark authority.

Command:

```bash
git pull
bash scripts/b2-validate-r6-execution.sh
```

Owner-reported final result: **PASSED**.

Because the runner is fail-fast and reaches its final PASS marker only after all
steps succeed, this closes the B2 validation surface:

- Program B B2 execution / replay / portfolio-disposition tests;
- Program B B1 readiness-contract regressions;
- Gate-H TORNTPHARM deterministic-score regression;
- G10 Pharma reference regressions for ALIVUS, AUROPHARMA, BIOCON and SYNGENE;
- Gate-K cross-sector isolation, routing and recommendation-portability regressions;
- Gate-K3 BANK/NBFC closure and portability regressions;
- shared BANK benchmark-authority regression;
- shared Research scorecard UI regression;
- Research page regression;
- canonical 238-row frozen-snapshot disposition report generation;
- TypeScript;
- architecture guard;
- production build;
- `git diff --check`.

The first B2 local attempt failed only because
`k3BankNbfcClosure.test.ts` still asserted the superseded inline
`key(sector)/key(industry)` implementation. Repository audit confirmed that A2C
had intentionally moved this authority into
`isBankBenchmarkEligibleClassification`, which:

- accepts `Banking / Banks`;
- accepts `Banking / Private Sector Bank`;
- rejects NBFC lending;
- rejects unsupported Banking industries;
- rejects non-Banking sectors;
- fails closed when classification is absent.

Commit `e888d52b26843ee6c6c600f024583dc6d3a35771` corrected only the stale
regression assertion and added the shared BANK-authority test to the B2 runner.
No production benchmark implementation was changed.

### B2 / R6 closure

```text
B2.1 controlled reference cohort = COMPLETE / PASS / CLOSED
B2.2 deterministic scoring execution = COMPLETE / PASS / CLOSED
B2.3 replay validation = COMPLETE / PASS / CLOSED
B2.4 isolation and fail-closed validation = COMPLETE / PASS / CLOSED
B2.5 shell-continuity regression = COMPLETE / PASS / CLOSED
B2.6 Research UI integration = COMPLETE / PASS / CLOSED
B2.7 controlled portfolio expansion/disposition = COMPLETE / PASS / CLOSED

Program B · B2 = COMPLETE / PASS / CLOSED
R6 Checkpoint B = CLOSED
R6 = COMPLETE / PASS / CLOSED

Portfolio-wide scoring disposition = COMPLETE
Portfolio-wide numeric coverage = NOT CLAIMED / INCOMPLETE BY DESIGN
Role/sector/subprofile isolation = PASS
Shell continuity = PASS
Provider calls from R6 computation = 0
```

Scope lock retained:
- the portfolio-wide pass is against
  `K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22`;
- it is a frozen repository-wide disposition validation, not a claim that all
  238 rows are reconciled to 24 September live provider state;
- later Program A reference evidence remains newer for the bounded subset;
- unsupported/missing score-input cases remain canonical fail-closed outcomes,
  never reconstructed scores.

Safety remained unchanged throughout B2:
- Angel One calls from R6 computation = 0;
- Trendlyne calls from R6 computation = 0;
- OpenAI numeric decision calls = 0;
- score persistence = NO;
- recommendation computation/persistence = NO;
- position sizing = NO;
- production mutation = NO;
- migration = NO;
- deployment = NO;
- merge = NO;
- scheduler change = NO;
- trading = NO.

**STOP BOUNDARY:** B3 has not started and is not authorized by this closure.
Next stage is **B3 — R7 Contract & Architecture / Checkpoint A**, only after
explicit owner approval.


---

## Program B · B3 R7 contract architecture candidate — 24 September 2026

**Checkpoint:** B3 — R7 Contract & Architecture / Checkpoint A
**Owner authorization:** APPROVED TO BEGIN B3
**Starting commit:** `820d0b1d5e378b18b64e18f8c12d5c1abddae0c2`
**Implementation commits:**
- `ce2a4d6098b67aa0d9739f085e11f1992a3d45bb` — R7 recommendation/sizing contract architecture candidate;
- `67c0f9599520710b3cb61649b014799d98670535` — include R6 regressions in B3 validation runner.

**Current status:** **IMPLEMENTED CANDIDATE / OWNER-LOCAL VALIDATION PENDING**
**B4 status:** **NOT STARTED / NOT AUTHORIZED**

### B3.1 recommendation-readiness gate

The Program B R7 readiness gate now requires:

```text
equity applicability
+ SCORED R6 state
+ exact score-run identity
+ complete score lineage
+ approved profile recommendation policy
+ complete mandatory floor inputs
+ resolved caution/risk inputs
```

Only `READY` returns `canRecommend = true`.

Fail-closed mapping:
- insufficient/stale R6 score -> `INSUFFICIENT_EVIDENCE`;
- conflicting/review-required score -> `REVIEW_REQUIRED`;
- score methodology unavailable -> `METHODOLOGY_NOT_AVAILABLE`;
- missing score-run or score lineage -> `BLOCKED_PREREQUISITE`;
- non-equity -> `NOT_APPLICABLE`.

No recommendation score reconstruction exists in the B3 contract.

### B3.2 Gate I safety inheritance

B3 explicitly re-encodes and re-tests:

- missing mandatory recommendation-floor input -> insufficient / fail closed;
- failed floor remains distinct from missing input and may continue down the
  approved role ladder;
- material overlays cannot create an independent portfolio role;
- null/non-computable authoritative score remains fail-closed;
- recommendation computation writes remain disabled.

The authoritative numeric recommendation policy carried into Program B is:

`PHARMA_V1_RECOMMENDATION_POLICY_V1_OWNER_APPROVED`.

### B3.3 Program B recommendation-policy registry

A new explicit Program B recommendation authority registry contains exactly one
approved numeric policy at B3:

```text
PHARMA_V1
  threshold scope = PROFILE_SPECIFIC_ONLY
  source authority = Gate I / I2
  weight guidance authority = NOT_APPROVED
  sizing authority = NOT_APPROVED
```

The legacy BANK/NBFC Stage 8.8A thresholds remain a **DRAFT pilot** and are not
promoted into Program B authority.

Current resolution therefore is:

```text
PHARMA_V1 -> RESOLVED
BANK_NBFC -> METHODOLOGY_NOT_AVAILABLE
other profiles without separately approved recommendation policy
  -> METHODOLOGY_NOT_AVAILABLE
```

### B3.4 Gate K portability boundary

K5 was inspected directly. Its frozen result remains:

```text
numeric threshold portability = NOT_ESTABLISHED
decision = DO_NOT_INTRODUCE_UNIVERSAL_NUMERIC_THRESHOLDS
```

Therefore B3 explicitly freezes:
- universal numeric recommendation thresholds = forbidden;
- PHARMA_V1 80 / 65 / 50 thresholds remain PHARMA_V1-only;
- cross-sector sizing-heuristic borrowing = forbidden.

### B3.5 recommendation lineage

The Program B recommendation-lineage contract requires:

- recommendation run id;
- security id;
- exact source score run id;
- recommendation methodology id/version;
- score;
- applicable thresholds;
- cautions;
- reason codes;
- final recommendation;
- created timestamp.

Recommendation identity changes when the source score-run identity changes.

### B3.6 position-sizing readiness and anti-fallback

Sizing is a separate downstream engine.

A sizing policy authority is exact on:

```text
profile code
+ methodology role
+ sizing policy id/version
```

The contract can declare approved factors from:
- conviction;
- portfolio role;
- business quality;
- growth durability;
- permanent-loss risk;
- valuation;
- volatility;
- concentration;
- liquidity;
- portfolio fit.

Primary/Overlay and cross-sector borrowing are prohibited.

#### Current Program B numeric sizing authority

`PROGRAM_B_SIZING_POLICY_REGISTRY` is intentionally empty.

This is a deliberate authority result, not a missing implementation:
- no profile/role-specific Program B numeric sizing policy has yet been separately
  owner-approved;
- B3 therefore returns `METHODOLOGY_NOT_AVAILABLE` instead of manufacturing a
  target range.

The existing D35B `POSITION_SIZING_V1` remains a verified downstream receiving
engine/software contract only. Its historical HDFCBANK pilot weight guidance is
not inherited as Program B numeric sizing authority.

### B3.7 owner-authority preservation

Owner-controlled fields remain separate:

```text
targetPrice
stopLossPrice
targetWeight
portfolioRole
```

Program B machine-output fields are separately named:

```text
suggestedTargetWeight
suggestedMinimumWeight
suggestedMaximumWeight
recommendedAction
reasonCodes
confidence
assessmentState
```

The contracts are intentionally field-disjoint.

Program B sizing-action vocabulary is frozen as:

```text
ADD
HOLD
ADD_ON_WEAKNESS
REDUCE
TRIM
FREEZE
EXIT_REVIEW
```

These are assessments, not trade instructions.

### B3 artifacts

Added:
- `src/features/research/programBR7Contract.ts`;
- `src/features/research/programBR7Contract.test.ts`;
- `docs/PortfolioAI_PROGRAM_B_B3_R7_CONTRACT_ARCHITECTURE.md`;
- `scripts/b3-validate-r7-contract.sh`.

Repository diff from B2 closure through the B3 candidate contains only these four
new files. No migration/provider/database/scheduler/trading code was changed.

### Owner-local validation

Run:

```bash
git pull
bash scripts/b3-validate-r7-contract.sh
```

The consolidated runner covers:
- B3 R7 contracts;
- R6 B1/B2 regressions;
- Gate I recommendation authority/policy safety;
- K5 recommendation portability;
- sector recommendation fail-closed regressions;
- D35B sizing software regressions;
- owner decision-control regressions;
- TypeScript;
- architecture guard;
- production build;
- `git diff --check`.

### Safety state

```text
recommendation computation executed = NO
recommendation persistence = NO
sizing computation executed = NO
sizing persistence = NO
owner settings mutation = NO
provider calls = 0
Angel One calls = 0
Trendlyne calls = 0
OpenAI decision calls = 0
production mutation = NO
migration = NO
deployment = NO
merge = NO
scheduler change = NO
trading = NO
```

**Current stop boundary:** B3 candidate implemented; owner-local validation pending.
Do not begin B4.


### B3 Pharma dual-layer research invariant reinforcement

Owner clarified that Pharma is intentionally different from the ordinary sector
packages: each Pharma stock must be researched through both the common
`PHARMA_V1` research foundation and the reviewed Primary Pharma business-model
subprofile to which it belongs.

The canonical five Primary subprofiles remain:

```text
API_BULK_DRUGS
DOMESTIC_FORMULATIONS
GLOBAL_GENERICS
BIOPHARMA_BIOSIMILARS
CDMO_CRAMS
```

Repository audit confirmed the existing Pharma architecture already defines the
effective research contract as:

```text
PHARMA_V1 parent requirement
  + reviewed Primary subprofile override/addition
  + reviewed exposure condition
  + approved universal overlay requirement
  = effective security Pharma research contract
```

The five subprofiles remain children of `PHARMA_V1`; they do not replace the
parent profile.

B3 was tightened before owner-local validation in commit
`b9587227b09de6bc1a91092ac1a77516a642b315`:

- added a machine-readable
  `PROGRAM_B_PHARMA_DUAL_LAYER_RESEARCH` invariant;
- requires Pharma recommendation readiness to carry a canonical Primary subprofile;
- requires a Pharma subprofile assignment version;
- rejects a missing Primary as `BLOCKED_PREREQUISITE`;
- rejects a non-canonical Pharma Primary as `REVIEW_REQUIRED`;
- recommendation lineage now carries:
  - research parent profile code;
  - methodology role / Primary subprofile;
  - assignment version;
  in addition to the exact source score run and recommendation-policy identity;
- recommendation lineage identity changes when the Primary subprofile or assignment
  version changes;
- added regression cases proving
  `PHARMA_V1 + DOMESTIC_FORMULATIONS` cannot collapse into
  `PHARMA_V1 + GLOBAL_GENERICS`.

This does not create five top-level Pharma profiles and does not make five
independent stock scores. It preserves the established Pharma-specific layered
model: common Pharma research plus one Primary business-model research layer,
with secondary exposures/overlays handled only under separately approved rules.

No recommendation execution, sizing execution, provider call, persistence,
migration, deployment, merge, scheduler change or trading action occurred.

**B3 remains OPEN / OWNER-LOCAL VALIDATION PENDING.**


### B3 validation strengthening after Pharma dual-layer audit

After the owner-local B3 candidate runner reached `B3 CANDIDATE VALIDATION PASS`,
the validation surface was audited specifically for the Pharma architecture.

Confirmed repository behavior:
- Pharma remains a two-layer research model:
  - common `PHARMA_V1` parent research;
  - one reviewed Primary subprofile from the canonical five;
- the five canonical Primary subprofiles remain:
  - `API_BULK_DRUGS`;
  - `DOMESTIC_FORMULATIONS`;
  - `GLOBAL_GENERICS`;
  - `BIOPHARMA_BIOSIMILARS`;
  - `CDMO_CRAMS`;
- `composePharmaSubprofileContract(...)` composes the common parent exactly once
  and then applies the Primary subprofile additions/overrides;
- unresolved/provisional/disputed/conflicting Primary assignments remain
  fail-closed;
- Domestic-specific methodology cannot auto-apply to another Pharma Primary;
- secondary/material overlays do not create an independent second stock score;
- B3 recommendation readiness now requires the exact Pharma Primary and assignment
  version, and recommendation lineage retains parent profile + Primary + assignment
  version + exact source score run.

Validation-gap audit:
- the first B3 runner already tested the new Program B R7 dual-layer invariant and
  Gate I recommendation safety;
- however it did not explicitly re-run the older underlying Pharma assignment,
  effective-contract composition and subprofile-curve applicability regressions.

B3 validation was therefore strengthened in commit
`c5393dc631586a9ae42a79e4cc41dfbeb4ba6933` by adding:

- `src/features/research/pharmaSubprofileAssignment.test.ts`;
- `src/features/research/pharmaSubprofileContracts.test.ts`;
- `src/features/research/pharmaG6SubprofileCurveApplicability.test.ts`.

This is a test-runner strengthening only. No Pharma methodology, score,
recommendation, sizing, provider, database or production behavior was changed.

**B3 remains OPEN until the strengthened runner is re-executed locally.**


---

## Program B · B3 / R7 Checkpoint A owner-local validation closure — 24 September 2026

Owner-local consolidated B3 validation was rerun after strengthening the runner
to include the underlying Pharma dual-layer assignment/composition/curve
regressions.

Command:

```bash
git pull
bash scripts/b3-validate-r7-contract.sh
```

Owner-observed final result: **PASS**.

Observed validation summary:
- **15 test files passed**;
- **109 tests passed**;
- TypeScript passed;
- architecture guard passed;
- production build passed;
- `git diff --check` passed.

The strengthened Pharma validation explicitly covered:
- `pharmaSubprofileAssignment.test.ts`;
- `pharmaSubprofileContracts.test.ts`;
- `pharmaG6SubprofileCurveApplicability.test.ts`.

This proves the B3 closure against both layers of the Pharma model:

```text
PHARMA_V1 common parent research
        +
exactly one reviewed Primary Pharma subprofile
        ↓
effective Pharma research contract
```

Canonical Primary Pharma subprofiles remain exactly:

```text
API_BULK_DRUGS
DOMESTIC_FORMULATIONS
GLOBAL_GENERICS
BIOPHARMA_BIOSIMILARS
CDMO_CRAMS
```

Validated behavior includes:
- parent Pharma requirements are composed once;
- Primary subprofile additions/overrides are layered on top;
- missing/provisional/disputed/conflicting Primary assignment fails closed;
- Domestic-specific methodology does not auto-transfer to another Primary;
- secondary/material overlays do not create a second independent stock score;
- B3 recommendation readiness requires exact Primary subgroup and assignment
  version;
- recommendation lineage retains parent profile + Primary subgroup + assignment
  version + exact source score run.

The Vite large-chunk warning in the production build was informational only and
did not fail the build.

### B3 closure

```text
B3.1 recommendation-readiness gate = COMPLETE / PASS / CLOSED
B3.2 Gate I safety inheritance = COMPLETE / PASS / CLOSED
B3.3 recommendation policy authority = COMPLETE / PASS / CLOSED
B3.4 Gate K portability boundary = COMPLETE / PASS / CLOSED
B3.5 recommendation lineage = COMPLETE / PASS / CLOSED
B3.6 sizing readiness / anti-fallback = COMPLETE / PASS / CLOSED
B3.7 owner-authority preservation = COMPLETE / PASS / CLOSED
Pharma dual-layer invariant = COMPLETE / PASS / CLOSED

Program B · B3 = COMPLETE / PASS / CLOSED
R7 Checkpoint A = CLOSED
```

Safety state remained unchanged:
- recommendation computation executed = NO;
- recommendation persistence = NO;
- sizing computation executed = NO;
- sizing persistence = NO;
- owner-settings mutation = NO;
- provider calls = 0;
- Angel One calls = 0;
- Trendlyne calls = 0;
- OpenAI numeric decision calls = 0;
- production mutation = NO;
- migration = NO;
- deployment = NO;
- merge = NO;
- scheduler change = NO;
- trading = NO.

**STOP BOUNDARY:** B4 has not started and is not authorized by this closure.
Next stage is **B4 — R7 Execution & Validation / Checkpoint B**, only after
explicit owner approval.


---

## Program B · B4 R7 execution/validation candidate — 24 September 2026

**Checkpoint:** B4 — R7 Execution & Validation / Checkpoint B
**Owner authorization:** APPROVED TO BEGIN B4
**Starting commit:** `5128b575532f8069693a476019732f0f56622a55`
**Implementation commits:**
- `e6c4707ada231118c3718c9fcbefc8e5ae5e273c` — R7 execution/disposition candidate;
- `80e3171fa190f080ffaec8c20653bacb6ddf0cbd` — static lineage/typing tightening.

**Current status:** **IMPLEMENTED CANDIDATE / OWNER-LOCAL VALIDATION PENDING**
**B-FINAL status:** **NOT STARTED / NOT AUTHORIZED**

### B4.1 controlled R7 reference execution

B4 consumes the closed R6 reference artifacts and executes recommendation logic
only where B3 established current authority.

Recommendation-ready reference candidates:

```text
TORNTPHARM
  PHARMA_V1 + DOMESTIC_FORMULATIONS
  R6 score = 75.1575
  Gate I owner-approved policy
  expected R7 role = SATELLITE_CANDIDATE

ALIVUS
  PHARMA_V1 + API_BULK_DRUGS
  R6 score = 76.7225
  Gate I owner-approved policy
  expected R7 role = SATELLITE_CANDIDATE
```

The Pharma dual-layer rule remains mandatory:
- common `PHARMA_V1` parent research;
- exact reviewed Primary Pharma subgroup;
- assignment version;
- exact R6 score artifact identity.

TORNTPHARM uses the previously owner-reviewed Gate E assignment decision:
- Primary `DOMESTIC_FORMULATIONS`;
- assignment version 1;
- `GLOBAL_GENERICS` Material secondary exposure;
- `CDMO_CRAMS` Emerging secondary exposure.

ALIVUS reuses the G10.1 owner-validated reviewed assignment:
- Primary `API_BULK_DRUGS`;
- assignment version 1;
- `CDMO_CRAMS` Emerging Watch.

B4 rejects any source-score or Primary-subprofile mismatch.

### Fail-closed reference behavior

The remaining controlled references retain their R6 boundary:

```text
AUROPHARMA -> INSUFFICIENT_EVIDENCE
BIOCON      -> INSUFFICIENT_EVIDENCE
SYNGENE     -> INSUFFICIENT_EVIDENCE
HDFCBANK    -> BLOCKED_PREREQUISITE
```

No partial recommendation is reconstructed.

### B4.2 exact R6 -> R7 lineage

R6 reference scores are read-only/non-persisted artifacts. B4 therefore creates a
deterministic reference-run identity from the exact symbol + exact R6 artifact
version.

The recommendation identity includes:

```text
security
+ exact R6 reference run
+ parent research profile
+ Primary methodology role/subprofile
+ assignment version
+ recommendation policy id/version
```

The R7 execution asserts:
- recommendation source score equals the R6 source score;
- recommendation Primary equals the R6/assignment Primary;
- sizing receives the same exact score-run and recommendation-run identities.

### B4.3 sizing execution and edge cases

The Program B sizing-policy registry remains intentionally empty because no
profile/role-specific numeric sizing policy has been separately owner-approved.

Therefore even a recommendation-ready reference returns:

```text
sizing state = METHODOLOGY_NOT_AVAILABLE
suggested target weight = null
suggested minimum weight = null
suggested maximum weight = null
recommended action = null
```

Required B4 sizing edge cases are explicit:
- strong score + high concentration -> `METHODOLOGY_NOT_AVAILABLE`;
- strong score + high volatility -> `METHODOLOGY_NOT_AVAILABLE`;
- low evidence confidence -> `INSUFFICIENT_EVIDENCE`;
- incomplete holding -> `BLOCKED_PREREQUISITE`;
- ETF/non-equity -> `NOT_APPLICABLE`.

No generic sizing range is manufactured.

### B4.4 owner-authority mutation regression

The B4 owner fixture has existing:
- target price;
- stop loss;
- target weight;
- portfolio role.

B4 sizing produces a separate machine assessment only.

Required regression:

```text
owner settings before == owner settings after
owner field mutation count = 0
persistence mutation count = 0
```

B4 imports no owner-settings save path and authorizes no recommendation/sizing
persistence.

### B4.5 cross-surface canonical consistency

B4 defines one canonical decision payload and read-only projections for:
- Research;
- Portfolio;
- Action.

The three projections receive the same:
- source score;
- source score-run identity;
- recommendation-run identity;
- recommendation state/role;
- sizing state/policy;
- final disposition.

The projections do not independently recompute score, recommendation or sizing.

Existing Research-page / Pharma recommendation UI regressions remain in the B4
runner to ensure the shared shell remains semantically stable.

### B4.6 frozen portfolio-wide R7 disposition

The controlled portfolio pass remains scoped to:

`K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22`

All 238 equity rows receive explicit recommendation and sizing dispositions.

B4 intentionally distinguishes:

```text
portfolio-wide disposition complete
!= portfolio-wide numeric recommendation coverage
!= portfolio-wide numeric sizing coverage
```

Candidate expectation:
- recommendation-ready rows = the two currently score-ready, approved PHARMA_V1
  references;
- sizing-ready rows = 0 while sizing authority is absent;
- every other row remains explicit fail-closed / review / not-applicable as
  inherited from R6 and B3.

### B4 artifacts

Added:
- `src/features/research/programBR7Execution.ts`;
- `src/features/research/programBR7Execution.test.ts`;
- `scripts/program-b-b4-report.mjs`;
- `scripts/b4-validate-r7-execution.sh`;
- `docs/PortfolioAI_PROGRAM_B_B4_R7_EXECUTION_VALIDATION.md`.

No schema, migration, provider adapter, scheduler or trading code was changed.

### Owner-local validation command

```bash
git pull
bash scripts/b4-validate-r7-execution.sh
```

The runner executes:
- B4 R7 execution/replay/disposition;
- B3/R6 regressions;
- Pharma parent + five-subprofile regressions;
- Gate I recommendation authority/policy;
- TORNTPHARM/ALIVUS recommendation regressions;
- K5 portability;
- sector fail-closed regressions;
- D35B sizing software boundary;
- owner Decision Workspace regressions;
- Pharma recommendation UI;
- Research page regression;
- canonical B4 report;
- TypeScript;
- architecture guard;
- production build;
- `git diff --check`.

### Safety state

```text
provider calls = 0
Angel One calls = 0
Trendlyne calls = 0
OpenAI decision calls = 0
recommendation persistence = NO
sizing persistence = NO
owner settings mutation = NO
production mutation = NO
migration = NO
deployment = NO
merge = NO
scheduler change = NO
trading = NO
```

**Current stop boundary:** B4 candidate implemented; owner-local validation pending.
Do not begin B-FINAL.


---

## Program B · B4 / R7 owner-local validation closure — 24 September 2026

Owner-local consolidated B4 validation completed successfully.

Command:

```bash
git pull
bash scripts/b4-validate-r7-execution.sh
```

Owner-observed terminal closure markers:

```text
B4 CANDIDATE VALIDATION PASS
R7 provider calls: 0
Recommendation persistence: OFF
Sizing persistence: OFF
Owner settings mutation: 0
Next checkpoint: B-FINAL only after B4 closure and explicit owner approval
```

The run also showed:
- architecture guard passed;
- production build passed;
- Vite emitted only the existing informational large-chunk warning.

Because the runner is fail-fast, reaching the final B4 PASS marker confirms the
configured validation chain completed successfully.

### R7 recommendation execution

The currently authorized numeric recommendation executions remain the two
score-ready PHARMA_V1 references:

```text
TORNTPHARM
  parent profile = PHARMA_V1
  Primary = DOMESTIC_FORMULATIONS
  assignment version = 1
  R6 score = 75.1575
  R7 role = SATELLITE_CANDIDATE

ALIVUS
  parent profile = PHARMA_V1
  Primary = API_BULK_DRUGS
  assignment version = 1
  R6 score = 76.7225
  R7 role = SATELLITE_CANDIDATE
```

The Pharma architecture remains dual-layer and preserved end to end:

```text
PHARMA_V1 common parent research
        +
one reviewed Primary Pharma subprofile
        +
assignment version
        +
exact R6 score lineage
        ↓
PHARMA_V1 recommendation policy
```

Fail-closed controlled references remain:
- AUROPHARMA -> insufficient evidence;
- BIOCON -> insufficient evidence;
- SYNGENE -> insufficient evidence;
- HDFCBANK -> blocked prerequisite.

No partial recommendation was reconstructed.

### R7 sizing outcome

No Program B profile/role-specific numeric sizing policy has been separately
owner-approved.

Therefore:
- sizing-ready holdings = 0;
- suggested target/minimum/maximum weight remains null;
- recommended action remains null;
- recommendation-ready holdings do not borrow a generic or another sector's
  sizing heuristic.

This is an intentional fail-closed result, not a missing execution.

### Owner-authority and cross-surface results

Validated:
- target price unchanged;
- stop loss unchanged;
- owner target weight unchanged;
- owner-selected portfolio role unchanged;
- owner field mutation count = 0;
- persistence mutation count = 0;
- Research / Portfolio / Action canonical projections consume one shared decision
  payload rather than independently recomputing score/recommendation/sizing.

### B4 / R7 closure

```text
B4.1 reference cohort / sizing edge cases = COMPLETE / PASS / CLOSED
B4.2 owner-authority mutation regression = COMPLETE / PASS / CLOSED
B4.3 replay and cross-surface validation = COMPLETE / PASS / CLOSED
B4.4 controlled portfolio-wide disposition = COMPLETE / PASS / CLOSED

Program B · B4 = COMPLETE / PASS / CLOSED
R7 Checkpoint B = CLOSED
R7 = COMPLETE / PASS / CLOSED

Portfolio-wide recommendation/sizing disposition = COMPLETE
Portfolio-wide numeric recommendation coverage = NOT CLAIMED / INCOMPLETE BY DESIGN
Portfolio-wide numeric sizing coverage = NOT CLAIMED / INCOMPLETE BY DESIGN
Owner-authority regression = PASS
Cross-surface canonical consistency = PASS
Provider calls from R7 computation = 0
```

Safety state:
- Angel One calls from R7 computation = 0;
- Trendlyne calls from R7 computation = 0;
- OpenAI numeric decision calls = 0;
- recommendation persistence = NO;
- sizing persistence = NO;
- owner settings mutation = NO;
- production mutation = NO;
- migration = NO;
- deployment = NO;
- merge = NO;
- scheduler change = NO;
- trading = NO.

**STOP BOUNDARY:** B-FINAL has not started and is not authorized by this closure.
Next stage is **B-FINAL — Program B Closure**, only after explicit owner approval.


---

## Program B · B-FINAL cross-pipeline closure candidate — 24 September 2026

**Checkpoint:** B-FINAL — Program B cross-pipeline closure
**Owner authorization:** APPROVED TO BEGIN B-FINAL
**Starting commit:** `5739c9030a9952fffc8f7be1f3afc9462c48ca74`
**Implementation commits:**
- `8c33a6e1f03166a13db1512d0a1ebf77f8900108` — B-FINAL audit/test/report/runner/closure document;
- `6d83dda69740d10dca0779bab1b987b601cb81a5` — static import correction in the final audit layer.

**Current status:** **IMPLEMENTED CANDIDATE / OWNER-LOCAL FINAL VALIDATION PENDING**

### Entry state

Repository evidence entering B-FINAL confirms:

```text
B0 = COMPLETE / PASS / CLOSED
B1 = COMPLETE / PASS / CLOSED
B2 = COMPLETE / PASS / CLOSED
R6 = COMPLETE / PASS / CLOSED
B3 = COMPLETE / PASS / CLOSED
B4 = COMPLETE / PASS / CLOSED
R7 = COMPLETE / PASS / CLOSED
```

B-FINAL is a regression/audit only. It introduces no new methodology, provider
workflow, recommendation policy, sizing policy or production action.

### Eleven-point Program B closure audit

The new `PROGRAM_B_FINAL_AUDIT_V1` validates simultaneously:

1. R6 -> R7 traceability for every recommendation-ready / sizing-ready result;
2. security + role + assignment-version lineage;
3. explicit R6 and R7 disposition for all 238 frozen K5 equities;
4. deterministic R6 and R7 replay;
5. cross-sector/subprofile/role anti-fallback contracts;
6. Gate H-K shell continuity through inherited regression suites;
7. B1-B4 stop-condition boundaries;
8. zero provider calls from Program B compute paths;
9. zero OpenAI numeric-decision calls;
10. zero owner-settings mutation;
11. zero Program B persistence/production/deployment/merge/scheduler/trading authority.

### R6 -> R7 lineage scope

Current score-ready/recommendation-ready reference lineage remains:

```text
TORNTPHARM
  PHARMA_V1 + DOMESTIC_FORMULATIONS
  assignment version 1
  R6 score 75.1575
  -> R7 SATELLITE_CANDIDATE

ALIVUS
  PHARMA_V1 + API_BULK_DRUGS
  assignment version 1
  R6 score 76.7225
  -> R7 SATELLITE_CANDIDATE
```

For every recommendation-ready row the final audit requires:
- exact source R6 score;
- exact source-score run identity;
- same parent profile / Primary methodology role;
- assignment version;
- recommendation-run identity containing the exact source-score run;
- downstream sizing lineage carrying the same score/recommendation identities.

No sizing-ready reference currently exists because no Program B profile/role
numeric sizing policy is approved.

### Pharma invariant retained

B-FINAL continues to enforce:

```text
PHARMA_V1 common parent research
        +
one reviewed Primary Pharma subprofile
        ↓
effective Pharma research contract
```

with exactly five canonical Primaries:

```text
API_BULK_DRUGS
DOMESTIC_FORMULATIONS
GLOBAL_GENERICS
BIOPHARMA_BIOSIMILARS
CDMO_CRAMS
```

The parent is not replaced by the subgroup. Cross-subprofile/cross-sector sizing
or recommendation fallback remains prohibited.

### Repository safety audit

A repository compare from B0 closure
`10c87a5d9a2eb5338db51f3f85e5f5ce1ff9a605`
through B4 closure
`5739c9030a9952fffc8f7be1f3afc9462c48ca74`
found:
- 23 Program B changed files;
- 0 `supabase/migrations/*` changes;
- 0 `supabase/functions/*` changes;
- 0 deployment/workflow configuration changes.

At B-FINAL start:
- Program B branch HEAD was
  `5739c9030a9952fffc8f7be1f3afc9462c48ca74`;
- `main` was
  `d0cc52dfcf61fc9a884f139fcc7931b3bd73c57b`;
- the long-lived Program B branch remained separate/diverged from `main`;
- no Program B merge was performed.

The B-FINAL local runner adds a strict changed-file allowlist and rejects any
Program B migration, Edge Function, deployment or workflow surface change.

### Intentional limitations retained

Program B closure must not overstate numeric or production coverage.

The final audit explicitly records:

```text
PORTFOLIO_WIDE_NUMERIC_SCORING_COVERAGE_NOT_COMPLETE
PORTFOLIO_WIDE_NUMERIC_RECOMMENDATION_COVERAGE_NOT_COMPLETE
PROGRAM_B_NUMERIC_SIZING_POLICY_NOT_APPROVED
FROZEN_PORTFOLIO_SNAPSHOT_IS_2026_09_22_NOT_LIVE_PRODUCTION_STATE
PROGRAM_B_BRANCH_IS_LOCAL_CANDIDATE_AND_UNMERGED
PIPELINE_NOT_PRODUCTION_OPERATIONAL
```

These are valid fail-closed/operational-boundary outcomes and do not prevent
Program B disposition closure.

### B-FINAL artifacts

Added:
- `src/features/research/programBFinalClosure.ts`;
- `src/features/research/programBFinalClosure.test.ts`;
- `scripts/program-b-final-report.mjs`;
- `scripts/b-final-validate-program-b.sh`;
- `docs/PortfolioAI_PROGRAM_B_FINAL_CLOSURE.md`.

Static audit found and corrected one import-only error in the new final audit
module at commit
`6d83dda69740d10dca0779bab1b987b601cb81a5`.
No R6/R7 business behavior changed.

### Owner-local final validation

Run:

```bash
git pull
bash scripts/b-final-validate-program-b.sh
```

The runner executes:
- B-FINAL audit;
- R6/R7 regressions;
- Gate H/G10 reference regressions;
- Pharma parent + five-subprofile regressions;
- Gate I recommendation regressions;
- K5 isolation/routing/portability;
- K3 BANK/NBFC and shared benchmark authority;
- D35B sizing software boundary;
- owner decision controls;
- shared Research/Pharma UI regressions;
- canonical final report;
- strict Program B repository allowlist;
- TypeScript;
- architecture guard;
- production build;
- `git diff --check`.

Expected terminal closure markers include:

```text
B-FINAL CANDIDATE VALIDATION PASS
Program B closure audit: PASS
Provider calls from Program B compute paths: 0
AI numeric decision calls: 0
Owner settings mutation: 0
Production mutation/deployment/merge/scheduler/trading authorization: NONE
Pipeline state: VALIDATED / APPROVED LOCAL-CANDIDATE / FAIL-CLOSED WHERE INCOMPLETE
Production operational: NO
```

**STOP BOUNDARY:** Program B is not formally closed until this final owner-local
runner passes. No next program is authorized.

---

## Program B · B-FINAL validation PASS / formal closure deferred by owner — 24 September 2026

The owner-local final Program B runner completed successfully.

Observed final terminal state:

```text
overallPass = true
Program B repository safety guard = PASS
TypeScript = PASS
architecture guard = PASS
production build = PASS

B-FINAL CANDIDATE VALIDATION PASS
Program B closure audit: PASS
Provider calls from Program B compute paths: 0
AI numeric decision calls: 0
Owner settings mutation: 0
Production mutation/deployment/merge/scheduler/trading authorization: NONE
Pipeline state: VALIDATED / APPROVED LOCAL-CANDIDATE / FAIL-CLOSED WHERE INCOMPLETE
Production operational: NO
```

This means all B-FINAL validation criteria passed, including the cross-pipeline
audit, repository-safety allowlist, R6/R7 replay/lineage checks, 238-row
disposition completeness, Pharma dual-layer protections, provider-free compute,
AI-free numeric decisions and owner-authority preservation.

The owner then explicitly instructed:

```text
Do not close Program B now.
```

Accordingly the authoritative state is:

```text
B0 = COMPLETE / PASS / CLOSED
B1 = COMPLETE / PASS / CLOSED
B2 = COMPLETE / PASS / CLOSED
R6 = COMPLETE / PASS / CLOSED
B3 = COMPLETE / PASS / CLOSED
B4 = COMPLETE / PASS / CLOSED
R7 = COMPLETE / PASS / CLOSED

B-FINAL validation = PASS
B-FINAL formal closure = DEFERRED BY OWNER
Program B formal closure = DEFERRED BY OWNER
Program B = VALIDATED / OPEN
Next program = NOT AUTHORIZED
```

Do not describe Program B as formally closed until the owner explicitly authorizes
closure. Do not describe the pipeline as production operational. No merge,
deployment, production reconciliation, scheduler activation or trading action was
performed by this validation.


---

## Program B · Codex review-ready handoff — 24 September 2026

Program B has completed its full local-candidate build and final validation, but
the owner has **explicitly deferred formal Program B closure** pending further
review.

### Authoritative repository state before Codex review

```text
Repository: drddutta-portfolio/PortfiolioAI
Branch: program-a-evidence-coverage
Program B validated HEAD before this handoff update:
  5a1aef89167f96aecd0552d615b538c57e61088f
```

Checkpoint state:

```text
B0 = COMPLETE / PASS / CLOSED
B1 = COMPLETE / PASS / CLOSED
B2 = COMPLETE / PASS / CLOSED
R6 = COMPLETE / PASS / CLOSED
B3 = COMPLETE / PASS / CLOSED
B4 = COMPLETE / PASS / CLOSED
R7 = COMPLETE / PASS / CLOSED

B-FINAL validation = PASS
B-FINAL formal closure = DEFERRED BY OWNER
Program B formal closure = DEFERRED BY OWNER
Program B = VALIDATED / OPEN
Next program = NOT AUTHORIZED
```

### Final local validation evidence

The owner ran:

```bash
git pull
bash scripts/b-final-validate-program-b.sh
```

Observed final result:

```text
overallPass = true
Program B repository safety guard = PASS
TypeScript = PASS
architecture guard = PASS
production build = PASS

B-FINAL CANDIDATE VALIDATION PASS
Program B closure audit: PASS
Provider calls from Program B compute paths: 0
AI numeric decision calls: 0
Owner settings mutation: 0
Production mutation/deployment/merge/scheduler/trading authorization: NONE
Pipeline state: VALIDATED / APPROVED LOCAL-CANDIDATE / FAIL-CLOSED WHERE INCOMPLETE
Production operational: NO
```

### Core Program B artifacts for review

Master/closure documents:

- `docs/PortfolioAI_PROGRAM_B_MASTER_PLAN.md`
- `docs/PortfolioAI_PROGRAM_B_B1_R6_CONTRACT_ARCHITECTURE.md`
- `docs/PortfolioAI_PROGRAM_B_B2_R6_EXECUTION_VALIDATION.md`
- `docs/PortfolioAI_PROGRAM_B_B3_R7_CONTRACT_ARCHITECTURE.md`
- `docs/PortfolioAI_PROGRAM_B_B4_R7_EXECUTION_VALIDATION.md`
- `docs/PortfolioAI_PROGRAM_B_FINAL_CLOSURE.md`
- `docs/PORTFOLIOAI_CUMULATIVE_DEVELOPMENT_HANDOFF.md`

R6 implementation:

- `src/features/research/programBR6Contract.ts`
- `src/features/research/programBR6Contract.test.ts`
- `src/features/research/programBR6Execution.ts`
- `src/features/research/programBR6Execution.test.ts`

R7 implementation:

- `src/features/research/programBR7Contract.ts`
- `src/features/research/programBR7Contract.test.ts`
- `src/features/research/programBR7Execution.ts`
- `src/features/research/programBR7Execution.test.ts`

Final closure audit:

- `src/features/research/programBFinalClosure.ts`
- `src/features/research/programBFinalClosure.test.ts`
- `scripts/program-b-final-report.mjs`
- `scripts/b-final-validate-program-b.sh`

Shared UI touched by Program B:

- `src/features/research/ResearchScorecardPanel.tsx`
- `src/features/research/ResearchScorecardPanel.test.tsx`
- `src/pages/ResearchPage.tsx`

### Non-negotiable architecture rules Codex must verify

1. No evidence readiness -> no score.
2. No valid score -> no recommendation.
3. No valid recommendation -> no sizing.
4. R6/R7 computation is cache-only.
5. Provider calls from Program B compute paths = zero.
6. OpenAI cannot create/alter numeric score, recommendation or sizing decisions.
7. No hidden renormalization or reconstruction of missing mandatory inputs.
8. No `GENERAL_FALLBACK`, nearest-sector or cross-sector methodology borrowing.
9. No sector may borrow another sector's sizing heuristics.
10. Owner target price, stop loss, target weight and owner-set role remain untouched.
11. No Program B recommendation/sizing persistence was authorized.
12. No production mutation, migration, deployment, merge, scheduler activation or
    trading was authorized.
13. Program B must remain fail-closed where methodology/evidence/policy is missing.

### Pharma-specific invariant Codex must verify carefully

Pharma is intentionally **not** handled like ordinary single-profile sectors.

Every Pharma stock must retain:

```text
PHARMA_V1 common parent research
        +
exactly one reviewed Primary Pharma subprofile
        ↓
effective Pharma research contract
```

Canonical Primary subprofiles are exactly:

```text
API_BULK_DRUGS
DOMESTIC_FORMULATIONS
GLOBAL_GENERICS
BIOPHARMA_BIOSIMILARS
CDMO_CRAMS
```

The Primary subgroup does not replace the common `PHARMA_V1` research layer.
Recommendation lineage must preserve parent profile + Primary subgroup +
assignment version + exact R6 score lineage.

Secondary exposures/overlays must not create a second independent stock score or
recommendation.

### Important intentional Program B limitations

These are intentional fail-closed boundaries, not automatically bugs:

```text
PORTFOLIO_WIDE_NUMERIC_SCORING_COVERAGE_NOT_COMPLETE
PORTFOLIO_WIDE_NUMERIC_RECOMMENDATION_COVERAGE_NOT_COMPLETE
PROGRAM_B_NUMERIC_SIZING_POLICY_NOT_APPROVED
FROZEN_PORTFOLIO_SNAPSHOT_IS_2026_09_22_NOT_LIVE_PRODUCTION_STATE
PROGRAM_B_BRANCH_IS_LOCAL_CANDIDATE_AND_UNMERGED
PIPELINE_NOT_PRODUCTION_OPERATIONAL
```

Current numeric recommendation authority is intentionally limited to the approved
PHARMA_V1 policy. The legacy BANK/NBFC recommendation policy remains DRAFT and
must not be promoted silently.

The Program B sizing-policy registry is intentionally empty because no
profile/role-specific numeric sizing policy has been owner-approved. Therefore
recommendation-ready holdings may correctly remain
`METHODOLOGY_NOT_AVAILABLE` for sizing.

### Codex review boundary

Codex review is requested as a **read-only audit first**.

Do not:
- close Program B;
- start a next program;
- merge branches;
- deploy;
- create/apply migrations;
- mutate production/local canonical data;
- call providers;
- enable recommendation/sizing persistence;
- change schedulers;
- trade;
- silently fix code before reporting findings.

Codex should first return findings with severity, evidence, affected files,
whether each issue is a true defect versus an intentional fail-closed boundary,
and the smallest safe corrective action if needed.

If no critical defect is found, explicitly say whether Program B is technically
ready for owner consideration of formal closure while still remaining
`VALIDATED / OPEN` until the owner authorizes closure.

---

## Program B corrective build — C1 local Pharma assignment repair

**Date:** 24 September 2026
**Status:** C1 COMPLETE / PASS; Program B remains VALIDATED / OPEN

The post-validation audit confirmed that local canonical assignments already
resolved TORNTPHARM, ALIVUS and AUROPHARMA correctly, while BIOCON and SYNGENE
had no rows in `research_subprofile_assignments`. Existing owner-approved Gate J
locks and exact local NSE/ISIN fixture identities were sufficient; no provider
call and no schema migration were required.

Added guarded local-only repair artifacts:

- `scripts/program-b-local-pharma-reference-assignment-repair.sql`
- `scripts/run-program-b-local-pharma-reference-assignment-repair.sh`

The repair materialized BIOCON as `BIOPHARMA_BIOSIMILARS` with reviewed
`CDMO_CRAMS` and `GLOBAL_GENERICS` Material Overlays, and SYNGENE as
`CDMO_CRAMS` with no secondary exposures. It writes no score, recommendation,
sizing, owner setting or trading record. The first run inserted two assignments;
the replay inserted zero and reused both, proving idempotence.

Local five-reference state after C1:

```text
TORNTPHARM -> PHARMA_V1 + DOMESTIC_FORMULATIONS
ALIVUS -> PHARMA_V1 + API_BULK_DRUGS
AUROPHARMA -> PHARMA_V1 + GLOBAL_GENERICS
BIOCON -> PHARMA_V1 + BIOPHARMA_BIOSIMILARS
SYNGENE -> PHARMA_V1 + CDMO_CRAMS
```

Production mutation, migration, deployment, merge, scheduler mutation and
trading remain unauthorized and did not occur.

### C5 — structural safety and honest boundary validation

**Status:** COMPLETE / PASS

The corrective validation now supplements declarative safety constants with a
static compute-path scan. `program-b-static-safety.mjs` rejects provider,
refresh, persistence-repository, scheduler, trade/order, network and canonical
write dependencies in the Program B R6/R7 compute modules. B-FINAL runs this
scan and its repository allowlist now covers only the reviewed C1-C5 files.

The three-surface regression is now described accurately as a contract-only
Research/Portfolio/Action projection test; actual application integration is
not claimed. The owner-authority regression now exercises a machine-assessment
writer boundary and proves the exact owner-settings object is returned without
writes to target price, stop loss, target weight or portfolio role. Exactly one
machine-assessment write is observed, with zero recommendation/sizing
persistence writes.

Focused result: 38 R6/R7 tests passed; the structural safety scan and
TypeScript passed. No provider call, migration, production mutation,
deployment, merge, scheduler mutation or trade occurred.

### C6 — Program B lint, report runner and naming cleanup

**Status:** COMPLETE / PASS

Removed the two unnecessary non-null assertions from the R7 sizing-readiness
success path after explicitly narrowing the normalized lineage identifiers.
Renamed the R7 portfolio aggregate `failClosed` field to `notSizingReady`, which
accurately includes recommendation-ready rows for which no sizing methodology
is approved. Disabled Vite HMR in the read-only final-report runner to avoid
WebSocket startup in restricted environments.

B-FINAL now runs scoped lint over the Program B contract, execution,
presentation, UI, report and safety files. That scope passes. A separate full
repository lint continues to report historical issues outside this correction;
in particular, unchanged assertion sites in the scoring repositories are not
silently broadened into C6 cleanup.

Focused result: 26 R7/final-closure tests passed and scoped Program B lint
passed after excluding the documented unchanged repository-wide lint debt.

### Program B corrective outcome

```text
Program B = CORRECTED / VALIDATED / OPEN
Corrective B-FINAL = PASS
Formal Program B closure = AWAITING EXPLICIT OWNER APPROVAL
Production operational = NO
```

Final corrective evidence: 30 test files / 202 tests passed; the canonical
final audit returned `overallPass: true`; the structural compute-path scan,
scoped Program B lint, repository safety allowlist, TypeScript, architecture
guard, production build and `git diff --check` passed. The five reference UI
contracts resolve to their expected `PHARMA_V1` Primary roles through the
Research presentation integration tests.

The separate repository-wide `npm run lint` remains non-green with 77 errors
and 4 warnings in historical, out-of-scope files. The two specifically reported
Program B R7 lint errors are fixed, and the scoped corrective files are clean.
No secret pattern, merge commit, migration, Edge Function, workflow, scheduler
or trading-path change was found in the corrective diff/history checks.

No production mutation, migration, deployment, merge, scheduler mutation,
automated recommendation/sizing persistence or trade was authorized or
performed.

### C2 — R6 Pharma enforcement and applicability contradictions

**Status:** COMPLETE / PASS

`evaluateProgramBScoringReadiness()` now derives the mandatory Pharma Primary
requirement from the resolved `PHARMA_V1` methodology authority. Caller-supplied
`assignment.required = false` cannot bypass it. A ready Pharma assignment must
have exactly one active reviewed assignment, a non-empty assignment id, a
positive/non-empty version, one of the five canonical Primary codes, and an
effective period containing the evaluation date. Missing, provisional,
disputed, conflicting, generic `PHARMA`, BANK and noncanonical roles fail closed.

Required evidence marked both `APPLICABLE` and `NOT_APPLICABLE`, and required
market history marked `NOT_APPLICABLE`, now return an explicit applicability
contradiction in `REVIEW_REQUIRED` rather than silently reaching READY.

Focused result: 13 R6 contract tests passed; TypeScript and `git diff --check`
passed.

### C3 — canonical R6 Research presentation boundary

**Status:** COMPLETE / PASS

Added `programBR6Presentation.ts` as the single feature-layer owner of the R6
Research presentation contract. It carries security, readiness, parent profile,
methodology version/role, assignment id/version, classification version,
snapshot/as-of identity, blockers, reason codes, score-run id, valid score and
separate evidence coverage. `ResearchScorecardPanel` now renders this contract
without deciding READY, blockers, fail-closed reasons or methodology role.
`ResearchPage` no longer uses the ordinary sector router as a Pharma Primary
fallback.

The score repositories now expose the canonical persisted score-run id, and the
subprofile repository exposes canonical assignment ids. Five-reference tests
cover the expected Primary roles; missing Primary, preview/non-complete runs,
stale/conflicting evidence, missing assignment id and invalid assignment version
all fail closed. Friendly long-role labels retain the canonical code in the UI.

Focused result: 38 tests passed; TypeScript and `git diff --check` passed.

### C4 — immutable R6-issued score-run lineage

**Status:** COMPLETE / PASS

Every scored R6 reference now contains an immutable `scoreLineage` object owned
and issued by R6. It includes the run/security identity, as-of and classification
versions, parent profile, methodology/Primary role, assignment identity/version,
evidence snapshot/freshness, metric and category payloads, overall score,
calculation version, readiness, reasons and deterministic reference timestamp.
Fail-closed references have no score lineage.

R7 no longer constructs `PROGRAM_B_R6_REFERENCE::<symbol>::<artifactVersion>`.
It consumes `reference.scoreLineage.runId` unchanged, rejects inconsistent
security/role/assignment/score lineage, and carries the exact R6 id into both the
recommendation and sizing result. B-FINAL now compares the R7 source id directly
with the R6-emitted id.

Focused result: 21 R6/R7/final tests passed; TypeScript, targeted lint and
`git diff --check` passed.

---

## Program B · FORMAL CLOSURE — owner approved — 24 September 2026

After Codex corrective work was pushed to GitHub and independently checked on
the remote `program-a-evidence-coverage` branch, the owner explicitly approved
formal Program B closure.

Corrective branch evidence before this documentation-only closure commit:

```text
HEAD = d7c700deb55765b7dca349d524e4dae7c2ba28ca

C1 local Pharma assignment repair = COMPLETE / PASS
C2 R6 Pharma enforcement + applicability contradictions = COMPLETE / PASS
C3 canonical R6 Research presentation = COMPLETE / PASS
C4 immutable R6-issued lineage into R7 = COMPLETE / PASS
C5 structural safety / owner-boundary validation = COMPLETE / PASS
C6 Program B lint/report/naming cleanup = COMPLETE / PASS

Corrective B-FINAL = PASS
30 test files / 202 tests = PASS
canonical final audit overallPass = true
TypeScript = PASS
architecture guard = PASS
scoped Program B lint = PASS
production Vite build = PASS
static safety scan = PASS
repository safety allowlist = PASS
git diff --check = PASS
```

The five canonical Pharma reference Primaries are now represented consistently:

```text
TORNTPHARM -> PHARMA_V1 + DOMESTIC_FORMULATIONS
ALIVUS     -> PHARMA_V1 + API_BULK_DRUGS
AUROPHARMA -> PHARMA_V1 + GLOBAL_GENERICS
BIOCON     -> PHARMA_V1 + BIOPHARMA_BIOSIMILARS
SYNGENE    -> PHARMA_V1 + CDMO_CRAMS
```

The special Pharma invariant remains:

```text
PHARMA_V1 common parent research
        +
exactly one valid reviewed Primary Pharma subprofile
        ↓
effective Pharma research contract
```

R6 now enforces that invariant, the Research UI consumes the canonical R6
presentation model, and R7 carries the exact immutable R6-issued score-run
identity.

### Formal closure state

```text
B0 = COMPLETE / PASS / CLOSED
B1 = COMPLETE / PASS / CLOSED
B2 = COMPLETE / PASS / CLOSED
R6 = COMPLETE / PASS / CLOSED
B3 = COMPLETE / PASS / CLOSED
B4 = COMPLETE / PASS / CLOSED
R7 = COMPLETE / PASS / CLOSED
B-FINAL = COMPLETE / PASS / CLOSED

Program B = COMPLETE / PASS / CLOSED
```

### Boundaries retained after closure

Program B closure does not overstate capability:

```text
portfolio-wide disposition = COMPLETE
portfolio-wide numeric scoring coverage = INCOMPLETE
portfolio-wide numeric recommendation coverage = INCOMPLETE
Program B numeric sizing policy = NOT APPROVED
frozen portfolio fixture = K5 snapshot dated 2026-09-22
branch merge to main = NO
production deployment = NO
production operational = NO
scheduler activation = NO
trading = NO
next program = NOT AUTHORIZED
```

No production mutation, migration, merge, deployment, persistence enablement,
scheduler change or trading action was performed as part of formal closure.

This section supersedes the earlier temporary
`CORRECTED / VALIDATED / OPEN` and `closure deferred` status markers while
preserving them as historical audit trail.

---

## Program C · master plan frozen / C0 only authorized — 24 September 2026

The owner approved freezing the revised Program C plan after joint Codex/ChatGPT
review.

Authoritative plan:

```text
docs/PortfolioAI_PROGRAM_C_MASTER_PLAN.md
```

Program B functional baseline:

```text
6a605f618ab67e3e8ad5d5faa2181796a1f43988
```

Program C plan-freeze documentation commit immediately preceding this handoff
update:

```text
2659e640cc95f70b066176dddb07e27f9cdd8003
```

Canonical scope:

```text
Program C = R8 + R9 + R10

R8  = Core Health / Portfolio Fit / Risk / Exit Intelligence
R9  = Meaningful Change / Movement Engine
R10 = Combined Action Center
```

Frozen checkpoint structure:

```text
C0 → C1 → C2 → C3 → C4 → C-FINAL
```

The frozen plan incorporates six mandatory clarifications beyond the original
Codex draft:

1. Program C development-branch discipline must be explicit before C1;
2. C1 must freeze a machine-readable R8 sub-engine dependency matrix;
3. R9 must distinguish first observation / no comparable baseline from no
   change, immaterial change and meaningful change;
4. initial R9 guarantees semantic event identity/idempotency only, not durable
   acknowledgement, snooze or cross-session notification deduplication;
5. `ADD_REVIEW` / `TRIM_REVIEW` remain candidate-only until C4 proves an
   already-approved deterministic upstream directional authority without
   inventing numeric sizing;
6. C0 must freeze/version the exact Program C validation universe before any
   portfolio-wide disposition claim.

Current authority:

```text
Gate H–K = COMPLETE / PASS / CLOSED
Program A = COMPLETE / PASS / CLOSED
Program B = COMPLETE / PASS / CLOSED

Program C master plan = FROZEN
Current authorized next checkpoint = C0 ONLY

C1 implementation = NOT AUTHORIZED
R8 execution = NOT AUTHORIZED
R9 = NOT AUTHORIZED
R10 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED

Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

Program C remains a deterministic portfolio-decision-engine program. It does
not authorize numeric sizing, provider calls inside R8/R9/R10 compute paths,
AI deterministic decisions, production mutation, persistence, scheduler
activation or trading.

Agent-swap rule:

Before changing Program C code, ChatGPT or Codex must read:

1. `docs/PortfolioAI_PROGRAM_C_MASTER_PLAN.md`;
2. the latest Program C section in this cumulative handoff;
3. the active checkpoint artifacts;
4. the exact current branch HEAD.

Conversation history is not the sole continuation authority.

No R8 source implementation was authorized or performed by the plan-freeze
documentation step. C0 is the only next authorized checkpoint.


---

## Program C · C0 contract freeze + inheritance audit — COMPLETE / PASS — 24 September 2026

C0 was executed under the frozen Program C master plan. No R8/R9/R10 source
implementation was authorized or performed.

### Repository / branch state

```text
repository = drddutta-portfolio/PortfiolioAI
incoming branch = program-a-evidence-coverage
incoming HEAD = d3b8a755885bd4ecc0be37aa59ea46f2eac0ca41

Program C branch = program-c-portfolio-decision-engines
branch base = d3b8a755885bd4ecc0be37aa59ea46f2eac0ca41
C0 checkpoint artifact end HEAD = 63b54da87ff5ea61ef662d9efe1dbdb4e0a879af
```

The incoming branch was verified as exactly two documentation commits ahead of
the formal Program B functional baseline
`6a605f618ab67e3e8ad5d5faa2181796a1f43988`. The only differences were the
Program C master plan and cumulative handoff; no Program C implementation had
been introduced.

The new Program C branch was explicitly created from that verified plan-freeze
state. This is not a merge to `main` and grants no productionization authority.

### C0 checkpoint artifact

Created:

```text
docs/PortfolioAI_PROGRAM_C_C0_CONTRACT_FREEZE_INHERITANCE_AUDIT.md
```

This document freezes the Program C continuation state and records the R6/R7
inheritance audit, validation universe, R8 dependency-matrix obligation, R9
baseline/idempotency semantics, R10 vocabulary boundary, owner-control boundary,
provider/AI/persistence boundaries, lineage rules, validation requirements and
stop conditions.

### R6/R7 inheritance audit

Audited current repository authorities:

- `src/features/research/programBR6Contract.ts`
- `src/features/research/programBR6Execution.ts`
- `src/features/research/programBR7Contract.ts`
- `src/features/research/programBR7Execution.ts`
- `src/features/research/programBFinalClosure.ts`

Confirmed inheritance:

- R6 readiness remains explicit and fail-closed;
- R6 issues immutable score-run lineage used downstream;
- R7 consumes exact R6 score-run identity;
- Pharma retains `PHARMA_V1 + exactly one reviewed Primary` semantics;
- recommendation policy remains profile-specific;
- cross-sector sizing-policy borrowing remains prohibited;
- `PROGRAM_B_SIZING_POLICY_REGISTRY` remains empty;
- owner target price, stop loss, target weight and portfolio role remain protected;
- provider/AI numeric-decision/persistence/production/scheduler/trading safety
  boundaries remain closed.

Program C must consume these authorities, not reconstruct them.

### Frozen Program C validation universe

C0 explicitly reuses the existing frozen K5 local fixture:

```text
Program C validation version = PROGRAM_C_VALIDATION_UNIVERSE_V1
source snapshot = K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
snapshot date = 2026-09-22
holding count = 238
asset universe = 238 EQUITY / 0 non-equity in fixture
source authority = src/features/research/k5CurrentPortfolioRoutingSnapshot.ts
state = frozen local deterministic fixture, not live production
```

Known limitations are preserved: this is not a live 24 September production
reconciliation; industry classification is incomplete for part of the fixture;
portfolio-wide numeric R6 and R7 coverage is intentionally incomplete; numeric
sizing policy remains unapproved.

Any change to this universe requires an explicit versioned re-freeze and owner
approval.

### R8 dependency-matrix requirement

C1 must freeze a machine-readable dependency matrix for exactly:

```text
Core Health
Portfolio Fit
Portfolio Risk
Exit Intelligence
```

Each must declare mandatory/optional upstream states, portfolio and owner
context, evidence requirements, applicability, blockers and whether R7 is
actually required. Missing R7 must not globally block independently valid R8
sub-engines.

### R9 baseline and idempotency boundary

R9 must distinguish:

```text
first observation / no comparable baseline
no change
raw but immaterial change
meaningful change
```

Initial Program C guarantees deterministic event identity, semantic idempotency
and same-input replay stability only.

It does not claim durable acknowledgement, snooze, persistent notification
suppression or cross-session seen/unseen state.

### R10 ADD/TRIM boundary

`ADD_REVIEW` / `TRIM_REVIEW` remain candidate-only. They cannot become
canonical unless C4 proves an already-approved deterministic upstream authority
supports that direction without inventing numeric sizing policy.

No Program C state may contain quantity, order details, exact add/trim
percentage, machine-generated target weight or a trade instruction.

### Frozen safety boundary

```text
numeric sizing authority = NO
provider calls in R8/R9/R10 compute = 0
AI deterministic decisions = 0
automatic persistence = 0
schema migration = 0
production mutation = 0
merge/deployment = 0
scheduler activation = 0
trading/order behavior = 0
owner-setting mutation = 0
```

### Files changed in C0

```text
docs/PortfolioAI_PROGRAM_C_C0_CONTRACT_FREEZE_INHERITANCE_AUDIT.md  ADDED
docs/PORTFOLIOAI_CUMULATIVE_DEVELOPMENT_HANDOFF.md                  APPENDED
```

No source file, migration, Edge Function, workflow, provider adapter, persistence
repository, scheduler or trading path was changed.

### C0 closure

```text
C0 = COMPLETE / PASS
Program C scope = FROZEN
R8/R9/R10 ordering = FROZEN
Program C branch = EXPLICIT
validation universe = EXPLICIT
upstream inheritance = AUDITED
owner/sizing/provider/AI boundaries = FROZEN
R8 dependency-matrix requirement = FROZEN
R9 baseline/idempotency semantics = FROZEN
R10 ADD/TRIM candidate-only rule = FROZEN
R8 implementation = NOT STARTED
```

### Stop boundary / next authorization

```text
Current stop point = after C0
Next possible checkpoint = C1 only
C1 authorization = NOT YET GRANTED
R8 execution / C2 = NOT AUTHORIZED
R9 / C3 = NOT AUTHORIZED
R10 / C4 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

Explicit owner approval is required before any C1 contract/architecture work.



---

## Program C · C1 R8 Contract & Architecture — implementation complete / executable validation pending — 24 September 2026

The owner explicitly authorized C1 after C0.

C1 was kept strictly to R8 Checkpoint A. No R8 evaluator, portfolio-wide R8
execution, UI integration, R9, R10 or later-program work was authorized or
performed.

### Branch and start state

```text
repository = drddutta-portfolio/PortfiolioAI
branch = program-c-portfolio-decision-engines
C1 starting HEAD = 497006335d4648c7f425691fe8598f9b170ddcd3
C1 source-contract review HEAD = c2b97b49d2cb962daae4e4e4517d929486357c95
C1 architecture document HEAD before this handoff = 01a36e1f87f0ecfb7df8e131e99ccb5bec58bf75
```

### C1 artifacts

Added:

```text
src/features/decision/r8CoreHealthContract.ts
src/features/decision/r8PortfolioFitContract.ts
src/features/decision/r8PortfolioRiskContract.ts
src/features/decision/r8ExitIntelligenceContract.ts
src/features/decision/r8PortfolioContext.ts
src/features/decision/r8DependencyMatrix.ts
src/features/decision/r8PortfolioDecisionContract.ts
src/features/decision/r8AuthorityRegistry.ts
src/features/decision/r8ContractArchitecture.test.ts

docs/PortfolioAI_PROGRAM_C_C1_R8_CONTRACT_ARCHITECTURE.md
```

No Program B source file was modified.

### Frozen C1 contract versions

```text
PROGRAM_C_R8_CORE_HEALTH_V1
PROGRAM_C_R8_PORTFOLIO_FIT_V1
PROGRAM_C_R8_PORTFOLIO_RISK_V1
PROGRAM_C_R8_EXIT_INTELLIGENCE_V1
PROGRAM_C_R8_PORTFOLIO_CONTEXT_V1
PROGRAM_C_R8_DEPENDENCY_MATRIX_V1
PROGRAM_C_R8_DECISION_CONTRACT_V1
PROGRAM_C_R8_AUTHORITY_REGISTRY_V1
PROGRAM_C_VALIDATION_UNIVERSE_V1
```

### Frozen R8 state vocabularies

Core Health:

```text
CORE_HEALTHY
CORE_WATCH
CORE_AT_RISK
CORE_DEMOTION_REVIEW
INSUFFICIENT_EVIDENCE
REVIEW_REQUIRED
BLOCKED_PREREQUISITE
NOT_APPLICABLE
```

Portfolio Fit:

```text
FIT_SUPPORTED
FIT_NEUTRAL
FIT_TENSION
CONCENTRATION_REVIEW
ROLE_COMPATIBILITY_REVIEW
INSUFFICIENT_EVIDENCE
REVIEW_REQUIRED
BLOCKED_PREREQUISITE
NOT_APPLICABLE
```

Portfolio Risk:

```text
RISK_ACCEPTABLE
RISK_MONITOR
RISK_ELEVATED
RISK_CRITICAL_REVIEW
INSUFFICIENT_EVIDENCE
REVIEW_REQUIRED
BLOCKED_PREREQUISITE
NOT_APPLICABLE
```

Exit Intelligence:

```text
NO_EXIT_SIGNAL
EXIT_MONITOR
EXIT_REVIEW_REQUIRED
EXIT_RISK_ELEVATED
HARD_EXIT_REVIEW
INSUFFICIENT_EVIDENCE
REVIEW_REQUIRED
BLOCKED_PREREQUISITE
NOT_APPLICABLE
```

### Mandatory R8 dependency matrix frozen

`PROGRAM_C_R8_DEPENDENCY_MATRIX_V1` contains exactly:

```text
CORE_HEALTH
PORTFOLIO_FIT
PORTFOLIO_RISK
EXIT_INTELLIGENCE
```

Each entry declares mandatory upstream states, optional upstream states,
portfolio-context requirements, market/risk evidence requirements, owner-context
requirements, applicability rules, blockers, R7 dependency and prohibited
fallbacks.

Frozen R7 dependency:

```text
CORE_HEALTH       = OPTIONAL_CONTEXT
PORTFOLIO_FIT     = NOT_REQUIRED
PORTFOLIO_RISK    = NOT_REQUIRED
EXIT_INTELLIGENCE = OPTIONAL_CONTEXT
```

R7 is therefore not a universal R8 prerequisite.

### R8 context and lineage contract

The C1 snapshot contract requires semantic holdings/snapshot fingerprints and
does not allow timestamp-only identity.

Financial values are carried as exact decimal strings at the contract boundary.

The composed R8 contract preserves exact upstream identity where available:

```text
R6 scoreRunId
R7 recommendationRunId
research profile
methodology id/version
methodology role
assignment id/version
evidence snapshot id
portfolio context snapshot id
R8 deterministic run id
```

No downstream identity reconstruction is authorized.

### Owner and sizing boundary

Owner-controlled fields remain:

```text
portfolioRole
targetPrice
stopLossPrice
targetWeight
minimumAllocation
maximumAllocation
investmentHorizon
freezeMonitoringPreference
```

Explicitly prohibited outputs include:

```text
machineGeneratedTargetWeight
machineGeneratedMinimumWeight
machineGeneratedMaximumWeight
exactAddPercentage
exactTrimPercentage
orderQuantity
orderInstruction
opaquePortfolioDecisionScore
```

Portfolio Fit is not a sizing engine.

### Risk / Exit safety

```text
missing risk evidence -> never RISK_ACCEPTABLE
price weakness alone -> never exit authority
valuation alone -> never exit authority
overweight alone -> never exit authority
HARD_EXIT_REVIEW -> advisory only
owner stop loss -> context only, not automatic trade authority
```

### R8 authority registry

All four R8 authorities are registered with:

```text
executionAuthority = C2_NOT_AUTHORIZED
numericSizingAuthority = NONE
providerAuthority = NONE
aiDecisionAuthority = NONE
persistenceAuthority = NONE
ownerMutationAuthority = NONE
```

### Static C1 architecture review

Diff review from the C1 start shows only C1 decision-contract/test files plus the
C1 documentation artifact.

No migration, Supabase function, provider adapter, persistence repository,
workflow, scheduler, trading path or consumer UI file was changed.

Static import review found no:

- Angel One import;
- Trendlyne import;
- OpenAI import;
- Supabase import;
- network fetch import;
- persistence repository import;
- scheduler import;
- brokerage/order-execution import.

The composed R8 contract imports Program B R6/R7 types only and does not
reimplement R6/R7 logic.

### Executable test artifact and validation state

Added:

```text
src/features/decision/r8ContractArchitecture.test.ts
```

It covers state vocabularies, dependency isolation, R7 independence, Core role
applicability, owner authority, no-sizing boundaries, missing-risk behavior,
Exit advisory behavior, cross-sector fallback prohibition, deterministic
identities, fail-closed identity validation, authority closure and C1 safety.

No GitHub Actions workflow run exists for the C1 commits. The current chat
execution environment also cannot clone GitHub, so the repository Vitest,
project TypeScript, architecture guard and scoped ESLint checks have not been
represented as executed passes.

Required owner-local validation:

```bash
git fetch origin
git switch program-c-portfolio-decision-engines
git pull --ff-only

npm test -- src/features/decision/r8ContractArchitecture.test.ts
npm run typecheck
npm run check:architecture
npm exec eslint -- src/features/decision/*.ts
git diff --check 497006335d4648c7f425691fe8598f9b170ddcd3..HEAD
```

### C1 safety result

```text
R8 execution = 0
portfolio-wide R8 disposition = 0
provider calls = 0
AI deterministic decisions = 0
numeric sizing authority = NO
opaque master score = NO
owner-setting mutation = 0
persistence = 0
migration = 0
production mutation = 0
merge/deployment = 0
scheduler mutation = 0
trading = 0
```

### Current checkpoint state

```text
C1 implementation = COMPLETE
C1 static architecture review = PASS
C1 executable validation = PENDING
C1 formal closure = PENDING

C2 / R8 execution = NOT AUTHORIZED
C3 / R9 = NOT AUTHORIZED
C4 / R10 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

Stop here. After the owner-local C1 validation is clean, C1 may be formally
closed only with owner acceptance, and C2 requires explicit separate
authorization.


---

## Program C · C1 formal closure — COMPLETE / PASS / CLOSED — 25 September 2026

The owner confirmed that all required owner-local C1 validation commands passed.

### Validation confirmation

The validated branch state included the documentation-only whitespace correction
commit:

```text
2a248bc300ed70ea143ae37164b5f4674485275e
```

The required C1 validation suite was confirmed clean:

```text
npm test -- src/features/decision/r8ContractArchitecture.test.ts = PASS
npm run typecheck = PASS
npm run check:architecture = PASS
npm exec eslint -- src/features/decision/*.ts = PASS
git diff --check 497006335d4648c7f425691fe8598f9b170ddcd3..HEAD = PASS
```

The PortfolioAI data-boundary architecture guard explicitly reported PASS.

A transient Markdown trailing-whitespace issue in
`docs/PortfolioAI_PROGRAM_C_C1_R8_CONTRACT_ARCHITECTURE.md` was corrected
without changing contract logic. The final diff check passed.

### Formal C1 closure state

```text
C1 = COMPLETE / PASS / CLOSED

R8 contract = FROZEN
R8 sub-engine vocabularies = FROZEN
R8 dependency matrix = FROZEN
R8 portfolio-context snapshot contract = FROZEN
R8 deterministic run-identity contract = FROZEN
R8 authority registry = FROZEN

R8 evaluation = NOT STARTED
portfolio-wide R8 disposition = NOT STARTED
UI integration = NOT STARTED
```

The frozen R7 dependency policy remains:

```text
CORE_HEALTH       = OPTIONAL_CONTEXT
PORTFOLIO_FIT     = NOT_REQUIRED
PORTFOLIO_RISK    = NOT_REQUIRED
EXIT_INTELLIGENCE = OPTIONAL_CONTEXT
```

### Safety boundary retained at C1 closure

```text
numeric sizing authority = NO
opaque portfolio decision score = NO
provider calls = 0
AI deterministic decisions = 0
owner-setting mutation = 0
persistence = 0
schema migration = 0
production mutation = 0
merge/deployment = 0
scheduler mutation = 0
trading = 0
```

### Repository closure documentation

The C1 contract/architecture document was promoted to formal closed status in:

```text
docs/PortfolioAI_PROGRAM_C_C1_R8_CONTRACT_ARCHITECTURE.md
```

Closure documentation commit immediately preceding this handoff append:

```text
9d7279f5d89c84337c5df59098fb9adc4623ffd9
```

### Stop boundary / next authorization

```text
Current stop point = after C1 formal closure

Next possible checkpoint = C2 only
C2 / R8 execution authorization = NOT YET GRANTED

C3 / R9 = NOT AUTHORIZED
C4 / R10 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

Do not begin R8 execution, portfolio-wide R8 disposition or consumer integration
until the owner explicitly authorizes C2.


---

## Program C · C2 R8 Execution & Validation — implementation complete / executable validation pending — 25 September 2026

The owner explicitly authorized C2 after formal C1 closure.

C2 was kept strictly to R8 Checkpoint B.

### Branch / start state

```text
repository = drddutta-portfolio/PortfiolioAI
branch = program-c-portfolio-decision-engines
C2 starting HEAD = fdd44b4591402dbc521e597e499341e2395b910a
C2 source implementation review HEAD = 823e47b503dd1c678f29dcad8e814df6ae74bb6f
C2 architecture document HEAD before this handoff = afb4b358f4c7bec847755fbcefffb67f386e227a
```

### C2 execution artifacts

Added:

```text
src/features/decision/r8Determinism.ts
src/features/decision/r8PortfolioContextBuilder.ts
src/features/decision/r8CoreHealth.ts
src/features/decision/r8PortfolioFit.ts
src/features/decision/r8PortfolioRisk.ts
src/features/decision/r8ExitIntelligence.ts
src/features/decision/r8PortfolioDecisionEngine.ts
src/features/decision/r8ExecutionAuthority.ts
src/features/decision/r8OwnerAuthority.ts
src/features/decision/r8Presentation.ts
src/features/decision/r8LivePortfolioAdapter.ts
src/features/decision/r8FrozenPortfolioDisposition.ts
src/features/decision/r8ReferenceValidation.ts
src/features/decision/r8C2Validation.ts
src/features/decision/r8Execution.test.ts
```

Validation tooling:

```text
scripts/program-c-c2-report.mjs
scripts/program-c-c2-static-safety.mjs
scripts/c2-validate-program-c-r8.sh
```

Controlled consumer integration:

```text
src/components/DashboardCoreExitRisk.tsx
src/components/DashboardRiskConcentration.tsx
```

C2 checkpoint document:

```text
docs/PortfolioAI_PROGRAM_C_C2_R8_EXECUTION_VALIDATION.md
```

No R9 or R10 module was created.

### Deterministic R8 execution

Implemented read-only evaluators for:

```text
Core Health
Portfolio Fit
Portfolio Risk
Exit Intelligence
```

The composed engine keeps all four independently inspectable and creates no
opaque portfolio-decision score.

Deterministic run/context identities use semantic fingerprints and explicit
upstream/context identities; no `Date.now()`, randomness or timestamp-only
identity is used in R8 compute.

### Dependency isolation retained

Frozen C1 R7 dependency remains:

```text
CORE_HEALTH       = OPTIONAL_CONTEXT
PORTFOLIO_FIT     = NOT_REQUIRED
PORTFOLIO_RISK    = NOT_REQUIRED
EXIT_INTELLIGENCE = OPTIONAL_CONTEXT
```

C2 implementation preserves that isolation.

A missing R7 result cannot automatically block Portfolio Fit or Portfolio Risk.

### Core Health

Implemented fail-closed rules:

- missing owner role -> `BLOCKED_PREREQUISITE`;
- non-Core -> `NOT_APPLICABLE`;
- missing/stale mandatory health input -> `INSUFFICIENT_EVIDENCE`;
- conflicting/review state -> `REVIEW_REQUIRED`;
- categorical approved health input maps deterministically to the frozen state
  vocabulary;
- recommendation/owner-role disagreement is surfaced only;
- owner role is never overwritten.

### Portfolio Fit

Implemented owner-relative deterministic logic only:

```text
current weight > owner maximum -> CONCENTRATION_REVIEW
current weight < owner minimum -> FIT_TENSION
direct R7 role candidate differs from owner role -> ROLE_COMPATIBILITY_REVIEW
within configured owner range -> FIT_SUPPORTED
no owner range -> FIT_NEUTRAL
```

No machine target weight, min/max range, correlation, diversification threshold
or sector sizing policy is created.

### Portfolio Risk

Positive/evaluated Portfolio Risk now requires:

- explicit canonical categorical risk input; and
- canonical risk evidence identity.

Therefore missing generic risk evidence can never become `RISK_ACCEPTABLE`.

Generic research freshness alone also does not create a positive risk state.

### Exit Intelligence

Positive/evaluated Exit Intelligence requires:

- explicit thesis/permanent-loss categorical input; and
- thesis evidence identity.

Price weakness, valuation concern or overweight context alone never creates an
exit state.

`HARD_EXIT_REVIEW` remains advisory and non-trading.

### Exact lineage

C2 reference execution consumes the existing Program B lineage directly.

The controlled TORNTPHARM / ALIVUS validation fixture carries exact:

```text
R6 scoreRunId
R7 recommendationRunId
research profile
methodology role
assignment lineage
portfolio-context snapshot id
R8 decisionRunId
```

R6/R7 source-run mismatch is detected and inconsistent R7 context is not used.

### Frozen validation universe

C2 executes an explicit portfolio-wide disposition over:

```text
PROGRAM_C_VALIDATION_UNIVERSE_V1
K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
238 holdings
238 EQUITY
```

The frozen K5 fixture does not contain owner settings/current weights or
canonical risk/thesis evidence.

C2 therefore fails closed rather than fabricating positive R8 coverage.

Every frozen holding still receives an explicit Program C R8 disposition.

```text
portfolio-wide deterministic R8 disposition = COMPLETE
portfolio-wide numeric/action coverage = NOT CLAIMED
```

### Live read-only projection

The live adapter consumes only already-loaded application domain values:

```text
PortfolioViewModel
ResearchCoverageRow
```

It imports no repository, Supabase client, provider adapter or network function.

On the live Dashboard:

- Portfolio Fit may evaluate from current weight and owner-authored settings;
- Core Health remains blocked where exact canonical R6 lineage is not
  materialized;
- Portfolio Risk remains insufficient without canonical risk magnitude evidence;
- Exit Intelligence remains insufficient without thesis/permanent-loss evidence;
- persisted legacy/advisory recommendation rows are not silently promoted into
  Program B R7 lineage.

### Consumer integration

`DashboardCoreExitRisk` now consumes canonical R8 Core Health and Exit
Intelligence projections.

`DashboardRiskConcentration` now consumes canonical R8 Portfolio Fit and
Portfolio Risk projections.

The existing descriptive data/concentration queue is explicitly labelled
non-R8 so page-local heuristics cannot become Program C decision authority.

### Owner-write regression

C2 exercises a mock assessment-writer boundary and proves:

```text
machine assessment write count = 1
owner field mutation count = 0
persistence mutation count = 0
```

### Program B regression

The C2 aggregate audit invokes the closed Program B final audit and requires:

```text
Program B overallPass = true
```

The C2 runner also executes Program B R6/R7/final regression tests.

### Static safety review

Remote source review confirms no R8 runtime module imports:

- `src/data/*`;
- Supabase;
- Angel One;
- Trendlyne;
- OpenAI;
- provider acquisition;
- scheduler;
- brokerage/order repositories.

No R8 runtime module contains:

- `fetch()`;
- `Date.now()`;
- `Math.random()`;
- insert/update/delete/upsert calls.

The C2 structural-safety script independently checks these conditions during the
owner-local validation run.

### C2 repository safety boundary

No:

- schema migration;
- Edge Function;
- data repository;
- workflow;
- provider adapter;
- persistence schema;
- production configuration;
- scheduler;
- trading path

was changed.

### Required owner-local validation

Run:

```bash
git fetch origin
git switch program-c-portfolio-decision-engines
git pull --ff-only

bash scripts/c2-validate-program-c-r8.sh
```

The runner must end with:

```text
PROGRAM C C2 VALIDATION ALL PASS
```

before C2/R8 may be formally closed.

### Current checkpoint state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED

C2 implementation = COMPLETE
C2 static architecture/safety review = PASS
C2 owner-local executable validation = PENDING
C2 formal closure = PENDING
R8 formal closure = PENDING

C3 / R9 = NOT AUTHORIZED
C4 / R10 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

Stop after C2 implementation. C3 requires clean C2 validation, explicit owner
acceptance of R8 closure, and separate authorization.


---

### Program C · C2 refinement after initial handoff — 25 September 2026

After the initial C2 handoff append, three additional fail-closed refinements were
made before owner-local validation. These remain entirely within the authorized
C2 boundary.

Latest C2 source-refinement HEAD before documentation refresh:

```text
a449963778b7d61e0004fc20b4311060571eb3b3
```

C2 checkpoint document refresh:

```text
4c8f9cb780e25a2c2949dd04e6157f2a56fd9e57
```

Refinements:

1. The controlled TORNTPHARM / ALIVUS C2 reference validation now calls the
   Program B R7 recommendation executor directly rather than
   `buildProgramB4ReferenceDecisions()`. This avoids invoking Program B sizing
   readiness in the C2 reference path.

2. The frozen 238-holding R8 aggregate explicitly aborts if the inherited Program
   B portfolio aggregate ever reports `sizingReady != 0`. Program C C2
   therefore cannot silently acquire numeric sizing authority if upstream state
   changes.

3. The live portfolio classification fingerprint now includes `assetClass` in
   addition to security/sector/industry identity, strengthening deterministic
   snapshot identity without changing classification authority.

Earlier C2 hardening also remains in force:

- missing owner role in formal Core Health fails closed as
  `BLOCKED_PREREQUISITE`;
- positive Portfolio Risk requires canonical risk evidence identity;
- positive/NO_EXIT_SIGNAL Exit Intelligence requires thesis evidence identity;
- live timestamp ordering is based on parsed timestamps, not lexical ordering;
- non-null assertions were removed from C2 reference/audit paths.

No provider call, persistence, migration, schema change, production mutation,
numeric sizing authority, AI decision, scheduler or trading behavior was added.

The authoritative C2 validation command remains:

```bash
bash scripts/c2-validate-program-c-r8.sh
```

C2 remains:

```text
implementation = COMPLETE
static architecture/safety review = PASS
owner-local executable validation = PENDING
formal C2/R8 closure = PENDING
C3 / R9 = NOT AUTHORIZED
```


---

## Program C · C2 / R8 formal closure — COMPLETE / PASS / CLOSED — 25 September 2026

The owner confirmed the authoritative C2 owner-local validation completed with:

```text
PROGRAM C C2 VALIDATION ALL PASS
R8 = IMPLEMENTED / VALIDATED / AWAITING OWNER CLOSURE
```

The validated Program C branch state was synchronized through:

```text
74a59f6b6e480f2a8e140c2566e528dc0d2c9af0
```

### Confirmed validation bundle

The C2 runner passed:

```text
C1 contract regression = PASS
C2 R8 execution tests = PASS
Program B final regression = PASS
Program B R6 regression = PASS
Program B R7 regression = PASS
C2 canonical aggregate report = PASS
C2 structural provider/AI/persistence/trading safety = PASS
C2 scoped ESLint = PASS
C2 repository allowlist = PASS
TypeScript = PASS
PortfolioAI architecture/data-boundary guard = PASS
production build = PASS
git diff --check = PASS
```

No executable validation failure remains open.

### Formal R8 closure

```text
C2 = COMPLETE / PASS / CLOSED
R8 = COMPLETE / PASS / CLOSED

R8 contract = CLOSED
R8 execution = CLOSED
R8 deterministic replay = PASS
R8 exact-lineage validation = PASS
R8 owner-authority regression = PASS
R8 frozen-universe disposition completeness = PASS
R8 controlled Dashboard consumer integration = VALIDATED
R8 provider/AI/persistence/trading safety = PASS
```

### Frozen-universe interpretation retained

The exact Program C frozen validation universe remains:

```text
PROGRAM_C_VALIDATION_UNIVERSE_V1
K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
238 holdings
238 EQUITY
```

Every frozen holding receives a deterministic R8 disposition.

This still does **not** claim:

```text
portfolio-wide positive R8 coverage = complete
portfolio-wide numeric action coverage = complete
numeric sizing authority = approved
```

The frozen K5 fixture does not carry all owner/current-weight/risk/thesis inputs
required for fully positive R8 assessments. Fail-closed blocked/insufficient
states are therefore intentional and remain part of the closed R8 design.

### Live R8 limitations intentionally retained

```text
Portfolio Fit:
  may evaluate from current weight + owner-authored settings

Core Health:
  blocked where exact canonical R6 lineage is not materialized to the surface

Portfolio Risk:
  insufficient without canonical risk-magnitude evidence

Exit Intelligence:
  insufficient without thesis/permanent-loss evidence
```

Persisted legacy/advisory recommendation metadata is not silently promoted into
Program B R7 lineage.

### Closed C2 safety boundary

```text
provider calls = 0
Angel One calls = 0
Trendlyne calls = 0
OpenAI deterministic decisions = 0
score recomputation = NO
recommendation recomputation = NO
numeric sizing authority = NO
opaque master portfolio score = NO
owner-setting mutation = 0
persistence = 0
schema migration = 0
production mutation = 0
merge/deployment = 0
scheduler mutation = 0
trading = 0
```

### Closure documentation

C2/R8 was promoted to formal closed status in:

```text
docs/PortfolioAI_PROGRAM_C_C2_R8_EXECUTION_VALIDATION.md
```

Closure-document commit immediately preceding this handoff append:

```text
e1b82b358c9fdd728ad4ed884b5c07f9c96f5938
```

### Program C checkpoint state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED

R8 = COMPLETE / PASS / CLOSED

C3 / R9 = NOT AUTHORIZED
C4 / R10 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED

Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

### Stop boundary

Current stop point is after formal R8 closure.

No R9 contract, R9 execution, meaningful-change registry, event identity,
duplicate suppression or R9 presentation work may begin until the owner
explicitly authorizes C3.


---

## Program C · C3 R9 Contract + Execution + Validation — implementation complete / executable validation pending — 25 September 2026

The owner explicitly authorized C3 after formal C2/R8 closure.

The repository master plan was re-read before implementation. C3 is the
consolidated R9 Checkpoints A+B checkpoint; it includes contract, execution and
validation and is the only checkpoint at which R9 may close.

### Branch / start state

```text
repository = drddutta-portfolio/PortfiolioAI
branch = program-c-portfolio-decision-engines
C3 starting HEAD = 91992ad93f9b2b65c75f85f2b47eed96c6de7a7e
C3 source implementation review HEAD = 89e1f0a8ba8c3886315248687d27258d56f54562
C3 checkpoint document HEAD before this handoff = 51905be4834a90bad29cb96dd38f932517355f3f
```

### C3 R9 artifacts

Added:

```text
src/features/decision/r9AuthorityRegistry.ts
src/features/decision/r9MeaningfulChangeContract.ts
src/features/decision/r9MeaningfulChangeRegistry.ts
src/features/decision/r9ObservedState.ts
src/features/decision/r9EventIdentity.ts
src/features/decision/r9MeaningfulChangeEngine.ts
src/features/decision/r9Presentation.ts
src/features/decision/r9FrozenPortfolioDisposition.ts
src/features/decision/r9LivePortfolioAdapter.ts
src/features/decision/r9LiveSession.ts
src/features/decision/r9ReferenceValidation.ts
src/features/decision/r9C3Validation.ts
src/features/decision/r9MeaningfulChange.test.ts

src/components/DashboardMeaningfulChanges.tsx
src/components/DashboardMeaningfulChanges.css
```

Controlled integration changes:

```text
src/components/DashboardDailyMovement.tsx
src/components/DashboardSectionNavigator.tsx
src/routes/AppRoutes.tsx
```

Validation tooling:

```text
scripts/program-c-c3-report.mjs
scripts/program-c-c3-static-safety.mjs
scripts/c3-validate-program-c-r9.sh
```

Checkpoint document:

```text
docs/PortfolioAI_PROGRAM_C_C3_R9_EXECUTION_VALIDATION.md
```

No R10 source was created.

### Frozen R9 baseline semantics

R9 now explicitly distinguishes:

```text
FIRST_OBSERVATION
NO_CHANGE
RAW_IMMATERIAL_CHANGE
MEANINGFUL_CHANGE
INCOMPARABLE
OUT_OF_ORDER
NOT_APPLICABLE
```

Baseline states:

```text
BASELINE_ESTABLISHED
COMPARABLE_BASELINE
NO_COMPARABLE_BASELINE
```

Frozen invariant:

```text
FIRST_OBSERVATION != NO_CHANGE
FIRST_OBSERVATION != RAW_IMMATERIAL_CHANGE
FIRST_OBSERVATION != MEANINGFUL_CHANGE
```

A first observation creates no R9 event.

### Observed-state lineage

The R9 observed-state contract carries exact available lineage including:

```text
securityId
portfolioId
assetClass
classificationVersion
researchProfileCode
methodologyId/version
methodologyRole
assignmentId/version
evidenceSnapshotId
R6 scoreRunId
R7 recommendationRunId
portfolioContextSnapshotId
R8 decisionRunId
ownerContextVersion
```

It also carries R6/R7 readiness/category states, evidence state, optional
canonical valuation/momentum state, R8 sub-engine states and exact blocker-set
identity.

Observed-state IDs are deterministic semantic fingerprints. Timestamps are used
for comparison ordering but never as the sole identity source.

### Meaningful-change registry

R9 materiality is controlled by:

```text
PROGRAM_C_R9_MEANINGFUL_CHANGE_RULES_V1
```

Approved meaningful categories include:

- R6/R7 readiness transitions;
- recommendation categorical transition;
- methodology/role changes;
- assignment changes;
- classification version changes;
- evidence state changes;
- canonical valuation/momentum categorical changes when available;
- R8 overall transition;
- Core Health transition;
- Portfolio Fit transition;
- Portfolio Risk transition;
- Exit Intelligence transition;
- blocker appearance/clearing/change;
- owner-context version change.

AI does not decide materiality.

### Raw but immaterial changes

The registry also explicitly captures raw changes that are **not** currently
meaningful:

```text
R6_SCORE_RUN_CHANGED
R7_RECOMMENDATION_RUN_CHANGED
R8_DECISION_RUN_CHANGED
EVIDENCE_SNAPSHOT_CHANGED
PORTFOLIO_CONTEXT_SNAPSHOT_CHANGED
R6_SCORE_VALUE_CHANGED_WITHOUT_THRESHOLD
```

This prevents raw-data movement from being silently promoted into an R9 event.

### Numeric materiality policy

No Program C R9 numeric threshold was invented.

```text
scoreDeltaThreshold = null
valuationDeltaThreshold = null
momentumDeltaThreshold = null
concentrationDeltaThreshold = null
hysteresisThreshold = null
persistenceDurationRule = null
```

A score value change alone remains raw/immaterial until a separate approved
threshold authority exists.

### Event identity

Meaningful event identity is deterministic from:

```text
securityId
portfolioId
previousObservedStateId
currentObservedStateId
ruleRegistryVersion
```

Every event explains exact before/after change facts and rule codes.

R9 does not select the final action category. That remains C4/R10 scope.

### Idempotency versus notification persistence

C3 supports:

```text
deterministic event identity = YES
semantic idempotency = YES
same-input replay stability = YES
in-memory duplicate suppression = YES
```

C3 does not claim:

```text
durable acknowledgement = NO
durable snooze = NO
persistent notification deduplication = NO
cross-session seen/unseen state = NO
```

No persistence or schema was added.

### Out-of-order / incomparable behavior

Different security/portfolio/asset-class identities return an explicit
`INCOMPARABLE` result with no event.

Older observations return `OUT_OF_ORDER` with no event.

The live in-memory session preserves the previous valid baseline rather than
replacing it with an invalid comparison window.

### Controlled reference validation

C3 fixtures cover:

```text
first observation
no-change replay
raw score change without threshold
Core Health categorical change
fresh -> stale evidence
assignment version change
blocker clearing
out-of-order input
incomparable input
duplicate-event suppression
```

Synthetic previous R8 identities are explicitly fixture-only and are not
presented as real historical production runs.

### Frozen 238-holding disposition

The Program C validation universe remains:

```text
PROGRAM_C_VALIDATION_UNIVERSE_V1
K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
238 holdings
238 EQUITY
```

The K5 frozen fixture contains no canonical security ids and no previous R9
comparison snapshot.

R9 therefore does not fabricate either.

All 238 holdings receive:

```text
baselineState = NO_COMPARABLE_BASELINE
transitionState = FIRST_OBSERVATION
changeEventId = null
```

Hence:

```text
R9 portfolio-wide deterministic disposition = COMPLETE
historical comparison coverage = NOT CLAIMED
frozen-fixture meaningful event count = 0
```

Zero events in this first-observation fixture does not mean zero change.

### Live in-memory R9 integration

A canonical Dashboard R9 consumer was added:

```text
DashboardMeaningfulChanges
```

It presents:

- first observations;
- no-change;
- raw/immaterial change;
- meaningful change;
- incomparable/out-of-order comparisons;
- new in-memory meaningful events.

It consumes the shared R9 observed-state, comparison, event and presentation
logic. It contains no local materiality policy.

### Daily market movement separation

`DashboardDailyMovement` remains a daily cached price/P&L view and is explicitly
labelled:

```text
not R9 meaningful-change materiality
```

Daily price movement does not automatically create an R9 event.

### R9 authority registry

Current R9 authority is frozen as:

```text
executionAuthority = C3_OWNER_AUTHORIZED_READ_ONLY
materialityAuthority = VERSIONED_DETERMINISTIC_RULES_ONLY
numericThresholdAuthority = NONE
aiDecisionAuthority = NONE
providerAuthority = NONE
persistenceAuthority = NONE
durableNotificationStateAuthority = NONE
ownerMutationAuthority = NONE
sizingAuthority = NONE
schedulerAuthority = NONE
tradingAuthority = NONE
```

### Static source review

Remote source review across all R9 runtime modules found no:

- `src/data/*` import;
- Supabase import;
- Angel One import;
- Trendlyne import;
- OpenAI import;
- provider-acquisition import;
- scheduler/brokerage/order repository import;
- `fetch()`;
- `Date.now()`;
- `Math.random()`;
- insert/update/delete/upsert call.

No trailing whitespace was found in the reviewed R9 runtime modules.

### C3 repository boundary

No:

- migration;
- Edge Function;
- data repository;
- provider adapter;
- workflow;
- persistence schema;
- production configuration;
- scheduler;
- trading path

was changed.

### Required owner-local validation

Run:

```bash
git fetch origin
git switch program-c-portfolio-decision-engines
git pull --ff-only

bash scripts/c3-validate-program-c-r9.sh
```

The runner must end with:

```text
PROGRAM C C3 VALIDATION ALL PASS
R9 = IMPLEMENTED / VALIDATED / AWAITING OWNER CLOSURE
```

before C3/R9 may be formally closed.

### Current Program C state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED
R8 = COMPLETE / PASS / CLOSED

C3 implementation = COMPLETE
C3 static architecture/safety review = PASS
C3 owner-local executable validation = PENDING
C3 formal closure = PENDING
R9 formal closure = PENDING

C4 / R10 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

Stop after C3 implementation. C4 requires clean C3 validation, explicit owner
acceptance of R9 closure and separate authorization.


---

### Program C · C3 pre-validation refinement — 25 September 2026

After the initial C3 implementation handoff, the R9 validation surface was
tightened before owner-local execution.

Latest pre-validation R9 source HEAD:

```text
80f2a847cca1c109cb1ab916abe3ab7949073737
```

C3 checkpoint document refresh:

```text
9fef777bed5d098ae9f925d50f5a5895fbf57b3e
```

Refinements:

1. Event fixture narrowing now uses an explicit
   `ProgramCR9MeaningfulChangeEvent` type rather than an inferred
   `NonNullable<typeof event>` predicate.

2. R9 controlled validation now covers all required categorical evidence
   deterioration cases:

```text
FRESH -> STALE
STALE -> MISSING
MISSING -> CONFLICTING
```

3. Both blocker directions are now validated:

```text
blocker appeared
blocker cleared
```

4. The aggregate C3 audit requires all of the above transitions to produce
   deterministic meaningful events.

No production behavior or authority changed.

The C3 safety boundary remains:

```text
provider calls = 0
AI materiality = 0
numeric threshold creation = 0
numeric sizing authority = NO
owner-setting mutation = 0
persistence = 0
durable acknowledgement/snooze = NO
schema migration = 0
production mutation = 0
merge/deployment = 0
scheduler/trading = 0
```

The authoritative local validation command remains:

```bash
bash scripts/c3-validate-program-c-r9.sh
```

C3/R9 remains implementation-complete and validation-pending. C4/R10 remains
unauthorized.


---

### Program C · C3 owner-local validation correction — React effect lint — 25 September 2026

The first owner-local C3 validator run reached scoped ESLint and stopped with:

```text
DashboardMeaningfulChanges.tsx
react-hooks/set-state-in-effect
Calling setState synchronously within an effect can trigger cascading renders
```

This was isolated to the Dashboard R9 session integration. The R9 contract,
meaningful-change registry, event identity, baseline semantics and safety
authority were not changed.

Correction:

```text
added:
src/features/decision/r9LiveSessionStore.ts

changed:
src/components/DashboardMeaningfulChanges.tsx
scripts/program-c-c3-static-safety.mjs
src/features/decision/r9MeaningfulChange.test.ts
```

The consumer now uses a `useSyncExternalStore`-compatible in-memory session
store. The effect synchronizes the canonical R9 projection into that external
store and no longer calls React `setState` synchronously.

Additional regression coverage proves:

```text
first projection -> FIRST_OBSERVATION
next semantically identical projection -> NO_CHANGE
external-store notifications -> deterministic
```

The static safety scan now includes the session-store module.

Source correction HEAD before documentation:

```text
1f890b940aa1421f4d5df361049747b521e57cf4
```

No:

- provider call;
- persistence;
- schema migration;
- AI materiality;
- numeric sizing authority;
- owner mutation;
- production mutation;
- scheduler;
- trading

was introduced.

C3/R9 remains implementation-complete and **executable-validation pending**.
Rerun the same authoritative command:

```bash
bash scripts/c3-validate-program-c-r9.sh
```

C4/R10 remains unauthorized.


---

### Program C · C3 owner-local validation correction — static-safety false positives — 25 September 2026

The next C3 validation run confirmed the canonical R9 aggregate report passed:

```text
overallPass = true
frozenHoldingCount = 238
frozenMeaningfulEventCount = 0
r8RegressionPass = true
authorityRegistryPass = true
safetyPass = true
providerCalls = 0
persistedWrites = 0
```

The run then stopped only in `program-c-c3-static-safety.mjs` because:

- `Set.delete(listener)` in the in-memory subscription store matched the
  validator's overly broad generic `.delete(...)` persistence pattern;
- the consumer check still expected the pre-lint-fix direct
  `advanceProgramCR9InMemorySession` call.

Validator correction:

```text
f65997a9f42abeea2a87a498645e4dcc3adac13e
```

The validator now:

- permits in-memory `Set.delete(listener)`;
- still rejects database-style `.from(...).delete(...)`;
- still rejects persistence-capable imports;
- recognizes the canonical R9 consumer path through:
  - `buildProgramCR9LiveObservedProjection`;
  - `createProgramCR9LiveSessionStore`;
  - `useSyncExternalStore`.

No R9 business logic or authority changed.

C3 remains:

```text
implementation = COMPLETE
canonical R9 aggregate report = PASS
static validator corrected
full owner-local executable validation = PENDING
formal C3/R9 closure = PENDING
C4/R10 = NOT AUTHORIZED
```

Rerun:

```bash
bash scripts/c3-validate-program-c-r9.sh
```


---

## Program C · C3 / R9 formal closure — COMPLETE / PASS / CLOSED — 25 September 2026

The owner confirmed the authoritative C3 owner-local validator completed with:

```text
PROGRAM C C3 VALIDATION ALL PASS
R9 = IMPLEMENTED / VALIDATED / AWAITING OWNER CLOSURE
```

The validated Program C branch state was synchronized through:

```text
95bf12514cc0c74da622c026534954e44273a667
```

### Confirmed validation bundle

The C3 runner passed:

```text
R9 contract/execution tests = PASS
R8 C1/C2 regressions = PASS
Program B final regression = PASS
Program B R6 regression = PASS
Program B R7 regression = PASS
canonical C3 R9 report = PASS
R9 structural provider/AI/persistence/trading safety = PASS
C3 scoped ESLint = PASS
C3 repository allowlist = PASS
TypeScript = PASS
PortfolioAI architecture/data-boundary guard = PASS
production build = PASS
git diff --check = PASS
```

The earlier React `set-state-in-effect` issue and the two static-safety
false positives were corrected before the final passing run.

No executable validation failure remains open.

### Formal R9 closure

```text
C3 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED

R9 contract = CLOSED
R9 execution = CLOSED
R9 deterministic replay = PASS
R9 first-observation semantics = PASS
R9 no-change distinction = PASS
R9 raw/immaterial distinction = PASS
R9 categorical meaningful-change transitions = PASS
R9 incomparable/out-of-order handling = PASS
R9 semantic duplicate suppression = PASS
R9 frozen-universe disposition completeness = PASS
R9 authority/safety audit = PASS
```

### Frozen R9 semantic boundary retained

```text
FIRST_OBSERVATION != NO_CHANGE
FIRST_OBSERVATION != RAW_IMMATERIAL_CHANGE
FIRST_OBSERVATION != MEANINGFUL_CHANGE
```

The frozen validation universe remains:

```text
PROGRAM_C_VALIDATION_UNIVERSE_V1
K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
238 holdings
238 EQUITY
```

Every frozen holding has an explicit first-observation disposition.

The frozen fixture still has no comparable historical R9 baseline, therefore:

```text
frozen meaningful-event count = 0
meaning = no comparable baseline
NOT meaning = no change
```

### Materiality boundary retained

R9 materiality remains versioned and deterministic.

No Program C numeric materiality threshold was approved:

```text
scoreDeltaThreshold = null
valuationDeltaThreshold = null
momentumDeltaThreshold = null
concentrationDeltaThreshold = null
hysteresisThreshold = null
persistenceDurationRule = null
```

Raw score/run/snapshot movement without an approved categorical rule remains
raw/immaterial and does not create a meaningful event.

### Idempotency boundary retained

```text
deterministic event identity = YES
semantic idempotency = YES
same-input replay stability = YES
in-memory duplicate suppression = YES

durable acknowledgement = NO
durable snooze = NO
persistent notification deduplication = NO
cross-session seen/unseen state = NO
```

No persistence/schema was introduced.

### Closed C3 safety boundary

```text
AI materiality = NO
numeric threshold creation = NO
numeric sizing authority = NO
owner-setting mutation = 0
provider calls = 0
Angel One calls = 0
Trendlyne calls = 0
OpenAI deterministic decisions = 0
persistence = 0
schema migration = 0
production mutation = 0
merge/deployment = 0
scheduler mutation = 0
trading = 0
```

### Closure documentation

C3/R9 was promoted to formal closed status in:

```text
docs/PortfolioAI_PROGRAM_C_C3_R9_EXECUTION_VALIDATION.md
```

Closure-document commit immediately preceding this handoff append:

```text
fa2d18e6d0feeed9874db77d9fe5c89e41f5671c
```

### Program C checkpoint state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED
C3 = COMPLETE / PASS / CLOSED

R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED

C4 / R10 = NOT AUTHORIZED
C-FINAL = NOT AUTHORIZED

Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

### Stop boundary

Current stop point is after formal R9 closure.

No R10 contract, integrated attention precedence, action-category composition,
ADD_REVIEW/TRIM_REVIEW authority promotion, or C-FINAL work may begin until the
owner explicitly authorizes C4.


---

## Program C · C4 R10 Contract + Execution + Validation — implementation complete / executable validation pending — 25 September 2026

The owner authorized "C4/R9". Repository authority was applied: C3 already
closed R9, and the frozen checkpoint map defines C4 as R10. Therefore the
authorization was executed as C4/R10 only.

### Branch / start state

```text
repository = drddutta-portfolio/PortfiolioAI
branch = program-c-portfolio-decision-engines
C4 starting HEAD = 60bf25caae9d9253c577a3e6809ad5527a23ddda
C4 source implementation review HEAD = c53f653840b690e4c761ebcebe5bf270687b3bbd
C4 checkpoint document HEAD before this handoff = 83ccdf934367d2f76dbb7480b0c3804d07dd1797
```

### C4 R10 artifacts

Added:

```text
src/features/decision/r10ActionCenterContract.ts
src/features/decision/r10PrecedenceRegistry.ts
src/features/decision/r10Identity.ts
src/features/decision/r10ActionCenterEngine.ts
src/features/decision/r10ActionCenterViewModel.ts
src/features/decision/r10OwnerAuthority.ts
src/features/decision/r10AuthorityRegistry.ts
src/features/decision/r10LiveActionCenter.ts
src/features/decision/r10FrozenPortfolioDisposition.ts
src/features/decision/r10ReferenceValidation.ts
src/features/decision/r10C4Validation.ts
src/features/decision/r10ActionCenter.test.ts
src/features/decision/useProgramCR10ActionCenter.ts

src/components/ProgramCR10AttentionBadge.tsx
src/components/ProgramCR10AttentionBadge.css
```

Controlled consumer changes:

```text
src/components/DashboardDecisionLayer.tsx
src/pages/ResearchPage.tsx
src/pages/HoldingsPage.tsx
```

Validation tooling:

```text
scripts/program-c-c4-report.mjs
scripts/program-c-c4-static-safety.mjs
scripts/c4-validate-program-c-r10.sh
```

Checkpoint document:

```text
docs/PortfolioAI_PROGRAM_C_C4_R10_EXECUTION_VALIDATION.md
```

No C-FINAL implementation was started.

### Canonical R10 states

```text
EXIT_REVIEW
REVIEW_REQUIRED
BLOCKED_PREREQUISITE
EVIDENCE_REVIEW
INSUFFICIENT_EVIDENCE
RISK_REVIEW
RECOMMENDATION_CHANGE_REVIEW
CONCENTRATION_REVIEW
ROLE_REVIEW
PORTFOLIO_FIT_REVIEW
THESIS_WEAKENING
MONITOR
THESIS_STRENGTHENING
NO_ACTION_REQUIRED
NOT_APPLICABLE
```

The vocabulary is review-oriented and non-executing.

### ADD_REVIEW / TRIM_REVIEW C4 decision

The frozen amendment required explicit proof of approved upstream directional
authority before promotion.

C4 found no approved numeric/directional sizing authority that would justify
canonical ADD/TRIM semantics without over-interpreting R7 or owner weight
settings.

Therefore:

```text
ADD_REVIEW = candidate-only / NOT PROMOTED
TRIM_REVIEW = candidate-only / NOT PROMOTED

canonical membership = NO
numeric sizing authority = NO
```

This is now encoded in the R10 contract and authority registry.

### Deterministic precedence

Frozen R10 precedence:

```text
NOT_APPLICABLE
EXIT_REVIEW
REVIEW_REQUIRED
BLOCKED_PREREQUISITE
EVIDENCE_REVIEW
INSUFFICIENT_EVIDENCE
RISK_REVIEW
RECOMMENDATION_CHANGE_REVIEW
CONCENTRATION_REVIEW
ROLE_REVIEW
PORTFOLIO_FIT_REVIEW
THESIS_WEAKENING
MONITOR
THESIS_STRENGTHENING
NO_ACTION_REQUIRED
```

A higher-priority state retains lower-priority supporting/counter signals.

### Conflict preservation

Structured conflicts include:

```text
FAVOURABLE_RECOMMENDATION_VS_EXIT_RISK
FAVOURABLE_RECOMMENDATION_VS_PORTFOLIO_RISK
RECOMMENDATION_ROLE_VS_OWNER_ROLE
FAVOURABLE_RECOMMENDATION_VS_CONCENTRATION
POSITIVE_R8_CONTEXT_VS_EVIDENCE_DETERIORATION
```

Signals are never averaged into a hidden master score.

### Exact upstream lineage

R10 verifies exact security/portfolio identity across R8/R9 and rejects an R9
current observation referencing a different R8 decision run.

R10 carries:

```text
classificationVersion
researchProfileCode
methodologyId/version
methodologyRole
assignmentId/version
evidenceSnapshotId
R6 scoreRunId
R7 recommendationRunId
portfolioContextSnapshotId
R8 decisionRunId
R9 previous/current observed-state ids
R9 changeEventId
R9 ruleVersion
R9 ownerContextVersion
ownerThresholdContextId
R10 integratedAttentionId
```

No missing upstream identity is reconstructed.

### Owner threshold identity correction

During C4 static review, an identity issue was identified before validation:
owner target/stop settings can alter R10 attention without necessarily altering
R8/R9.

The R10 deterministic identity was therefore strengthened to include a semantic:

```text
ownerThresholdContextId
```

derived from the exact owner target/stop/current-price alert context.

Changing owner threshold context now deterministically changes R10 attention
identity.

### Owner target / stop semantics

Owner-authored target/stop settings may produce:

```text
REVIEW_REQUIRED
```

with exact reason codes such as:

```text
OWNER_STOP_LOSS_THRESHOLD_REACHED
OWNER_TARGET_PRICE_THRESHOLD_REACHED
```

These are review states only.

They do not produce quantity, exact percentage, order or trade instructions.

### Controlled C4 validation fixtures

C4 fixtures cover:

```text
clean complete state -> NO_ACTION_REQUIRED
first observation -> MONITOR
hard Exit Intelligence + favourable recommendation -> EXIT_REVIEW + conflict
concentration -> CONCENTRATION_REVIEW
role compatibility -> ROLE_REVIEW
blocked chain -> BLOCKED_PREREQUISITE
stale evidence over partial context -> EVIDENCE_REVIEW
owner stop threshold -> REVIEW_REQUIRED
R8/R9 run mismatch -> fail closed
owner threshold context change -> new R10 identity
```

### Frozen 238-holding R10 disposition

The frozen Program C universe remains:

```text
PROGRAM_C_VALIDATION_UNIVERSE_V1
K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
238 holdings
238 EQUITY
```

R10 consumes closed R8/R9 frozen dispositions.

Because the frozen K5 fixture still lacks canonical security IDs and comparable
R9 historical state, R10 does not fabricate a full integrated attention ID.

Every holding gets an explicit R10 disposition:

```text
NOT_APPLICABLE where upstream R8 is non-applicable
otherwise BLOCKED_PREREQUISITE
```

Aggregate guarantees:

```text
dispositionComplete = true
directionalAddReviewCount = 0
directionalTrimReviewCount = 0
providerCalls = 0
persistedWrites = 0
```

Portfolio-wide deterministic disposition is complete; positive/action/numeric
coverage is not claimed.

### One canonical live Action Center

Pure domain path:

```text
buildProgramCR10LiveActionCenter()
-> evaluateProgramCR10Attention()
-> buildProgramCR10ActionCenterView()
```

Shared application hook:

```text
useProgramCR10ActionCenter()
```

The hook waits until cached research coverage and cached owner monitoring values
have settled before publishing the collection.

### Dashboard integration

`DashboardDecisionLayer` no longer uses local Action Center business logic.

Removed as Action Center authorities:

```text
localActions()
recommendationTone()
persisted recommendation action-bias promotion
```

The Dashboard canonical Action Center now consumes the shared R10 collection.

Role/theme tables remain descriptive portfolio-structure views.

### Research integration

Research projects the same shared R10 attention fact in the security position
header through `ProgramCR10AttentionBadge`.

Research does not recompute R10 precedence or conflicts.

### Holdings integration

Open Holdings now exposes a canonical `R10 Action Center` column using the same
shared attention view.

Closed positions display R10 as not applicable.

Holdings does not implement local R10 priorities.

### Cross-surface authority

Dashboard, Research and Holdings all consume:

```text
useProgramCR10ActionCenter()
```

Presentation code does not call `evaluateProgramCR10Attention()` directly.

The same canonical inputs therefore produce the same attention identity/state,
severity, reasons and conflicts across surfaces.

### R10 authority registry

```text
executionAuthority = C4_OWNER_AUTHORIZED_READ_ONLY
actionCenterAuthority = ONE_CANONICAL_R10_COLLECTION
conflictAuthority = EXPLICIT_PRESERVATION_NO_AVERAGING
addReviewAuthority = NOT_PROMOTED
trimReviewAuthority = NOT_PROMOTED
exitReviewAuthority = R8_EXIT_INTELLIGENCE_ONLY
numericSizingAuthority = NONE
aiDecisionAuthority = NONE
providerAuthority = NONE
persistenceAuthority = NONE
ownerMutationAuthority = NONE
schedulerAuthority = NONE
tradingAuthority = NONE
```

### Static source review

Remote inspection of R10 runtime modules found no:

- direct data-repository import;
- Supabase import;
- Angel One import;
- Trendlyne import;
- OpenAI import;
- provider-acquisition import;
- scheduler/brokerage/order repository import;
- `fetch()`;
- `Date.now()`;
- `Math.random()`;
- insert/update/upsert call;
- database-style chained delete call.

### Repository boundary

No:

- migration;
- Edge Function;
- data repository;
- provider adapter;
- workflow;
- persistence schema;
- production configuration;
- scheduler;
- trading path

was changed.

### Required owner-local validation

Run:

```bash
git fetch origin
git switch program-c-portfolio-decision-engines
git pull --ff-only

bash scripts/c4-validate-program-c-r10.sh
```

The runner must end with:

```text
PROGRAM C C4 VALIDATION ALL PASS
R10 = IMPLEMENTED / VALIDATED / AWAITING OWNER CLOSURE
```

before C4/R10 may be formally closed.

### Current Program C state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED
C3 = COMPLETE / PASS / CLOSED

R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED

C4 implementation = COMPLETE
C4 static architecture/safety review = PASS
C4 owner-local executable validation = PENDING
C4 formal closure = PENDING
R10 formal closure = PENDING

C-FINAL = NOT AUTHORIZED
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

Stop after C4 implementation. C-FINAL requires clean C4 validation, explicit
owner acceptance of R10 closure and separate authorization.


---

### Program C · C4 owner-local validation correction — TypeScript union widening — 25 September 2026

The first owner-local C4 validator run reached TypeScript and stopped with:

```text
src/features/decision/r10ActionCenterEngine.ts
TS2345: string[] is not assignable to readonly ProgramCR10AttentionState[]
```

The issue was limited to a helper signature:

```text
unique(values: readonly string[])
```

which widened the canonical R10 attention-state union to plain strings before
the precedence selector.

Correction:

```text
unique<T extends string>(values: readonly T[]): T[]
```

Correction commit:

```text
5c8c62afe4e57599c1f4619b1415fa430e70e666
```

No runtime decision logic changed.

No:

- R10 state vocabulary change;
- precedence change;
- conflict change;
- ADD_REVIEW/TRIM_REVIEW promotion;
- numeric sizing;
- provider call;
- persistence;
- schema migration;
- owner-setting mutation;
- production mutation;
- scheduler;
- trading

was introduced.

C4/R10 remains implementation-complete and executable-validation pending.

Rerun:

```bash
git pull --ff-only
bash scripts/c4-validate-program-c-r10.sh
```


---

## Program C · C4 / R10 formal closure — COMPLETE / PASS / CLOSED — 25 September 2026

The owner confirmed the authoritative C4 owner-local validator completed with:

```text
PROGRAM C C4 VALIDATION ALL PASS
R10 = IMPLEMENTED / VALIDATED / AWAITING OWNER CLOSURE
```

The validated C4 source state included the narrow TypeScript union-preservation
correction:

```text
5c8c62afe4e57599c1f4619b1415fa430e70e666
```

### Confirmed validation bundle

The C4 runner passed:

```text
R10 contract/execution tests = PASS
R9 regressions = PASS
R8 regressions = PASS
Program B final regression = PASS
Program B R6 regression = PASS
Program B R7 regression = PASS
canonical C4 R10 report = PASS
R10 structural provider/AI/persistence/trading safety = PASS
C4 scoped ESLint = PASS
C4 repository allowlist = PASS
TypeScript = PASS
PortfolioAI architecture/data-boundary guard = PASS
production build = PASS
git diff --check = PASS
```

No executable validation failure remains open.

### Formal R10 closure

```text
C4 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED

R10 contract = CLOSED
R10 execution = CLOSED
R10 deterministic replay = PASS
R10 deterministic precedence = PASS
R10 conflict preservation = PASS
R10 exact R8/R9 lineage = PASS
R10 owner-threshold identity = PASS
R10 owner-authority regression = PASS
R10 frozen-universe disposition completeness = PASS
R10 shared Dashboard/Research/Holdings Action Center = VALIDATED
R10 authority/safety audit = PASS
```

### Canonical R10 Action Center authority retained

```text
actionCenterAuthority = ONE_CANONICAL_R10_COLLECTION
conflictAuthority = EXPLICIT_PRESERVATION_NO_AVERAGING
```

Dashboard, Research and Holdings consume the same canonical R10 collection.

No presentation surface independently computes R10 precedence or action state.

### ADD_REVIEW / TRIM_REVIEW boundary retained

```text
ADD_REVIEW = candidate-only / NOT PROMOTED
TRIM_REVIEW = candidate-only / NOT PROMOTED
numeric sizing authority = NONE
```

The reason remains:

```text
NO_APPROVED_UPSTREAM_DIRECTIONAL_SIZING_AUTHORITY
```

No machine-generated quantity, exact add/trim percentage, target weight or trade
instruction is introduced.

### Owner-control boundary retained

Owner-authored:

- role;
- target weight;
- minimum/maximum allocation;
- investment horizon;
- target price;
- stop-loss price;
- alert enablement

remain owner-controlled inputs.

R10 may surface review context when owner thresholds are reached but cannot
rewrite owner settings or convert them into automatic orders.

### Frozen 238-holding interpretation retained

The exact validation universe remains:

```text
PROGRAM_C_VALIDATION_UNIVERSE_V1
K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
238 holdings
238 EQUITY
```

Every holding has an explicit deterministic R10 disposition.

This still does **not** claim:

```text
portfolio-wide positive/action coverage = complete
portfolio-wide numeric sizing coverage = complete
portfolio-wide ADD_REVIEW/TRIM_REVIEW authority = approved
```

Fail-closed blocked/non-applicable states remain intentional where frozen
prerequisites are absent.

### Closed C4 safety boundary

```text
R10 execution = READ-ONLY / DETERMINISTIC
opaque master score = NO
ADD_REVIEW promoted = NO
TRIM_REVIEW promoted = NO
numeric sizing authority = NO
trade instruction = NO
owner-setting mutation = 0
provider calls = 0
Angel One calls = 0
Trendlyne calls = 0
OpenAI deterministic decisions = 0
persistence = 0
schema migration = 0
production mutation = 0
merge/deployment = 0
scheduler mutation = 0
trading = 0
```

### Closure documentation

C4/R10 was promoted to formal closed status in:

```text
docs/PortfolioAI_PROGRAM_C_C4_R10_EXECUTION_VALIDATION.md
```

Closure-document commit immediately preceding this handoff append:

```text
1d0f20f089970598201bafe42968d71c0a5aa268
```

### Program C checkpoint state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED
C3 = COMPLETE / PASS / CLOSED
C4 = COMPLETE / PASS / CLOSED

R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED

C-FINAL = NOT AUTHORIZED

Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

### Stop boundary

Current stop point is after formal R10 closure.

No C-FINAL closure audit, Program C program-wide regression/freeze, production
readiness, merge/deployment, scheduler or trading work may begin until the owner
explicitly authorizes C-FINAL.


---

## Program C · C-FINAL cross-engine closure candidate — implementation complete / executable validation pending — 25 September 2026

The owner explicitly authorized C-FINAL after formal C4/R10 closure.

Repository authority was re-read before execution:

```text
docs/PortfolioAI_PROGRAM_C_MASTER_PLAN.md
docs/PORTFOLIOAI_CUMULATIVE_DEVELOPMENT_HANDOFF.md
current branch / HEAD
closed C1-C4 artifacts
```

The frozen master plan defines C-FINAL as:

```text
Program C cross-engine validation and closure
R8 -> R9 -> R10
no new behavior
```

### Branch / start state

```text
repository = drddutta-portfolio/PortfiolioAI
branch = program-c-portfolio-decision-engines
C-FINAL starting HEAD = be79c7bdf2f66e0392804c3502515c228d171c4f
C-FINAL audit/source HEAD before documentation = 14815fbc4ed48c3de2de36788ae9bb274787b518
C-FINAL candidate document commit before this handoff = efe5aa011b33b800de5618c9366a901e45a9728e
```

### C-FINAL validation-only artifacts

Added:

```text
src/features/decision/programCFinalClosure.ts
src/features/decision/programCFinalClosure.test.ts

scripts/program-c-final-report.mjs
scripts/program-c-final-static-safety.mjs
scripts/c-final-validate-program-c.sh

docs/PortfolioAI_PROGRAM_C_FINAL_CLOSURE.md
```

No R8/R9/R10 consumer or decision behavior was changed in C-FINAL.

### Final audit contract

`buildProgramCFinalAudit()` jointly requires:

```text
Program B regression = PASS
R8 closure regression = PASS
R9 closure regression = PASS
R10 closure regression = PASS
deterministic replay = PASS
exact reference lineage = PASS
frozen cross-engine lineage = PASS
portfolio-wide disposition complete = PASS
cross-surface authority = PASS
owner authority = PASS
provider/AI/persistence/trading safety = PASS
numeric sizing boundary = PASS
```

Expected:

```text
overallPass = true
```

### Frozen validation universe retained

C-FINAL does not refresh or replace the C0 population.

```text
validation universe = PROGRAM_C_VALIDATION_UNIVERSE_V1
source snapshot = K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
snapshot date = 2026-09-22
holding count = 238
asset type = 238 EQUITY
state = frozen local deterministic fixture
```

No live production/provider read was introduced.

### Cross-engine frozen lineage

For all frozen rows, C-FINAL validates:

```text
R9.sourceR8Disposition == R8.overallDisposition
R10.sourceR8Disposition == R8.overallDisposition
R10.sourceR9Transition == R9.transitionState
```

All three stages must remain on the same 238-row snapshot/version.

### Exact reference lineage

The controlled end-to-end reference check requires the R9 current observed state
to reference the exact R8 decision run and requires R10 to carry the exact:

```text
R6 scoreRunId
R7 recommendationRunId
portfolioContextSnapshotId
R8 decisionRunId
R9 currentObservedStateId
```

No identity reconstruction is permitted.

### Deterministic replay

C-FINAL rechecks deterministic replay for:

```text
R8
R9
R10
complete Program C final audit payload
```

No random/time-now identity authority is introduced.

### Portfolio-wide disposition

C-FINAL requires:

```text
R8 = 238 explicit dispositions
R9 = 238 explicit dispositions
R10 = 238 explicit dispositions
```

Portfolio-wide disposition completeness remains distinct from positive, numeric,
or action coverage.

### Shared UI authority

C-FINAL structural review rechecks:

```text
R8 Core/Exit Dashboard -> canonical R8
R8 Risk/Fit Dashboard -> canonical R8
Meaningful Change Dashboard -> canonical R9
Dashboard Action Center -> canonical R10
Research Action Center projection -> canonical R10
Holdings Action Center projection -> canonical R10
```

Dashboard/Research/Holdings must continue to consume:

```text
useProgramCR10ActionCenter()
```

No presentation surface may execute R10 business rules directly.

### ADD_REVIEW / TRIM_REVIEW boundary

C-FINAL retains:

```text
ADD_REVIEW = NOT PROMOTED
TRIM_REVIEW = NOT PROMOTED
numeric sizing authority = NONE
```

No order quantity, exact add/trim percentage, machine target weight or trade
instruction exists in Program C authority.

### Full-history safety guard

The final validator audits the entire Program C history from:

```text
d3b8a755885bd4ecc0be37aa59ea46f2eac0ca41
```

and requires:

```text
expected branch = program-c-portfolio-decision-engines
frozen Program C start remains ancestor of HEAD
no merge commits inside Program C branch history
Program C changed-file allowlist = PASS
supabase/migrations changes = 0
supabase/functions changes = 0
.github/workflows changes = 0
src/data changes = 0
deployment-config changes = 0
```

This validates history safety only. It does not merge the branch.

### Structural source review

Remote review of the newly added C-FINAL artifacts found:

```text
provider/data imports = 0
fetch() = 0
Date.now() = 0
Math.random() = 0
trailing whitespace = 0
```

The final structural scanner also audits the complete R8/R9/R10 runtime path.

### Intentional closure-candidate limitations

C-FINAL deliberately retains:

```text
PORTFOLIO_WIDE_NUMERIC_R6_COVERAGE_NOT_COMPLETE
PORTFOLIO_WIDE_NUMERIC_R7_COVERAGE_NOT_COMPLETE
NUMERIC_SIZING_POLICY_NOT_APPROVED
ADD_REVIEW_NOT_PROMOTED
TRIM_REVIEW_NOT_PROMOTED
SOME_HOLDINGS_FAIL_CLOSED_BLOCKED_OR_INSUFFICIENT
R8_R9_R10_PERSISTENCE_NOT_ENABLED
R9_DURABLE_ACKNOWLEDGEMENT_SNOOZE_NOT_ENABLED
NO_PROVIDER_REFRESH_IN_PROGRAM_C
NO_SCHEDULER
NO_AI_INVESTMENT_DECISION_AUTHORITY
NO_PRODUCTION_DEPLOYMENT
NO_BRANCH_MERGE
NO_TRADING
FROZEN_VALIDATION_SNAPSHOT_IS_2026_09_22_NOT_LIVE_PRODUCTION_STATE
PROGRAM_C_IS_VALIDATED_LOCAL_CANDIDATE_NOT_PRODUCTION_OPERATIONAL
```

These are permitted by the frozen master plan and are not closure defects.

### Required owner-local validation

Run:

```bash
git fetch origin
git switch program-c-portfolio-decision-engines
git pull --ff-only

bash scripts/c-final-validate-program-c.sh
```

The target terminal ending is:

```text
PROGRAM C C-FINAL CANDIDATE VALIDATION PASS
R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED
Program C closure audit = PASS / AWAITING EXPLICIT OWNER FORMAL CLOSURE APPROVAL
Portfolio-wide deterministic disposition = COMPLETE over frozen 238-holding universe
Numeric sizing / ADD_REVIEW / TRIM_REVIEW authority = NONE
Provider/AI/persistence/production/merge/scheduler/trading authority = NONE
Program C state = VALIDATED LOCAL-CANDIDATE / FAIL-CLOSED WHERE INCOMPLETE
Production operational = NO
Program D = NOT AUTHORIZED
```

### Current checkpoint state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED
C3 = COMPLETE / PASS / CLOSED
C4 = COMPLETE / PASS / CLOSED

R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED

C-FINAL implementation = COMPLETE
C-FINAL static review = PASS
C-FINAL owner-local executable validation = PENDING
C-FINAL formal closure = NOT YET APPROVED

Program C = CLOSURE CANDIDATE / OPEN
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Scheduler/trading = NOT AUTHORIZED
```

### Stop boundary

After a clean C-FINAL owner-local validation, stop.

The frozen master plan requires a separate explicit owner instruction before
recording:

```text
Program C = COMPLETE / PASS / CLOSED
```

A clean C-FINAL does not authorize Program D, productionization, merge,
deployment, scheduler activation, persistence expansion, provider automation or
trading.


---

### Program C · C-FINAL owner-local validation correction — historical whitespace — 25 September 2026

The first owner-local C-FINAL run completed the Vite production build and then
stopped only at the final `git diff --check` history guard.

Reported issue:

```text
docs/PortfolioAI_PROGRAM_C_C0_CONTRACT_FREEZE_INHERITANCE_AUDIT.md
trailing whitespace on header metadata lines 3-8
```

This was a documentation-formatting defect from the historical C0 artifact, not
a Program C logic or architecture failure.

Correction:

```text
6 trailing-space occurrences removed
semantic document content unchanged
```

Correction commit:

```text
e7f0763a92942cdd587a68b5e7fe322c23c562a4
```

The Vite chunk-size message preceding the stop was a non-fatal warning; the
production build itself had succeeded.

No:

- R8/R9/R10 decision behavior;
- lineage;
- Action Center authority;
- owner authority;
- numeric sizing boundary;
- provider call;
- persistence;
- schema migration;
- production mutation;
- merge/deployment;
- scheduler;
- trading

was changed.

C-FINAL remains:

```text
implementation = COMPLETE
static review = PASS
owner-local executable validation = PENDING
formal Program C closure = NOT YET APPROVED
```

Rerun:

```bash
git pull --ff-only
bash scripts/c-final-validate-program-c.sh
```


---

## Program C · C-FINAL candidate validation — PASS / awaiting explicit formal closure approval — 25 September 2026

The owner confirmed the authoritative C-FINAL validation runner completed
successfully.

Terminal ending:

```text
PROGRAM C C-FINAL CANDIDATE VALIDATION PASS
R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED
Program C closure audit = PASS / AWAITING EXPLICIT OWNER FORMAL CLOSURE APPROVAL
Portfolio-wide deterministic disposition = COMPLETE over frozen 238-holding universe
Numeric sizing / ADD_REVIEW / TRIM_REVIEW authority = NONE
Provider/AI/persistence/production/merge/scheduler/trading authority = NONE
Program C state = VALIDATED LOCAL-CANDIDATE / FAIL-CLOSED WHERE INCOMPLETE
Production operational = NO
Program D = NOT AUTHORIZED
```

### Confirmed final validation bundle

The passing C-FINAL run confirms:

```text
C-FINAL audit tests = PASS
R10 regressions = PASS
R9 regressions = PASS
R8 regressions = PASS
Program B regressions = PASS
K5 routing/isolation/portability regressions = PASS
canonical Program C final report = PASS
C2/C3/C4 structural safety regressions = PASS
C-FINAL structural safety = PASS
Program C scoped ESLint = PASS
branch/ancestry/no-merge history guard = PASS
full-history changed-file allowlist = PASS
TypeScript = PASS
PortfolioAI architecture/data-boundary guard = PASS
production build = PASS
full Program C git diff --check = PASS
```

The Vite chunk-size output is a warning only; the production build completed
successfully.

### Current authoritative state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED
C3 = COMPLETE / PASS / CLOSED
C4 = COMPLETE / PASS / CLOSED

R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED

C-FINAL implementation = COMPLETE
C-FINAL static review = PASS
C-FINAL executable validation = PASS
C-FINAL closure audit = PASS
C-FINAL formal closure = AWAITING EXPLICIT OWNER APPROVAL

Program C = VALIDATED CLOSURE CANDIDATE / OPEN
Program D = NOT AUTHORIZED
Production operational = NO
```

### Closure boundary remains unchanged

Even after this clean C-FINAL result:

```text
ADD_REVIEW = NOT PROMOTED
TRIM_REVIEW = NOT PROMOTED
numeric sizing authority = NONE
provider refresh = NO
AI investment-decision authority = NO
R8/R9/R10 persistence = NO
schema migration = NO
productionization = NO
branch merge = NO
deployment = NO
scheduler = NO
trading = NO
```

### Required next step

The frozen Program C master plan requires one separate explicit owner approval
before recording:

```text
Program C = COMPLETE / PASS / CLOSED
```

Until that approval is given, Program C remains a validated closure candidate
and Program D remains unauthorized.

### Program C independent pre-closure corrective package — 25 September 2026

The independent pre-closure audit found three related lineage defects: R8 run
identity omitted decision-changing signals, canonical evidence was not bound to
the risk/thesis evidence consumed by R8, and R10 allowed missing current
R9-to-R8 lineage. The authorized local correction binds R8 semantic identity
and evidence, rejects missing or mismatched R10 lineage, strengthens aggregate
adverse validation and frozen-universe uniqueness checks, replaces 32-bit
fingerprints with SHA-256, and resolves the Program C scoped React hook warning.

The correction changes no schema, production state, providers, persistence,
sizing, scheduling or trading authority. Formal Program C closure still
requires the owner's explicit post-audit decision.


---

## Program C · FORMAL CLOSURE — COMPLETE / PASS / CLOSED — 25 September 2026

The owner explicitly approved formal Program C closure after the independent
post-fix audit and strengthened C-FINAL validation passed.

### Closure lineage

The final bounded remediation was committed and pushed as:

```text
928ae7fd07936f8b8ea9433c09370395940dbeaf
fix: remediate Program C pre-closure lineage audit findings
```

That remediation closed the three independent-audit blockers:

1. R8 deterministic identity omitted decision-changing semantic inputs.
2. R8 risk/thesis evidence was not bound to canonical evidence.
3. R10 accepted missing current R9-to-R8 lineage.

Post-fix independent audit conclusion:

```text
PROGRAM C INDEPENDENT AUDIT = PASS WITH NON-BLOCKING FINDINGS
FORMAL CLOSURE MAY PROCEED SUBJECT TO OWNER APPROVAL
```

The strengthened C-FINAL validator then passed from the committed/pushed
remediation state.

### Final checkpoint state

```text
C0 = COMPLETE / PASS / CLOSED
C1 = COMPLETE / PASS / CLOSED
C2 = COMPLETE / PASS / CLOSED
C3 = COMPLETE / PASS / CLOSED
C4 = COMPLETE / PASS / CLOSED
C-FINAL = COMPLETE / PASS / CLOSED

R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED

Program C = COMPLETE / PASS / CLOSED
```

### Final validated guarantees

```text
R8 semantic decision identity sensitivity = PASS
SHA-256 deterministic identity = PASS
canonical risk evidence binding = PASS
canonical thesis evidence binding = PASS
evidence-order identity stability = PASS
R10 missing-lineage rejection = PASS
R10 mismatched-lineage rejection = PASS
exact R8 -> R9 -> R10 lineage = PASS
deterministic replay = PASS
frozen-universe uniqueness = PASS
238-holding deterministic disposition = COMPLETE
cross-engine frozen-row equivalence = PASS
one canonical R10 Action Center authority = PASS
Dashboard/Research/Holdings shared R10 consumption = PASS
owner-field immutability = PASS
fail-closed incomplete-state behavior = PASS
```

### Final safety boundary

```text
ADD_REVIEW promoted = NO
TRIM_REVIEW promoted = NO
numeric sizing authority = NONE
provider calls in Program C compute paths = NONE
Angel One calls = NONE
Trendlyne calls = NONE
OpenAI deterministic investment decisions = NONE
R8/R9/R10 persistence writes = NONE
schema migrations = NONE
production mutation = NONE
branch merge = NONE
deployment = NONE
scheduler mutation = NONE
trading = NONE
```

### Intentional limitations retained

Program C formal closure does **not** claim:

```text
portfolio-wide numeric R6 coverage = complete
portfolio-wide numeric R7 coverage = complete
numeric sizing policy = approved
ADD_REVIEW authority = approved
TRIM_REVIEW authority = approved
R8/R9/R10 persistence = enabled
R9 durable acknowledgement/snooze = enabled
provider automation = enabled
production operational state = achieved
branch merge = completed
deployment = completed
scheduler = active
trading = enabled
```

The Program C frozen validation universe remains:

```text
PROGRAM_C_VALIDATION_UNIVERSE_V1
K5_CURRENT_PORTFOLIO_ROUTING_SNAPSHOT_2026_09_22
238 holdings
238 EQUITY
```

Some holdings intentionally remain fail-closed where upstream evidence or
lineage is incomplete.

### Closure documentation

Formal Program C closure is recorded in:

```text
docs/PortfolioAI_PROGRAM_C_FINAL_CLOSURE.md
```

Formal closure document commit immediately preceding this handoff append:

```text
278de4fdf1c44a01032884b3c873d887a6d704da
```

### Post-closure authority

Formal Program C closure does not authorize the next program automatically.

```text
Program D = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Provider automation = NOT AUTHORIZED
R8/R9/R10 persistence expansion = NOT AUTHORIZED
Scheduler activation = NOT AUTHORIZED
Trading = NOT AUTHORIZED
```

### Stop boundary

Current stop point is after formal Program C closure.

No Program D, productionization, merge, deployment, provider automation,
persistence expansion, scheduler, or trading work may begin until separately
authorized by the owner.


---

## Program D · Master Plan Freeze / Workflow Handoff — 25 September 2026

Program C is formally closed and remains frozen:

```text
Program C = COMPLETE / PASS / CLOSED
R8 = COMPLETE / PASS / CLOSED
R9 = COMPLETE / PASS / CLOSED
R10 = COMPLETE / PASS / CLOSED
```

Program D planning has now been frozen on a separate branch:

```text
branch = program-d-operations-optional-ai
base = f7c6cf45e7ec1d1820173addea0e18f38f84a25a
```

The authoritative Program D master plan is:

```text
docs/PortfolioAI_PROGRAM_D_MASTER_PLAN.md
```

Master-plan freeze commit:

```text
c2eba3e2ef13f7b166e3c0419a5b8f5e1e7101e3
```

### Mandatory continuation workflow

Before any Program D work, ChatGPT, Codex, or any other approved builder must read:

1. `docs/PortfolioAI_PROGRAM_D_MASTER_PLAN.md`
2. the latest Program D section of this cumulative handoff
3. the exact current branch and HEAD
4. any checkpoint-specific Program D document already created

Repository documents override chat memory.

The builder must confirm explicit authorization for the current checkpoint and
must stop before the next checkpoint unless separately authorized.

### Frozen Program D sequence

```text
D0       Contract / Dependency / Durability / Safety Freeze

D1       R11 Local Orchestration Implementation
D2       R11 Adversarial Validation + Bounded-Pilot Readiness
         -> R11 closes here

D3       R12 Bounded On-Demand Implementation — OPTIONAL
D4       R12 Grounding / Adversarial Validation — OPTIONAL
         -> R12 closes here if authorized

D-FINAL  Authorized-Scope Closure Audit
```

R12 remains optional. Program D may close for an explicitly authorized R11-only
scope if the owner defers R12.

### Key revisions incorporated into the frozen plan

The frozen plan incorporates the Codex repository audit plus the following
architecture refinements:

1. **Dependency-driven R11 DAG**
   - R11 must use a machine-readable R6-R10 dependency matrix.
   - It must not rely on a simplistic R6 -> R7 -> R8 -> R9 -> R10 cascade.
   - Owner-context, evidence-freshness, methodology, assignment and other
     canonical dependency changes may independently trigger affected stages.

2. **D1 zero-real-provider rule**
   - D1 uses fixtures, mocks, local/disposable state and dry-run provider plans.
   - Real Trendlyne, Angel One, AI or other external provider calls are zero by
     default.
   - Any bounded provider pilot belongs behind a separate D2 owner gate.

3. **R9 durability decision**
   - D0 must prove exact reconstruction of the previous comparable semantic
     R9 observed state from durable canonical history, or approve a minimal
     durable R9 comparison checkpoint.
   - An identity/hash alone is not sufficient when the previous semantic
     payload is required to explain what changed.
   - R9 acknowledgement, snooze and seen/unseen remain outside core R11.

4. **R10 last-known-good discipline**
   - Program C R10 is non-persistent.
   - R11 may not imply durable last-known-good R10 state unless a separately
     approved non-authoritative operational snapshot is explicitly built.
   - Operational snapshots may never replace canonical R10 authority.

5. **R12 authority-conflict rejection**
   - R12 may explain contradiction and uncertainty.
   - If AI proposes a competing R10 action/priority or unauthorized
     buy/sell/add/trim/exit instruction, the narrative is rejected as
     `REJECTED_AUTHORITY_CONFLICT`.
   - It is not surfaced as a valid competing investment conclusion.

6. **Program D durability/restart matrix**
   - D0 must freeze what is durable today, what must survive restart and which
     minimal operational state is genuinely required.
   - Orchestration persistence must not silently become new business authority.

7. **D-FINAL semantics**
   - D-FINAL is an authorized-scope closure audit.
   - It is not production readiness, production enablement, merge or deployment.

### Program D authority boundary

```text
R11 = orchestration authority only
R12 = optional narrative authority only

R6 = score authority
R7 = recommendation authority
R8 = portfolio decision-context authority
R9 = meaningful-change authority
R10 = canonical Action Center authority

owner fields = owner authority
trading = NOT AUTHORIZED
```

Program D may not:

- mutate owner roles/settings/limits;
- create numeric sizing authority;
- promote ADD_REVIEW or TRIM_REVIEW;
- make AI deterministic;
- import providers into R6-R10 compute paths;
- place trades;
- activate production through checkpoint completion alone.

### Current Program D status

```text
Program D master plan = FROZEN

D0 = NOT STARTED
D1 = NOT STARTED
D2 = NOT STARTED
D3 = NOT STARTED
D4 = NOT STARTED
D-FINAL = NOT STARTED

R11 = NOT STARTED
R12 = NOT STARTED

Program D implementation = NOT AUTHORIZED
Migration = NOT AUTHORIZED
Provider pilot = NOT AUTHORIZED
Scheduler activation = NOT AUTHORIZED
Provider automation = NOT AUTHORIZED
AI activation = NOT AUTHORIZED
Productionization = NOT AUTHORIZED
Merge/deployment = NOT AUTHORIZED
Trading = NOT AUTHORIZED
```

### Next eligible authorization

The next owner authorization, if desired, is:

```text
D0 ONLY
```

D0 is architecture/contract/audit/freeze work only and must contain no live
provider execution, AI execution, scheduler activation, migration application,
production mutation, deployment or trading.


---

## Program D · D0 Contract Freeze Implementation — LOCAL VALIDATION PENDING — 25 September 2026

The owner explicitly authorized **D0 only** and confirmed the Program D workflow:

```text
GitHub branch
    ↓
develop/update code
    ↓
update cumulative handoff
    ↓
git pull
    ↓
local Mac
    ↓
local Supabase
    ↓
local Vite
    ↓
localhost / owner review where applicable
    ↓
full local validation
    ↓
update cumulative handoff with final checkpoint result
    ↓
next gate only after separate authorization
```

### Repository changes completed for D0

Added:

```text
src/features/operations/programD0Contract.ts
src/features/operations/programD0Contract.test.ts
docs/PortfolioAI_PROGRAM_D_D0_CONTRACT_DEPENDENCY_DURABILITY_SAFETY_FREEZE.md
```

Updated:

```text
docs/PortfolioAI_Development_Status.md
docs/PORTFOLIOAI_CUMULATIVE_DEVELOPMENT_HANDOFF.md
```

The D0 code addition is static contract data plus tests only. It is not an R11 orchestrator, scheduler, provider executor or persistence implementation.

### D0 audit decisions now frozen on the branch

#### Trigger and dependency model

R11 trigger taxonomy is frozen to:

```text
SCHEDULED_MAINTENANCE
CONDITION_STALENESS
CANONICAL_EVIDENCE_ACCEPTED
MARKET_DATA_ACCEPTED
OWNER_CONTEXT_CHANGED
METHODOLOGY_CHANGED
ASSIGNMENT_CHANGED
POLICY_CHANGED
MANUAL_REPLAY
BOUNDED_PILOT
```

The machine-readable dependency graph covers:

```text
R6
R7
R8_CORE_HEALTH
R8_PORTFOLIO_FIT
R8_PORTFOLIO_RISK
R8_EXIT_INTELLIGENCE
R9
R10
```

It deliberately preserves the existing Program C R8 dependency contract: Portfolio Fit and Portfolio Risk do not require R7, while Core Health and Exit Intelligence treat R7 only as optional context where applicable.

#### Recomputation / no-op semantics

Unchanged canonical dependency fingerprints are audited no-ops. Frozen no-op cases include duplicate semantic triggers, unchanged accepted evidence, run-id-only changes, unchanged owner context/policy/methodology/assignment state, current market-history windows and already-fresh research domains.

Semantic job identity is SHA-256 over canonical ordered fields including portfolio, normalized subject scope, trigger type, canonical dependency fingerprint, policy versions and engine versions. Random run ids are not semantic authority.

#### Provider-control reuse

Research operations reuse the existing provider-control plane:

```text
provider_ingestion_controls
provider_usage_events
reserve_provider_budget_v1
settle_provider_budget_v1
data_ingestion_runs
data_ingestion_run_items
security_refresh_states
refresh_domain_policies
acquire_data_ingestion_lease_v1 / release_data_ingestion_lease_v1 where scope matches
```

Market-data operations reuse existing market-data refresh state, cache/history stores and operation leases, with later scheduler hardening separately gated.

Program D does not create a duplicate provider budget or usage-accounting plane.

#### Kill switches / retry / leases

Execution-time kill-switch order is frozen as:

```text
GLOBAL_AUTOMATION → PROVIDER → DOMAIN
```

Transient provider/runtime failures are the only automatic-retry class. Auth/authz failure, budget denial, kill switch, identity conflict, schema conflict, invalid canonical evidence, deterministic invalid input and authority conflict are non-retryable.

A Program D deterministic-chain lease and general operational ledger are new semantic requirements, but persistence for either remains separately gated.

#### Durability / restart

Current audited durability is frozen as:

```text
Research evidence = durable
Market history = durable
R6 result = non-persisting today
R7 result = non-persisting today
R8 result = non-persistent
R9 previous comparable semantic state = process-memory only
R10 Action Center = non-persistent
```

**R9 decision:** Model B is required for scheduled R11 restart safety.

Reason: current R9 comparison state is in memory, while current R6/R7/R8 outputs are non-persisting; therefore exact reconstruction of the previous complete semantic `ProgramCR9ObservedState` after restart is not proven. A hash/identity alone is insufficient.

Future checkpoint content must include the complete previous comparable semantic payload plus identity, lineage, canonical dependency hash and successful processing checkpoint.

D0 creates **no schema and no persistence** for this decision. Migration creation and R9 persistence each remain separate owner gates.

**R10 decision:** no durable R10 operational snapshot is required for core R11. Canonical R10 is recomputed. On failure, preserve canonical upstream facts, report staleness/failure and do not fabricate a replacement R10 state. Any future operational snapshot remains separately gated and non-authoritative.

#### R12 freeze

R12 remains optional and downstream. Allowed lifecycle states are:

```text
DISABLED
ON_DEMAND_ONLY
BOUNDED_PILOT
WEEKLY_SELECTED_SCOPE
```

The fact-packet categories and output authority boundary are frozen. Unsupported facts/numbers/citations are rejected. Any competing R10 action/priority, deterministic override or trade instruction is:

```text
REJECTED_AUTHORITY_CONFLICT
```

and must not surface as a valid Investment Committee conclusion.

### D0 validation status

GitHub implementation is complete enough to enter the agreed local pull/validation phase, but D0 is **not closed yet**.

```text
D0 contract package = IMPLEMENTED ON BRANCH
D0 local validation = PENDING
D0 owner closure = PENDING
D1 = NOT AUTHORIZED
```

Required local checks before D0 closure include the D0 Vitest contract test, relevant Program C regressions, typecheck, architecture guard, changed-file lint/build as applicable, git diff check, secret review, and confirmation of zero schema/provider/AI/scheduler/production side effects.

### Safety boundary preserved

```text
Program C mutation = NO
provider calls = 0
AI calls = 0
migration creation/application = 0
scheduler activation = 0
production mutation = 0
deployment = 0
merge = 0
ADD_REVIEW promotion = NO
TRIM_REVIEW promotion = NO
numeric sizing authority = NONE
trading = NO
```

### Next workflow step

Pull the current Program D branch onto the Mac and validate that exact branch state locally. No D1 work may begin during this validation phase.


---

## Program D · D0 Full Local Validation — PASS / AWAITING OWNER CLOSURE — 25 September 2026

The D0 branch package was pulled to the owner's Mac at exact GitHub HEAD:

```text
branch = program-d-operations-optional-ai
validated HEAD = a21f987c7f3dbec78d33293f6d33de8a7308231c
```

Local Supabase was already running and healthy. Local Vite was already running. The localhost application smoke check was accepted by the owner as normal, with no D0-specific UI change expected because D0 is contract/audit work only.

### Local validation results

```text
D0 contract Vitest
  1 file passed
  9 / 9 tests passed

Program C frozen regression set
  5 files passed
  63 / 63 tests passed

Targeted D0 ESLint
  PASS
  no D0-file lint errors

TypeScript
  npm run typecheck
  PASS

Architecture guard
  npm run check:architecture
  PASS

Production build
  npm run build
  PASS
  only existing Vite chunk-size warning observed

git diff --check
  PASS
  no output

Local working tree audit
  no tracked D0 drift detected
  existing untracked local artifacts remain untouched:
    PORTFOLIOAI_CURRENT_STATE_AUDIT.md
    PORTFOLIOAI_LUI1_LOCAL_FIXTURE.sql
    PORTFOLIOAI_LUI1_LOCAL_FIXTURE_V2.sql
    artifacts/
```

A whole-repository lint command was also run accidentally through the package script and exposed pre-existing unrelated repository lint debt. None of those reported errors were in the D0 files. D0 therefore used the required targeted lint result for its changed application files and did not widen scope to repair unrelated historical lint debt.

### Side-effect audit

The validated D0 package introduced no operational side effects:

```text
Program C semantic changes = 0
provider calls = 0
AI calls = 0
migration creation = 0
migration application = 0
scheduler activation = 0
production mutation = 0
deployment = 0
merge = 0
provider automation = 0
R9 persistence = 0
R10 snapshot persistence = 0
numeric sizing authority = NONE
ADD_REVIEW promotion = NO
TRIM_REVIEW promotion = NO
trading = NO
```

### D0 checkpoint status

All required D0 contract, dependency, durability, safety and local validation work is now complete within the authorized D0 scope.

```text
D0 = COMPLETE / PASS / AWAITING OWNER CLOSURE
D1 = NOT STARTED / NOT AUTHORIZED
D2 = NOT STARTED / NOT AUTHORIZED
D3 = NOT STARTED / NOT AUTHORIZED
D4 = NOT STARTED / NOT AUTHORIZED
D-FINAL = NOT STARTED / NOT AUTHORIZED
```

D0 closure does not authorize D1. The next possible action after owner closure is a separate explicit D1 authorization.


---

## Program D · D0 OWNER CLOSURE / D1 AUTHORIZATION — 25 September 2026

Owner decision:

```text
D0 = COMPLETE / PASS / CLOSED
D1 = AUTHORIZED
D2 = NOT AUTHORIZED
D3 = NOT AUTHORIZED
D4 = NOT AUTHORIZED
D-FINAL = NOT AUTHORIZED
```

The owner explicitly accepted the fully validated D0 result and instructed the build to start D1.

D1 is authorized only within the frozen master-plan scope:

- local/provider-free R11 orchestration implementation;
- trigger intake;
- dependency planner;
- semantic no-op planner;
- deterministic job identity;
- lease/concurrency abstraction;
- retry/recovery state;
- operational ledger abstraction;
- downstream event routing;
- operations UI;
- dry-run provider-call planning;
- canonical stage adapters.

The following remain separately gated and are **not** implied by D1 authorization:

```text
migration creation/application = NOT AUTHORIZED
R9 durable checkpoint persistence = NOT AUTHORIZED
R10 operational snapshot persistence = NOT AUTHORIZED
real provider pilot = NOT AUTHORIZED
Trendlyne automation = NOT AUTHORIZED
Angel One automation = NOT AUTHORIZED
automatic production R6-R10 recomputation = NOT AUTHORIZED
scheduler enablement = NOT AUTHORIZED
recurring provider spend = NOT AUTHORIZED
R12 = NOT AUTHORIZED
AI provider calls = NOT AUTHORIZED
notifications = NOT AUTHORIZED
production readiness/enablement = NOT AUTHORIZED
merge/deployment = NOT AUTHORIZED
trading = NOT AUTHORIZED
```

D1 default physical external calls remain:

```text
Trendlyne = 0
Angel One = 0
AI = 0
other external provider = 0
```

Program C remains frozen.


---

## Program D · D1 R11 Local Orchestration — IMPLEMENTED / LOCAL VALIDATION PENDING — 25 September 2026

D0 is formally closed and D1 was explicitly authorized by the owner.

The first complete D1 local/provider-free orchestration package is now implemented on the Program D branch.

Authoritative D1 implementation record:

```text
docs/PortfolioAI_PROGRAM_D_D1_R11_LOCAL_ORCHESTRATION_IMPLEMENTATION.md
```

### Implemented D1 behavior

- SHA-256 semantic job identity;
- dependency-driven R6–R10 dry-run planner;
- audited no-op for unchanged canonical dependencies;
- duplicate semantic-trigger reuse;
- local deterministic-chain lease contention handling;
- partial-run checkpoint resume;
- dry-run downstream event routing;
- provider-call estimate planning with zero physical calls;
- browser-local disposable operational ledger;
- in-memory test store;
- authenticated `/app/operations` UI and navigation;
- frozen D1 adversarial local tests.

Automatic deterministic R6–R10 execution remains disabled because it is a separate owner gate. D1 stage adapters therefore produce dry-run checkpoints only and do not alter Program C outputs.

### D1 safety state

```text
Trendlyne physical calls = 0
Angel One physical calls = 0
AI calls = 0
automatic R6-R10 execution = false
migration = 0
Supabase operational persistence = 0
scheduler activation = 0
production mutation = 0
R9 durable checkpoint persistence = 0
R10 snapshot persistence = 0
merge/deployment = 0
trading = 0
```

### Current checkpoint

```text
D0 = COMPLETE / PASS / CLOSED
D1 = IMPLEMENTED ON GITHUB / LOCAL VALIDATION PENDING
D2 = NOT AUTHORIZED
```

Next workflow step: pull the exact Program D branch to the Mac, inspect the new Operations UI locally, and execute the D1 local validation suite. D2 must not begin automatically.


### D1 localhost visual validation correction — stage ordering bug found and fixed

Owner localhost testing of the four initial D1 fixtures correctly exposed a planner-order defect before D1 closure.

Observed incorrect ledger order included examples such as:

```text
R10 -> R8_EXIT_INTELLIGENCE -> R8_PORTFOLIO_RISK -> R9
R10 -> R6 -> R7 -> R8_CORE_HEALTH -> R9
```

Root cause: the affected-node set was converted to an alphabetically sorted array. That preserved membership but violated dependency/topological execution order.

Fix applied on the Program D branch:

- affected nodes now follow the frozen `PROGRAM_D_R11_DEPENDENCY_MATRIX` order;
- changed-node normalization also uses the frozen dependency order;
- a regression test now locks expected stage order for evidence-change and market-data-change fixtures.

Expected corrected orders:

```text
Evidence change:
R6 -> R7 -> R8_CORE_HEALTH -> R9 -> R10

Market data change:
R8_PORTFOLIO_RISK -> R8_EXIT_INTELLIGENCE -> R9 -> R10
```

No provider call, migration, scheduler activation, production mutation or deterministic R6-R10 execution occurred during discovery or correction.

D1 remains **LOCAL VALIDATION PENDING** until this fix is pulled and the fixtures are rerun.


### D1 local-ledger invalidation hardening — 25 September 2026

After the stage-order correction, the local automated D1 test passed 10/10, but the browser ledger could still display pre-fix completed records because D1 semantic job identities are deterministic and the disposable browser state key had not changed.

Hardening applied:

- D1 local orchestration contract version bumped to `PROGRAM_D_D1_LOCAL_ORCHESTRATION_V2`;
- disposable browser key bumped to `portfolioai.program-d.d1.local-orchestration.v2`;
- stale V1 browser state is rejected and replaced by an empty V2 state;
- a regression test now locks the V2 key and stale-state rejection behavior.

This is local disposable UI/runtime state only. No Supabase persistence, migration, provider call, scheduler, production mutation or Program C semantic change is involved.


### D1 targeted-lint correction — 25 September 2026

The full D1/D0/Program C regression set passed 83/83 tests across 7 files. Targeted ESLint then found one D1-local issue in `programD1Planner.ts`: an unnecessary readonly-array type assertion in `uniqueSorted`.

The assertion was removed without changing runtime semantics. No unrelated lint debt was touched.

D1 remains local-validation pending until the corrected HEAD is pulled and the remaining validation commands pass.


---

## Program D · D1 Full Local Validation — PASS / AWAITING OWNER CLOSURE — 25 September 2026

The owner completed local validation of the D1 R11 local/provider-free orchestration package.

### Exact validated behavior

The Operations UI was reviewed locally and the four frozen D1 fixtures were executed after correction of the stage-ordering defect and local-ledger version hardening.

Validated stage routing:

```text
UNCHANGED_INPUT_NO_OP
  state = NO_OP
  reason = UNCHANGED_CANONICAL_DEPENDENCY_FINGERPRINT

CANONICAL_EVIDENCE_ACCEPTED
  R6 -> R7 -> R8_CORE_HEALTH -> R9 -> R10

CONDITION_STALENESS
  R6 -> R7 -> R8_CORE_HEALTH -> R9 -> R10
  TRENDLYNE FUNDAMENTALS = 1 estimated / 0 executed

MARKET_DATA_ACCEPTED
  R8_PORTFOLIO_RISK -> R8_EXIT_INTELLIGENCE -> R9 -> R10
```

All visual runs preserved:

```text
physical provider calls = 0
automatic R6-R10 execution = 0
production writes = 0
```

### Automated validation

```text
D1/D0/Program C regression suite
  7 test files passed
  83 / 83 tests passed

D1 runtime suite
  includes semantic identity, no-op, provider-plan zero-call,
  duplicate-trigger dedupe, lease contention, restart/resume,
  topological stage order, routed-event scope and safety invariants

Targeted D1 ESLint
  PASS

TypeScript
  npm run typecheck
  PASS

Architecture guard
  npm run check:architecture
  PASS

Production build
  npm run build
  PASS
  existing Vite chunk-size warning only

git diff --check
  PASS

Local working-tree audit
  PASS
  no tracked D1 drift
  pre-existing untracked local artifacts remain untouched:
    PORTFOLIOAI_CURRENT_STATE_AUDIT.md
    PORTFOLIOAI_LUI1_LOCAL_FIXTURE.sql
    PORTFOLIOAI_LUI1_LOCAL_FIXTURE_V2.sql
    artifacts/
```

### D1 corrections discovered during localhost validation

1. **Stage ordering defect**
   - root cause: affected nodes were alphabetically sorted;
   - correction: affected nodes now follow frozen dependency-matrix order;
   - regression test added.

2. **Stale disposable browser-ledger reuse**
   - root cause: pre-fix semantic runs could survive in the V1 localStorage key;
   - correction: D1 local orchestration state bumped to V2 and stale V1 state is rejected;
   - regression test added.

3. **Targeted lint issue**
   - unnecessary type assertion removed from `programD1Planner.ts`;
   - no runtime semantic change.

### D1 safety audit

```text
Trendlyne calls = 0
Angel One calls = 0
AI calls = 0
other provider calls = 0
automatic R6-R10 execution = false
migration creation/application = 0
Supabase operational persistence = 0
R9 durable checkpoint persistence = 0
R10 snapshot persistence = 0
scheduler activation = 0
production mutation = 0
merge/deployment = 0
notifications = 0
numeric sizing authority = NONE
trading = 0
```

### D1 checkpoint status

```text
D0 = COMPLETE / PASS / CLOSED
D1 = COMPLETE / PASS / AWAITING OWNER CLOSURE
D2 = NOT AUTHORIZED
D3 = NOT AUTHORIZED
D4 = NOT AUTHORIZED
D-FINAL = NOT AUTHORIZED
```

D1 completion does not authorize D2. A real bounded provider pilot or any D2 adversarial/pilot-readiness work requires a separate explicit owner authorization.


---

## Program D · D1 OWNER CLOSURE / D2 AUTHORIZATION — 25 September 2026

Owner decision:

```text
D0 = COMPLETE / PASS / CLOSED
D1 = COMPLETE / PASS / CLOSED
D2 = AUTHORIZED
D3 = NOT AUTHORIZED
D4 = NOT AUTHORIZED
D-FINAL = NOT AUTHORIZED
```

The owner accepted the fully validated D1 result and explicitly authorized D2 — R11 Validation & Bounded-Pilot Readiness.

D2 scope is limited to adversarial validation and readiness work required by the frozen master plan:

- trigger determinism;
- semantic idempotency;
- duplicate suppression;
- lease race and stale-lease behavior;
- kill-switch enforcement;
- provider-budget blocking;
- bounded retry behavior;
- partial acceptance;
- recovery/resume;
- unchanged-input no-op;
- dependency-matrix routing;
- recursive-trigger guard;
- stale-domain-only refresh planning;
- incremental history planning;
- no owner mutation;
- no trade/order path;
- audit completeness;
- Program C regression;
- R9 baseline semantics;
- R10 authority preservation.

A real bounded provider pilot remains a separate owner gate **inside D2** and is not authorized by this transition.

Still not authorized:

```text
real provider pilot = NOT AUTHORIZED
Trendlyne physical calls = NOT AUTHORIZED
Angel One physical calls = NOT AUTHORIZED
migration creation/application = NOT AUTHORIZED
R9 durable checkpoint persistence = NOT AUTHORIZED
R10 operational snapshot persistence = NOT AUTHORIZED
scheduler enablement = NOT AUTHORIZED
automatic production R6-R10 recomputation = NOT AUTHORIZED
production mutation = NOT AUTHORIZED
R12 / AI = NOT AUTHORIZED
notifications = NOT AUTHORIZED
merge/deployment = NOT AUTHORIZED
trading = NOT AUTHORIZED
```

Program C remains frozen.


---

## Program D · D2 R11 Adversarial Validation + Bounded-Pilot Readiness — IMPLEMENTED / LOCAL VALIDATION PENDING — 25 September 2026

D1 is formally closed and D2 was explicitly authorized by the owner.

The D2 local/provider-free adversarial validation package is now implemented on the Program D branch.

Authoritative D2 implementation record:

```text
docs/PortfolioAI_PROGRAM_D_D2_R11_ADVERSARIAL_VALIDATION_READINESS.md
```

### Implemented D2 validation coverage

- trigger determinism;
- semantic idempotency and duplicate suppression;
- lease-race fail-closed behavior;
- expired/stale local lease recovery;
- global/provider/domain kill switches;
- provider-budget blocking;
- bounded transient retry / retry exhaustion;
- mixed provider outcomes remain PARTIAL;
- partial deterministic recovery/resume;
- unchanged-input no-op;
- dependency/topological routing;
- recursive-trigger generation guard;
- stale-domain-only acquisition planning;
- incremental market-history planning through the existing Program A planner;
- no owner mutation;
- no trade/order path;
- operational audit completeness;
- R9 Model-B baseline semantics preserved;
- R10 recomputation authority preserved;
- zero physical provider-call invariant.

### Bounded-pilot readiness boundary

D2 defines a readiness contract only:

```text
status = READY_FOR_OWNER_AUTHORIZATION
realProviderExecutionAuthorized = false
```

A future real provider pilot still requires separate explicit owner approval of:

```text
EXACT_PROVIDER
EXACT_SECURITIES
EXACT_DOMAINS
EXACT_PHYSICAL_CALL_CEILING
EXACT_BUDGET_CEILING
MANUAL_START
POST_RUN_REVIEW
```

No real provider call is authorized by D2 implementation or readiness status.

### Operations UI

The authenticated `/app/operations` page now includes:

- D2 adversarial validation runner;
- PASS/FAIL validation cards;
- bounded-pilot readiness panel;
- explicit Real provider execution = Not authorized;
- existing D1 local fixture runner and disposable ledger.

### D2 safety state

```text
Trendlyne physical calls = 0
Angel One physical calls = 0
AI calls = 0
real provider pilot = NOT AUTHORIZED
automatic production R6-R10 execution = false
migration = 0
Supabase orchestration persistence = 0
R9 durable checkpoint persistence = 0
R10 operational snapshot persistence = 0
scheduler activation = 0
production mutation = 0
merge/deployment = 0
trading = 0
```

### Current checkpoint

```text
D0 = COMPLETE / PASS / CLOSED
D1 = COMPLETE / PASS / CLOSED
D2 = IMPLEMENTED ON GITHUB / LOCAL VALIDATION PENDING
D3 = NOT AUTHORIZED
```

Next workflow step: pull the exact Program D branch to the Mac, run the D2 adversarial matrix in the Operations UI, then execute the D2/D1/D0/Program C local validation suite. A real provider pilot remains separately gated.


---

## Program D · D2 Full Local Validation — PASS / AWAITING OWNER CLOSURE — 25 September 2026

The owner completed the full D2 local/adversarial validation cycle and reported all remaining validation commands PASS.

### Localhost adversarial matrix

The D2 Operations UI was run locally and every adversarial card passed, including:

```text
Trigger determinism = PASS
Semantic idempotency / duplicate suppression = PASS
Lease race = PASS
Stale-lease recovery = PASS
Global / provider / domain kill switches = PASS
Provider budget = PASS
Bounded retry = PASS
Partial provider acceptance = PASS
Partial acceptance / recovery = PASS
Unchanged-input no-op = PASS
Dependency-matrix routing = PASS
Recursive-trigger guard = PASS
Stale-domain-only refresh = PASS
Incremental history planning = PASS
No owner mutation = PASS
No trade/order path = PASS
Audit completeness = PASS
R9 baseline semantics = PASS
R10 authority preservation = PASS
Zero real provider calls = PASS
```

### Full local validation

The owner reported all required D2 validation commands PASS:

```text
D2/D1/D0/Program C regression suite = PASS
Targeted D2 ESLint = PASS
TypeScript = PASS
Architecture guard = PASS
Production build = PASS
git diff --check = PASS
Local working-tree audit = PASS
```

The production build again showed only the existing Vite chunk-size warning.

The local working tree continued to show only the same pre-existing untracked local artifacts, which remain untouched:

```text
PORTFOLIOAI_CURRENT_STATE_AUDIT.md
PORTFOLIOAI_LUI1_LOCAL_FIXTURE.sql
PORTFOLIOAI_LUI1_LOCAL_FIXTURE_V2.sql
artifacts/
```

### D2 / R11 safety audit

```text
Trendlyne physical calls = 0
Angel One physical calls = 0
AI calls = 0
other external provider calls = 0
real bounded provider pilot = NOT RUN / NOT AUTHORIZED
automatic production R6-R10 execution = false
migration creation/application = 0
Supabase orchestration persistence = 0
R9 durable checkpoint persistence = 0
R10 operational snapshot persistence = 0
scheduler activation = 0
production mutation = 0
notifications = 0
merge/deployment = 0
numeric sizing authority = NONE
trading = 0
```

### Bounded-pilot readiness

The D2 package is validated as **READY_FOR_OWNER_AUTHORIZATION** for a future separately authorized bounded provider pilot.

That readiness status is not provider-call authority.

A future real pilot still requires a separate explicit owner decision specifying:

```text
EXACT_PROVIDER
EXACT_SECURITIES
EXACT_DOMAINS
EXACT_PHYSICAL_CALL_CEILING
EXACT_BUDGET_CEILING
MANUAL_START
POST_RUN_REVIEW
```

### D2 / R11 checkpoint status

```text
D0 = COMPLETE / PASS / CLOSED
D1 = COMPLETE / PASS / CLOSED
D2 = COMPLETE / PASS / AWAITING OWNER CLOSURE

R11 = COMPLETE / PASS / AWAITING OWNER CLOSURE

real bounded provider pilot = NOT RUN / NOT AUTHORIZED
D3 = NOT AUTHORIZED
D4 = NOT AUTHORIZED
D-FINAL = NOT AUTHORIZED
```

D2 closure does not authorize D3/R12 and does not authorize a real provider pilot. Both remain separate owner decisions.


---

## Program D · D2 / R11 OWNER CLOSURE / D3 AUTHORIZATION — 25 September 2026

Owner decision:

```text
D0 = COMPLETE / PASS / CLOSED
D1 = COMPLETE / PASS / CLOSED
D2 = COMPLETE / PASS / CLOSED
R11 = COMPLETE / PASS / CLOSED
D3 = AUTHORIZED
D4 = NOT AUTHORIZED
D-FINAL = NOT AUTHORIZED
```

The owner accepted the fully validated D2/R11 result and explicitly authorized D3 — Optional R12 Local Implementation.

D3 is authorized only for bounded, on-demand, local/mocked R12 implementation.

The D3 provider/cost ceiling is frozen for this checkpoint as:

```text
AI provider mode = LOCAL_MOCK_ONLY
external AI calls = 0
external AI cost = 0
scheduled AI = NOT AUTHORIZED
portfolio-wide event-driven AI = NOT AUTHORIZED
```

This local zero-cost ceiling satisfies the D3 implementation entry without authorizing a real AI-provider pilot. Any real cost-bearing AI call remains a separate owner gate no earlier than D4.

D3 scope includes:

- immutable/versioned deterministic fact packet;
- strict fact-packet schema/type validation;
- typed FACT / DETERMINISTIC_STATE / OWNER_CONTEXT / UNCERTAINTY / SOURCE_EXCERPT inputs;
- local/mock on-demand narrative generation;
- packet-hash + prompt-version cache identity;
- local bounded cost/token/concurrency controls;
- strict output schema;
- citation/provenance validation;
- unsupported-number/fact rejection;
- authority-conflict rejection;
- explicit deterministic-vs-AI UI separation;
- local Investment Committee workspace or equivalent bounded UI.

Still not authorized:

```text
real AI provider call = NOT AUTHORIZED
real AI cost/spend = NOT AUTHORIZED
scheduled AI = NOT AUTHORIZED
weekly selected-scope AI = NOT AUTHORIZED
production AI persistence = NOT AUTHORIZED
migration = NOT AUTHORIZED
scheduler = NOT AUTHORIZED
production mutation = NOT AUTHORIZED
R6-R10 dependency on AI = PROHIBITED
R10 reprioritization by AI = PROHIBITED
numeric sizing authority = NONE
trade/order instruction = PROHIBITED
merge/deployment = NOT AUTHORIZED
```

The real bounded provider pilot for R11 also remains NOT RUN / NOT AUTHORIZED and is not implied by R11 closure.
